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Abstract 
Background: Several studies have supported a beneficial role of dietary flavonoids in 
reducing the risk/progression of chronic diseases (including hypertension, cardiovascular 
disease, certain cancers, type-2-diabetes, cognitive dysfunction, age-related bone disease). 
Their beneficial properties are likely to be affected by their structure, distribution in foods, 
food matrix, life habits (physical activity). Most dietary polyphenols reach the colon where 
they are metabolized to phenolic acids by gut bacteria.  Lack of knowledge of the factors 
affecting flavonoid metabolism and bioavailability hinders understanding of their health 
effects. Therefore, this thesis aimed to investigate the effect of factors on bioavailability and 
metabolism of dietary polyphenols from orange juices (OJ) in in vitro and in vivo studies.  
Studies: In chapter 3, the variability of orange juice polyphenolic content was assessed. In 
addition, in vitro models of the human gastrointestinal tract were used to evaluate the release 
and metabolism of flavanones from orange juices (smooth OJ and OJ with pulp ‘bits’).  There 
was no difference in fibre content between smooth OJ and OJ ‘with bits’. Total phenols were 
significantly higher in OJ ‘with bits’ than smooth OJ (225.9 ± 16.7 µg GAE/ml vs. 208.4 ± 
10.7 µg GAE/ml, p < 0.05). Hesperidin content correlated with total flavonoids (Pearson 
correlation coefficient = 0.67) and antioxidant capacity (Pearson correlation coefficient = 
0.86).  Hesperidin in smooth OJ was more stable in gastric fluid than OJ ‘with bits’ (28.6 ± 
1.3 mg/250 ml vs. 22.0 ± 0.6 mg/250 ml, p < 0.05). In the small intestine model, Hesperidin 
and narirutin were similar in the small intestinal phase. However, narirutin decreased in both 
juices (OJ; p < 0.018 and OJ with bits (p < 0.009). Total phenolic content decreased to 104.1 
± 13.5 mg GAE/250 ml and 112.3 ± 0.6 mg GAE/250 ml respectively, and antioxidant 
capacity decreased by 56.1 % and 41.6 %. In the fermentation model hesperidin was higher 
for smooth OJ at 2 h (89.6 ± 9.5 µM vs. 77.1 ± 8.9 µM, p< 0.05). There was higher 
production of 3, 4-dihydroxyphenylpropionic acid at 6 h with OJ ‘with bits’ (8.6 ± 2.8 µM vs. 
3.4 ± 1.6 µM, p < 0.05). pH reduced to 4.5 after 24 h fermentation with OJ. However, there 
was no change of total phenol and antioxidant capacity.   
In chapter 4, to explain previously published data of reduced  urinary phenolic acids after OJ 
and yoghurt (Y) in humans compared to OJ alone, (Roowi et al., 2009a),  in vitro models of 
the human gut were used. OJ or OJ with bits and Y were subjected to gastric, small intestinal 
and colonic phases. Hesperidin was increased by 1.5 fold in OJ and 1.8 fold in OJ bits after 
gastric digestion and by 1.4 fold in OJ bits after the small intestinal digestion with Y. In 
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addition, Y increased four phenolic acids (3, 4-dihydroxyphenylacetic acid, 3-hydroxy-4-
methoxyphenyl propionic acid, 3-methoxy-4-hydroxyphenyl propionic acid, 3, 4-
dihydroxyphenylpropionic acid) from 0.6 ± 0.0 mM to 6.1 ± 2.0 mM in the upper GI 
digestion with OJ bits. FY significantly increased four phenolic acids in OJ during upper GI 
digestion compared with Y and PY, but did increase phenolic acids in OJ bits compared with 
PY. Hesperidin degradation reached 44 ± 11 % and 39 ± 15 % respectively from OJ and OJ 
bits with Y after 24 h fermentation. However, Y did not affect hesperetin, naringenin and 
phenolic acids. On the other hand, Y increased total phenolic contents from 104.1 ± 13.5 mg 
GAE/250 ml to 339.4 ± 1.5 mg in OJ and from 112.3 ± 0.6 mg to 352.4 ± 12.0 mg in OJ bits 
after upper GI digestion (p < 0.05). This does not explain the results of the human study.  In 
chapter 5, raftiline (1g /50 ml; selectively used by bacteria) and glucose (0.5/50ml; used by a 
wide range of bacteria) were tested for effects on metabolism of hesperidin (flavanone not 
OJ). Raftiline reduced the metabolism of hesperidin by gut bacteria. Hesperidin recovery was 
35.2 ± 4.1 µM and 27.6 ± 6.1 µM after 24 h fermentation with or without raftiline 
respectively and 0.4 ± 0.2 µM and 0.2 ± 0.1 µM of hesperetin production. Raftiline 
significantly decreased phenolic acids from 220.3 ± 46.8 µM to 126.6 ± 44.1 µM (p < 0.05). 
However, glucose had no effect on phenolic acids at 24h but increased production from 38.0 
± 6.8 µM to 62.1 ± 11.0 µM at 4 h fermentation (p < 0.02) suggesting increased rate of 
metabolism rather than increased total production.  Dietary fibre inhibited degradation 
production of phenolic acids which may change flavanone metabolites in the colon.  In 
chapter 6 after published cross-sectional studies suggested that athletes had different 
flavonoid bioavailability to sedentary individuals, an intervention study of 4 weeks moderate 
intensity exercise determined whether exercise affected bioavailability and metabolism of OJ 
flavanones in healthy sedentary females. Hesperetin metabolites significantly decreased in 
urine over 0-5 h after juice consumption (21.6 ± 2.8 µmol vs. 14.0 ± 2.0 µm, p < 0.05). 
Hesperidin glucuronide significantly reduced from 10.4 ± 2.9 µmol to 6.2 ± 1.7 µmol after 4 
weeks exercise (p < 0.02), and 3’-hydrophenylacetic acid reduced from 11.8 ± 3.4 µmol to 
6.0 ± 2.3 µmol (p < 0.05). Mouth to caecum transit time was prolonged from 3.0 ± 0.2 h to 
4.5 ± 0.7 h after exercise. Thus, 4 weeks exercise decreased bioavailability of OJ flavanones 
probably affecting transit time, but not colonic metabolism of all flavanone metabolites. 
Conclusion: The studies in this thesis showed that food sources, food matrix and physical 
exercise may determine the significant variations in bioavailability and metabolism of 
flavonoids, seen in a number of studies. These factors could result in differences in 
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bioactivity and bioefficacy of polyphenols, and need to be taken into account in further 
studies of the effects of flavanones on disease risk. 
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1.1 Orange juice and Health 
Consumption of fruits and vegetables has been reported to reduce the risk of non-
communicable diseases such as cardiovascular disease and cancer (WHO, 2014). Fruits and 
their juices have been increasingly considered an integral part of a healthy diet (Niva, 2007), 
although juice is not recommended due to its high sugar content (Malik et al., 2006). The 
WHO report (2015) recommended adults and children to have restrict free sugars to less than 
10 % of their total energy intake (Organization, 2015). In the recent SACN report (2015) 
which used more stringent criteria for evidence, the conclusions on the relationship of sugar 
containing drinks with chronic disease such as obesity and type II diabetes were less definite 
but it was recognised that increasing sugar intake increases energy intake in individuals and 
there is increasing evidence for effects on dental caries and some chronic disease. They 
recommend that “the population average of free sugars should not exceed 5% of total dietary 
energy for age groups from 2 years upwards” and “the consumption of sugars-sweetened 
beverages should be minimised, in both children and adults” (SACN, 2015). From 2000 to 
2013, over 10 billion litres of fruit juice and nectar were consumed in the European Union 
(European Fruit Juice Association 2014 Market Report). By 2019, intake is expected to 
stabilize at about 9 billion litres consumed by EU countries, among which Germany, France, 
the UK, Spain and Poland are the top five markets (European Fruit Juice Association 2014 
Market Report) (Figure 1-1).  
 
 
Figure 1-1 Total EU fruit juice and nectar consumption from 1989 to 2019e 
 (Source: European Fruit Juice Association 2014 Market Report) 
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These fruits and juices are a source of polyphenols that have been shown to have anti-
inflammatory (Coelho et al., 2013, Jung et al., 2009, Marchi et al., 2014, Murakami et al., 
2000), anti-oxidative (Dussossoy et al., 2011, Kuntz et al., 2014), anti-hypertensive (Asgary 
et al., 2014), and lipid-lowering actions (Aptekmann and Cesar, 2013, Ravn-Haren et al., 
2013) in clinical and experimental studies and their consumption has been associated with 
reduced risk of chronic diseases in epidemiological studies, such as cardiovascular disease 
(Bahorun et al., 2012, Lai et al., 2015), some cancers (Gates et al., 2007, Kolonel et al., 2000, 
Simons et al., 2009, Zamora-Ros et al., 2014), type 2 diabetes (Jacques et al., 2013, Wedick 
et al., 2012), Parkinson disease(Gao et al., 2012), and aging (Maras et al., 2011). 
 
Figure 1-2 Market share of fruit juice in the United Kingdom in 2013 
 (Zenith International Statista 2014) 
Orange juice is a key source of fruit juice rich in flavonoids, especially flavanones (Kelebek 
et al., 2009) (Figure 1-3). Flavanones have been shown to have the properties mentioned 
above in clinical and experimental studies, and consumption of orange juice has been 
associated with reduced risk of chronic diseases in epidemiological studies. For example, 
consumption of orange juice or flavanone intake has been associated with reduced risk of 
cardiovascular diseases and mortality (Mink et al., 2007b, Vinson et al., 2002), certain 
cancers (colon and ovarian cancer (Cassidy et al., 2014, Miyagi et al., 2000), enhanced 
cognitive function (Kean et al., 2015b), modulated inflammatory markers, such as 
interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α) and monocyte chemoattractant 
protein-1 (MCP-1) (Choi and Lee, 2010), interleukin-6 (IL-6), interleukin-8 (IL-8), 
interleukin-10 (IL-10), inactivated nuclear factor-kappaB and mitogen-activated protein 
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kinases (Park et al., 2012), reduced diastolic blood pressure and  LDL-cholesterol 
(Aptekmann and Cesar, 2013), improved postprandial microvascular endothelial reactivity 
(Morand et al., 2011), and increased antioxidant capacity (Constans et al., 2014, Rangel-
Huerta et al., 2015b), inhibited bone loss and decreased serum and hepatic lipids (Chiba et al., 
2003), affected leukocyte gene expression (Milenkovic et al., 2011). The evidence for these 
potential actions is discussed in detail later in this chapter (Section 1.9.2 and Tables 1-4, 1-5).  
Thus ingestion of orange juice may be a good way to prevent disease but we need to ensure 
the most efficient effects without increasing sugar intake which may instead increase risk, 
since caloric intake has been linked to oxidative and inflammatory stress (Dandona et al., 
2010). Thus this thesis explores factors, such as food source, food matrix and physical 
activity, which influence the bioavailability of flavonoids from orange juice and their 
resultant phenolic acids produced in the gut to potentially enhance benefits of orange juice 
flavanones in human health.    
1.2 Flavonoids 
Plant polyphenols are common secondary metabolites involved in inhibition of pathogens and 
predators in plants (Bravo, 1998), and protection of the plant from other damaging exposures 
(Sharma et al., 2012). Flavonoids are the most studied due to their bioactive properties in 
humans, and belong to one subclass of polyphenols with common structural features (C15 
phenylchromane core, composed of a C6-C3-C6 backbone) (Figure 1-3). Fruits, vegetables, 
grains and their processed products are main sources of flavonoids in the human diet 
(Middleton Jr, 1998). These flavonoids are categorized into subclasses based on their 
molecular structure. Main sources of specific flavonoids are illustrated in Table 1-1.  
 
Figure 1-3 General structure of flavonoids 
 (Cook and Samman, 1996a). 
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Table 1-1 Structures and food sources of flavonoids 
Flavonoids Structure Compounds Source 
Flavonols 
 
Keampferol (R2=OH) 
Quercetin (R1=R2=OH) 
Isorhamnetin 
(R1=OCH3, R2=OH) 
Myricetin 
(R1=R2=R3=OH) 
Leak, Broccoli, 
Lettuce, Tomato, 
Blueberry, black 
currant, Apple, Beans, 
Red wine 
Flavones 
 
Apigenin (R2=OH) 
Luteolin (R1=R2=OH) 
Parsley, Celery 
Isoflavones 
 
Daidzein (R1=H) 
Genistein (R1=OH) 
Glycitein (R1=OCH3) 
Soybean 
Flavanones 
 
Hesperetin (R1=OH, 
R2=OCH3) 
Naringenin (R2=OH); 
Eriodictyol (R1=R2=OH) 
Citrus fruits and juices 
Anthocyanidins 
 
Cyanidin (R1=OH) 
Pelargonidin 
(R1=R2=H) 
Peonidin (R1=OCH3) 
Dlphinidin (R1=R2=OH) 
Petunidin 
(R1=OCH3,R2=OH) 
Malvidin 
(R1=R2=OCH3) 
Blackberry, Blueberry, 
Black grape, Cherry, 
Rhubarb, Strawberry, 
Plum, Red wine, 
Cocoa 
Flavan-3-ols 
 
Catechin 
Epicatechin 
Cocoa, Grape, Peach 
Apricot, Apple, 
Blackberry, Green tea, 
Black tea, Red wine, 
Cider 
Table was drawn based on previous studies (Tripoli et al., 2007b, Manach et al., 2004)     
Flavonoids are usually present in food as glycosides. The common sugar moieties include D-
glucose and L-rhamnose. O-glycosides are major glycosides bound to the hydroxyl group at 
C-7 or C-3. The sugar moiety influences absorption and bioavailability of flavonoids in the 
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host. Quercetin glucoside was 20 times higher than quercetin rutinoside in terms of maximal 
concentration of quercetin (Cmax) in plasma, and 10 times faster to reach Cmax (Tmax) in men, 
and bioavailability of quercetin rutinoside was 5 times lower than quercetin glucoside 
(Hollman et al., 1999).  Some researchers have applied enzymatic treatments to enhance the 
bioavailability. For example, bioavailability as measured by urinary excretion of flavanone 
metabolites was increased from 7 % to 47 % by treatment of orange juice with α-
rhamnosidase (Bredsdorff et al., 2010). The concentration of hesperetin metabolites in plasma 
was enhanced by two fold in humans through treatment of orange juice with hesperidinase 
(Nielsen et al., 2006a). 
1.2.1 Flavanones in citrus fruits and juices 
Citrus fruits and juices contain several potentially bioactive molecules including vitamin C, 
folate, dietary fibre and flavonoids, especially flavanones (Tripoli et al., 2007a). It is 
important to consider potential confounding factors when studying possible effects of 
flavonoids on health. The most abundant flavanone is hesperidin, followed by narirutin and 
didymin, which are conjugated with rutinosides (Gattuso et al., 2007). Other flavanones are 
found in very low concentration. Hesperidin and narirutin are naturally present as hesperetin-
7-O-rutinosides and naringenin-7-O-rutinosides (Figure 1-4).  
Citrus peel and seeds also contain a great number of phenolic acids and flavonoids (Molina-
Calle et al., 2015),including non-extractable polyphenols that are closely associated with cell 
wall constituents (polysaccharides and protein) (Arranz et al., 2010, Hasni et al., 2011, 
Yuksel et al., 2010), and are not easier to detect by the usual analytical procedures (Perez-
Jimenez et al., 2013). Hesperidin and narirutin are abundant in common sweet oranges 
(Sawalha et al., 2009). Their chemical structures are illustrated in Figure 1-4. Lemon juices 
and sour oranges contain more eriocitrin and neoeriocitrin respectively (Sawalha et al., 2009). 
Flavanone rutinosides are tasteless, whereas flavanone neohesperidoside, such as hesperetin-
7-O-neohesperidoside (neohesperidin) in bitter orange and naringenin-7-O-neohesperidoside 
(naringin) in grapefruit, are intensely bitter (Tomás‐Barberán and Clifford, 2000). Bitterness 
of grapefruit fruits and juices is attributed to naringin and neohesperidin (Davis, 1947, Fisher 
and Wheaton, 1976).   
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Figure 1-4 Structures of hesperetin and naringenin glycosides 
 (Wei et al., 2004). 
 
1.3 Phenolic acids 
Phenolic acids (Figure 1-5 A), including benzoic acid derivatives and cinnamic acid 
derivatives, are present in plants, such as p-coumaric acid (4-hydroxycinnamic acid), caffeic 
acid (3,4-dihydroxycinnamic acid), ferulic acid (4-hydroxy-3-methoxycinnamic acid), and 
sinapic acid (4-hydroxy-3,5-dimethoxycinnamic acid) and their esters with quinic and tartaric 
acids (chlorogenic, caftaric, etc.) (Manach et al., 2004), but are also metabolites produced in 
the body from polyphenols.  
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Figure 1-5 Phenolic acids in plants (A) and in biological fluids (B) derived from flavonoids by 
gut microbiota 
(Manach et al., 2004, Crozier et al., 2010). 
Phenolic acids identified in biological fluids (urine, plasma) as metabolites after ring fission 
of flavonoids by the gut microbiota, include phenylpropionic acids, phenylacetic acids, 
benzoic acids and hippuric acids (Figure 1-5 B) (Serra et al., 2011, Crozier et al., 2010, Lafay 
and Gil-Izquierdo, 2008, Tsao, 2010). 
Colonic transformations of flavonoids into phenolic acids have been widely investigated. 
Most of these studies focused on in vitro incubation of specific flavonoids with human gut 
bacteria considering ring-cleavage, decarboxylation, demethylation, and dehydroxylation 
reactions (Selma et al., 2009, Aura, 2008, Laparra and Sanz, 2010, Rechner et al., 2002) 
(Table 1-2). For example, Selma et al showed that quercetin could be degraded into 2-(3,4-
dihydroxyphenyl)acetic acid, 2-(3-hydroxyphenyl)acetic acid and 3,4-dihydroxybenzoic acid 
from the B ring, 3-(3,4-dihydroxyphenyl) propionic acid and 3-(3-hydroxyphenyl)propionic 
acid (Selma et al., 2009). Myricetin can be transformed into 2-(3,5-dihydroxyphenyl)acetic 
acid, 2-(3-hydroxyphenyl)acetic acid, and 2-(3,4,5-trihydroxyphenyl)acetic acid, and 
kaempferol was mainly degraded into 2-(4-hydroxyphenyl)acetic acid (Rechner et al., 2002). 
Phloroglucinol, 3-(3,4-dihydroxyphenyl)propionic acid and 3-(m-hydroxyphenyl)propionic 
acid were derived from naringin by human colonic microflora, while 3-hydroxyphenylacetic 
acid and 3-(3-hydroxyphenyl)-propionic acid was the major phenolic end products from rutin 
(Rechner et al., 2004). 2-(p-hydroxyphenyl)acetic acid, 2-(p-hydroxyphenyl)-propionic acid, 
A 
B 
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2-(m-hydroxyphenyl)acetic acid, 2-(m-hydroxyphenyl)propionic acid, 5-(m-
hydroxyphenyl)valeric acid, and phenylpropionic acid were found by incubation of 
proanthocyanidins with human gut bacteria (Déprez et al., 2000). 2,4-dihydroxyphenylacetic 
acid, resorcinol and phlorogpucinol  were found in fermentation of hesperidin by gut bacteria 
(Kim et al., 1998).  (−)-Epicatechin and (+)-catechin could be degraded into 5-(3′,4′-
dihydroxyphenyl)-γ-valerolactone, 5-phenyl-γ-valerolactone, and 3-phenylpropionic acid by 
human gut mictrobiota (Tzounis et al., 2008). Pyrogallol, 5-(3,4-dihydroxyphenyl)valeric 
acid, 5-(3-hydroxyphenyl)valeric acid, 3-(3,4-dihydroxyphenyl)propionic acid, 3-(3-
hydroxyphenyl)propionic acid, 3-(3-methoxyphenyl)valeric acid, and 2,3-dihydroxyphenoxyl 
3-(3′,4′-dihydroxyphenyl)propionic acid were derived from epicatechin by human intestinal 
bacteria (Meselhy et al., 1997). Caffeic acid was degraded into 3-hydroxyphenylpropionic 
acid and benzoic acid (Gonthier et al., 2006).  
1.4 Metabolism of flavonoids 
The bioavailability of flavonoids is an important factor determining their bioactivity and 
beneficial effects in cells and tissues (Silberberg et al., 2005). It is important to understand 
how the flavonoids are absorbed and metabolised in the gut and the form which reaches the 
systemic blood and tissues (Figure 1-5). The bioavailability of flavonoids has been 
investigated by measuring metabolites in plasma and urine, and flavonoid metabolites in 
tissues in animal models (Mullen et al., 2002, Suganuma et al., 1998, El Mohsen et al., 2006). 
Furthermore, the ranges from 11.7 % of peonidin-3, 5-O-diglucoside to 103.3 % of catechins 
and epicatechins in ileal fluid after ingesting a juice drink containing a diversity of dietary 
(poly)phenols derived from green tea, apples, grapes and citrus fruit by ileostomists (Borges 
et al., 2013), indicated that less anthocyanidins and more catechins could reach the colon. 
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Table 1-2 Phenolic metabolites produced from flavonoids 
Flavonoids Evidence Parent 
Compound 
Metabolites (phenolic acids) produced by 
colonic bacteria. 
    
Flavonols (Rechner et al., 
2002) 
Kaempferol 2-(4-Hydroxyphenyl)acetic acid 
(Selma et al., 2009) Quercetin 2-(3,4-Dihydroxyphenyl)acetic acid, 
2-(3-Hydroxyphenyl)acetic acid, 
3,4-Dihydroxybenzoic acid, 
3-(3,4-Dihydroxyphenyl) propionic acid 
3-(3-Hydroxyphenyl)propionic acid 
(Rechner et al., 
2002) 
Myricetin 2-(3,5-Dihydroxyphenyl)acetic acid,  
2-(3-Hydroxyphenyl)acetic acid, 
2-(3,4,5-Trihydroxyphenyl)acetic acid 
(Rechner et al., 
2004) 
Rutin 3-Hydroxyphenylacetic acid  
3-(3-Hydroxyphenyl)-propionic acid 
Flavanones (Kim et al., 1998) Hesperidin 2,4-Dihydroxyphenylacetic acid, 
 resorcinol  
Phlorogpucinol 
(Rechner et al., 
2004) 
Naringin Phloroglucinol,  
3-(3,4-Dihydroxyphenyl)propionic acid  
3-(m-hydroxyphenyl)propionic acid 
Anthocyanidins (Déprez et al., 
2000) 
Pro 
anthocyanidin 
2-(p-hydroxyphenyl)acetic acid,  
2-(p-hydroxyphenyl)-propionic acid,  
2-(m-hydroxyphenyl)acetic acid, 
2-(m-hydroxyphenyl)propionic acid,  
5-(m-hydroxyphenyl)valeric acid,  
phenylpropionic acid 
(Aura et al., 2005) Cyanidin-3-
glucoside 
2,4,6-Trihydroxybenzaldehyde, 
4-Hydroxybenzoic acid,  
2,4,6-Trihydroxybenzoic acid,  
4-Hydroxyphenylacetic acid  
3,4-Dihydroxyphenylacetic acid 
Flava-3-ol (Tzounis et al., 
2008) 
(−)-Epicatechin 
(+)-Catechin 
5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone,  
5-Phenyl-γ-valerolactone,  
3-Phenylpropionic acid 
(Meselhy et al., 
1997) 
Epicatechin Pyrogallol,  
5-(3,4-Dihydroxyphenyl)valeric acid, 
 5-(3-Hydroxyphenyl)valeric acid,  
3-(3,4-Dihydroxyphenyl)propionic acid,  
3-(3-Hydroxyphenyl)propionic acid, 
 3-(3-Methoxyphenyl)valeric acid, 
 2,3-Dihydroxyphenoxyl propionic acid, 
3-(3′,4′-Dihydroxyphenyl)propionic acid 
Phenolic acid (Gonthier et al., 
2006) 
Caffeic acid 3-hydroxyphenylpropionic acid  
Benzoic acid 
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Flavonoid glycosides are cleaved off by acids or enzymes (mainly β-glucosidases) in the GI 
tract or by gut bacteria (Erlund et al., 2001b, Landete, 2012, Nmeth et al., 2003, Berrin et al., 
2002, Day et al., 2003). Aglycones are then conjugated to glucuronides, sulfate esters and 
methyl esters by enzymes in the cells of the small intestine, colon and liver, prior to systemic 
circulation through blood stream in the body (Landete, 2012). Methylated, glucuronidated 
and sulphated metabolites are then eliminated via the kidney into urine or are excreted back 
into the gut via the biliary route. When excreted into bile, these metabolites flow into the 
small intestine and then reach the large intestine to be degraded into phenolic acids by the 
colon microflora, which are reabsorbed into blood and tissues (Spencer et al., 2004) . 
 
Figure 1-6 Formation of metabolites and conjugates of flavonoids in humans  
Author’s own figure based on published studies (Erlund et al., 2001b, Landete, 2012, Nmeth et al., 
2003, Berrin et al., 2002, Day et al., 2003, Spencer et al., 2004) 
 
1.4.1 Flavanone metabolites 
Hesperidin is hydrolysed to release hesperetin by the colonic bacteria when it reaches the 
large intestine, and then hesperetin is conjugated into glucuronides or sulfates. The main 
hesperetin metabolites were glucuronidated and sulfoglucuronidated at the 7- and 3’- 
hydroxyl positions in  urine collected from subjects after consumption of orange juices 
(Manach et al., 2003, Bredsdorff et al., 2010, Vallejo et al., 2010a). In a previous study, 5, 7-
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O-diglucuronide and 3’, 7-O-diglucuronide were also identified in urine after orange juice 
consumption (Bredsdorff et al., 2010). However, sulphoglucuronides were less abundant or 
absent in plasma (Mullen et al., 2008a).   
The types of metabolites produced from narirutin can be different in humans and animals. For 
example, naringenin glucuronides and sulphate metabolites were the main naringenin 
metabolites in human plasma and urine after consumption of orange juice (Vallejo et al., 
2010b). whereas in rats  the main metabolites after oral administration of narirutin (Abe et al., 
1993) were naringenin 4′-glucuronide, naringenin-7, 4′-O-disulfate and naringenin-7-O-
glucuronide in urinary and plasma, and the main biliary metabolites were naringenin-7-
glucuronide, naringenin-7-sulfate 4′-glucuronide and naringenin-7-glucuronide 4′-sulfate. 
This may be due to differences in the microbiota and cellular metabolism. 
Ring fission products are derived from hesperetin or metabolites by colonic bacteria. Roowi 
and colleagues reported  3-hydroxyphenylacetic acid, 3-hydroxyphenylhydracrylic acid, 
dihydroferulic acid, 3-methoxy-4-hydroxyphenylhydracrylic acid and 3-hydroxyhippuric acid 
in urine after orange juice consumption in humans (Roowi et al., 2009a).   
1.4.2 Bioavailability of flavanones  
The bioavailability of flavanones determines their health effects in the host. They are poorly 
absorbed from the intestine and rapidly eliminated into urine via kidney (Manach et al., 
2004). As described in section 1.4, parent compounds can be degraded into aglycones and 
phenolic acids as they pass through the gut. Hesperidin is subject to both mucosal and gut 
bacterial metabolism and then its alycone (hesperetin) and catabolites (phenolic acids) can be 
absorbed in the body and excreted into urine. The fate of hesperidin in the gut has been 
studied in several human studies (Table 1-3). A study of ileostomists observed 30 % of 
hesperidin intake was recovered in 24 h ileal fluid after consumption of a polyphenol-rich 
juice (Borges et al., 2013). It is not clear how much phenolic acid absorption occurs in the 
small intestine.  
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Table 1-3 Recovery of hesperidin and metabolites after consumption of orange juice in 
humans 
 Recovery Reference 
Hesperidin passing to the colon 
Phenolic acids passing to the colon 
30 % 
-- 
(Borges et al., 2013) 
-- 
Hesperidin excreted in urine 0.8 -16 % (Pereira-Caro et al., 2014b, Brett et 
al., 2009, Bredsdorff et al., 2010, 
Erlund et al., 2001c, Silveira et al., 
2014, Vallejo et al., 2010c, Tomas-
Navarro et al., 2014, Manach et al., 
2003) 
Hesperidin and its catabolites 
(phenolic acids) in urine 
37 – 88 % (Pereira-Caro et al., 2014a, Roowi 
et al., 2009b) 
 
There have been a number of studies focusing on the bioavailability of flavanones in orange 
juice, which ranged from 0.8 % ~ 16 % of ingested dose (Table 1-4). Pereira-Caro and 
colleagues reported the highest recovery of flavanones in urine at 16 % of flavanone intake 
after consumption of pulp enriched orange juice, where phenolic acids accounted for 88 % of 
flavanone dose in urine (Pereira-Caro et al., 2014b).  Mullen et al found a lower urinary 
excretion of flavanone metabolites (7 % of hesperidin and narirutin intakes) than (Pereira-
Caro et al., (2014b) , and characterised the excretion of five phenolic acids in urine after 
consumption of 250 mL orange juice (Mullen et al., 2008a, Roowi et al., 2009b). In addition, 
Brett and Bredsdorff reported 5.3 % and 7.0 % of flavanone intake excreted in urine after 
consumption of orange juice from concentrated and commercial orange juice respectively 
(Brett et al., 2009, Bredsdorff et al., 2010). In Erlund’s study, 1.1 % of naringenin and 5.3 % 
of hesperetin were recovered in urine after ingestion of orange juice from concentrate (Erlund 
et al., 2001c). On the other hand, Silveira et al investigated urinary flavanone and metabolite 
after consumption of freshly-squeezed and commercially processed orange juices, They 
recovered  respectively to 4.1 % and 3.8 % of hesperidin intake, 3.8 % and 8.7 % of 
naringenin intake in urine (Silveira et al., 2014). Vallejo et al estimated the bioavailability of 
five different beverages containing hesperidin and narirutin including two commercial orange 
juices and a pulp-enriched orange juice. The bioavailability of flavanones was   4.6 %, 1.4 % 
and 0.8 % (Vallejo et al., 2010c). In addition, Tomas-Navarro and colleagues reported 
various levels of bioavailability of flavanones after consumption of fresh hand-squeezed 
orange juice, high pressure homogenised orange juice and pasteurised orange juice ranging 
from 6.7 % - 11 % (Tomas-Navarro et al., 2014). Furthermore, Manach and colleagues 
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investigated two doses of orange juice (0.5 L and 1 L) and reported 4.6 % and 6.7 % of 
urinary recovery of flavanone intake in urine, but there was no significant difference and no 
doubling of flavanone bioavailability with the higher dose of orange juice (Manach et al., 
2003). Thus with a wide range of estimates for bioavailability in the literature, it is important 
to determine the factors which affect this in humans. 
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Table 1-4 Bioavailability of flavanone (hesperidin and narirutin) after consumption of orange juice 
Reference 
No. of 
subjects 
Orange Juice Source 
Consumption 
Volume 
(mL) 
Intake of total 
flavanone (mg) 
AUC (μg/L.h) 
Percentage as urinary 
excretion of 
flavanone intake (%) 
(Silveira et al., 
2014) 
24 
Fresh-squeezed 
Citrosuco, 
Matao, Brazil 
786 
41.4 255 1.6 
Commercial 250.2 848 0.9 
(Vallejo et al., 
2010c) 
10 
Commercial from 
concentrate 
400 
86.4 1218.5/375.7 4.6 
Commercial from 
concentrate 
Spain 176.8 1532.9/485.6 1.4 
Pulp-enriched juice  247.2 695.9/206.5 0.8 
(Mullen et al., 
2008a) 
8 Commercial 
Somerfield’s, 
Glasgow, U.K. 
250 109.4 1959.8 7.0 
(Erlund et al., 
2001c) 
8 
Commercial from 
concentrate 
Valio Ltd., Helsinki, 
Finland 
8 mL/kg (400 ~ 760 
ml) 
41 mg/L of 
narigenin 
and 218 mg/L 
of hesperetin 
3818 
1.1 % of naringenin 
intake and 5.3 % of 
hesperetin intake 
(Manach et al., 
2003) 5 Commercial 
France 500 270 1383 4.6 
  1000 540 3156 6.7 
(Brett et al., 2009) 20 Commercial from UK 300 g 81.2 522 5.3 
  
16 
 
concentrate 
(Bredsdorff et al., 
2010) 
16 Commercial Nestlé, Thailand -- 
0·83 mg/kg 
body weight 
81.6 of naringenin 7.0 of naringenin 
(Tomas-Navarro 
et al., 2014) 
18 
Fresh hand-squeezed 
juice 
Valencia, Spain 400 
56.5 -- 11.0 
 
High-pressure 
homogenized 
161.6 -- 7.7 
 Pasteurized 172.7 -- 6.7 
(Pereira-Caro et 
al., 2014b) 
12 Pulp enriched UK 250 230.3 -- 16.0 
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1.5 Food matrix 
The food matrix has been investigated for its effects on the metabolism and bioavailability of 
flavonoids. Foods containing proteins, lipids and polysaccharides might impact on the 
bioavailability and then the bioactivity of simultaneously consumed flavonoids through their 
interactions in the gastrointestinal tract. These effects must be considered when metabolism 
and bioavailability, and beneficial effects of flavonoids are studied. 
1.5.1 Milk and milk products 
Milk or milk products (yoghurt) are often added to polyphenol rich food (cocoa, tea, fruits, 
vegetables) or processed as commercial products (chocolate, fruit yoghurt). Flavonoids have 
the capacity for hydrophilic and hydrophobic interactions with proteins. The effect of milk or 
milk products has been wildly assessed for on interactions with flavonoids which affect their 
metabolism or bioavailability. In previous studies, tea polyphenols have been found bind to 
hydrophobic proline-rich proteins (α- and β-caseins) via both hydrophilic and hydrophobic 
interactions (Hasni et al., 2011, Yuksel et al., 2010). 
Cocoa, as a flavonoid-rich food, has been linked to a range of beneficial effects, such as 
cardio-protective effects (Dower et al., 2015, Kris-Etherton and Keen, 2002), reduction of 
LDL cholesterol, elevation of HDL cholesterol and suppression of oxidized LDL (Baba et al., 
2007), inhibition of platelet activation and function (Rein et al., 2000b, Rein et al., 2000a), 
enhancement of vascular function (Fisher et al., 2003, Rodriguez-Mateos et al., 2013).  
Regular consumption of cocoa powder and milk modulated the lipid profile and increased 
urinary polyphenol metabolites in subjects at high-risk of cardiovascular disease (Khan et al., 
2012). However, Schroeter et al proposed that milk proteins and chocolate flavonoids interact 
to inhibit the absorption of epicatechin into the bloodstream (Schroeter et al., 2003). There 
was a minor effect on epicatechin-O-sulfate in plasma, reduced excretion of 4 flavan-3-ol 
metabolites in urine, and O-methyl-epicatechin-O-sulfate was not affected by milk in the 
cocoa. In some studies, milk had no effect on bioavailability and absorption of flavonoids. 
Roura et al showed that milk did not affect the bioavailability of epicatechin metabolite in 
terms of epicatechin-glucuronide in plasma (Roura et al., 2007a).  
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Milk has also been reported to change the metabolite profiles after intake of flavonoids. 
Roura and his colleagues reported that milk (250 ml) increased epicatechin sulfate when 
epicatechin glucuronide was still the main metabolite 0-6 h after intake, and milk influenced 
the sulfation position of epicatechin in terms of concentration of three isomers, but did not 
affect total epicatechin metabolites in urine after intake cocoa powder (40 g) containing 28.2 
mg (-)-epicatechin, 25.5 mg procyanidin B2, 8.4 mg (+)-catechin, and 2 mg flavonols (Roura 
et al., 2008). 
On the other hand, Neilson and colleagues conducted in vivo and in vitro studies. They found 
that the Cmax of epicatechin metabolites was enhanced over 6 h after intake of catechin (C) 
and epicatechin (EC) from cocoa (approximately 9.44 mg C and 27.39 mg EC/serving (250 
ml) in the form of sucrose milk protein (BSMP) and non-nutritive sweetener milk protein 
(BNMP) (9.46 mg C and 27.44 mg EC /serving) compared with that of a reference dark 
chocolate (CDK) (9.35 mg C and 27.13 mg EC)with high milk protein (CMP) (Neilson et al., 
2009). They also found higher bioavailability of catechin from BSMP and BNMP than CDK,  
high sucrose and CMP in an in vitro gastric and small intestinal digestion model, while there 
was no difference in epicatechin (Neilson et al., 2009). This suggests that the food matrix has 
a different impact on metabolism and bioavailability of dietary polyphenols depending on 
their chemical structure. In addition, some of the effect of milk on cocoa flavonoids may be 
due to the dose of flavonoids ingested. It appears that at high dose (97.2 μmol EC and 29.0 
μmol C) little effect is seen (Roura et al., 2007b) but effects are evident at low dose (45 μmol 
EC and C) (Mullen et al., 2009a). This may be due to saturation of the binding potential 
(Mullen et al., 2009a). Thus, it is important to consider the levels of flavonoids present in 
common foods. 
There is a similar controversy with regards to the effect of milk on tea flavonoids.  
Consumption of black tea significantly increased concentrations of total phenols, catechins, 
and the flavonols quercetin and kaempferol with improvement of plasma antioxidant capacity 
within 80 min, but consumption of milk and tea did not affect these metabolites in the plasma 
(Kyle et al., 2007). In an in vitro digestion study, catechin recovery was 59 % for English 
black tea made with 5.6 % milk and was about 40 % for English and Indian black teas with 
15-40% milk, but did not influence total catechin recovery after stimulated gastric and 
intestinal digestion (van der Burg-Koorevaar et al., 2011). Furthermore, polyphenol-protein 
complexes could be degraded during digestion. Blood catechin levels were not significantly 
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affected by the addition of milk (100 mL) to black tea (600 mL) (Van het Hof et al., 1998). 
Consumption of milk also did not change the plasma concentration-time curve of quercetin or 
kaempferol after drinking black tea by men (Hollman et al., 2001). In addition, plasma total 
catechin and antioxidant activity was not affected by addition of milk after consumption of 
black or green tea (Leenen et al., 2000).  
However, defatted milk did not significantly affect plasma anthocyanins levels after the 
consumption of blackberry juices (Hassimotto et al., 2008).    
For the isoflavones, milk decreased the urinary excretion of daidzein, genistein (parent 
compound) and increased the equol concentration (metabolites) in urine after tempeh 
(fermented beans) consumption in postmenopausal Malay women (Haron et al., 2011). 
However, urinary genistein recovery was higher after soya-milk consumption than textured 
vegetable protein (soyabean products) (Faughnan et al., 2004).  
In an in vitro study, skimmed milk powder significantly increased degradation of isoflavone 
glycosides into isoflavone aglycones after 24 h incubation of soymilk with Lactobacillus, 
which was supposed due to growth of Lactobacillus stimulated by skim milk powder 
providing lactose and others nutrients (Pham and Shah, 2008). 
Yoghurt, as a dairy product, was also investigated for its effect on bioavailability of 
flavonoids in orange juice (Mullen et al., 2008a). In this study, there was a significant delay 
in the  initial appearance of flavanone metabolites, and reduced excretion of flavanone 
metabolites at 0-5 h after orange juice ingestion with yoghurt, but no significant difference in 
the excretion of flavanone metabolites (three hesperetin-O-glucuronide, two hesperetin-O-
glucuronide-O-sulfates, a hesperetin-O-diglucuronide, a naringenin-O-diglucuronide, and 
naringenin-7-O-glucuronide and naringenin-4′-O-glucuronide) over the 24 h period after 
consuming orange juice without and with yoghurt (Mullen et al., 2008a). This may be 
attributed to a prolonged transit time to reach the large intestine after consumption of orange 
juice with yoghurt. However, full fat yoghurt reduced the excretion of the five phenolic acids 
equivalent to 37% of the ingested flavanones over 24h after orange juice consumption, 
compared with after drinking orange juice without full fat natural yoghurt (Roowi et al., 
2009). Meanwhile, urinary excretion of 3-hydroxyphenylacetic acid, 3-
hydroxyphenylhydracrylic acid, dihydroferulic acid, 3-methoxy-4-hydroxyphenylhydracrylic 
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acid and 3-hydroxyhippuric acid, which were derived from flavanone in orange juice by gut 
bacteria, reduced markedly from 62 ± 18 μmol to 6.7 ± 1.8 μmol after consumption of orange 
juice with yoghurt (Roowi et al., 2009a). In addition, soy consumption increased plasma 
phytoestrogen concentrations (P < 0.0001), but plasma phytoestrogen concentrations and the 
number of equol producers were not different between the soy protein and soy + probiotics 
diets in a 6-wk randomized, crossover design (20 women without a history of cancer and 20 
women successfully treated for breast cancer)(Nettleton et al., 2004). The reasons for the 
impact of yoghurt on the phenolic acids in urine are unclear and are explored further in the 
studies described in this thesis. 
1.5.2 Dietary fibre 
Dietary fibre consists of non-starch polysaccharides, resistant oligosaccharides, resistant 
starch and lignin associated with the dietary fibre polysaccharides which include, 
hemicellulose, pectin, β-glucans, gums, classified as soluble dietary fibre and cellulose as 
insoluble dietary fibre (Gallaher and Schneeman, 2001, Gorinstein et al., 2001, Dhingra et al., 
2012). Dietary fibre is considered to play an important role in human health and may interact 
with phytochemicals in food to influence the metabolism and beneficial effects of flavonoids 
in human. In an animal study, oatmeal (6.7 % (w/w)) increased anthocyanin rutinosides, but 
reduced anthocyanin glucosides in digesta, and decreased Cmax of anthocyanins from 0.37 ± 
0.07 μmol/L to 0.20 ± 0.05 μmol/L in plasma with delayed time from 0.25 h to 1 h, in 
addition to reduced maximum urinary excretion time of anthocyanins from 2 h to 3 h after 
consumption of blackcurrant powder containing 250 mg total anthocyanins per kg body 
weight of rats (Walton et al., 2009). A diet containing hydrolysed wheat, wheat, barley, maize 
and oats stabilised procyanidins in grape seed procyanidin extracts under GI digestion 
conditions using in vitro model, but reduced Cmax of procyanidin trimer in plasma after 
feeding grape seed procyanidin extracts to rats (Serra et al., 2010). In addition, supplements 
of  rice bran hemicellulose significantly reduced plasma daidzein in rats after feeding 
cellulose-daidzein diet for 30 days in rats (Tamura et al., 2009). Furthermore, phenolic 
metabolites have also been investigated. Gu et al reported that diet containing sorghum bran 
containing cellulose, catechin and epicatechin increased urinary excretion of catechin, 3'-O-
methylcatechin in rats, 3-methoxy-4-hydroxyphenylacetic acid, 3-hydroxyphenylacetic acid, 
and 3-hydroxyphenylpropionic acid in rats after 50 days of consumption (Gu et al., 2007).  
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Different dietary fibre might have various effects on the bioavailability of flavonoids due to 
their different properties and fermentability. Nishijima and colleagues reported that co-
ingestion of apple pectin (10 mg/ml) caused 2.5 times higher urinary excretion of quercetin 
and its metabolites (isorhamnetin & tamarixetin) after consumption of 250 ml drink 
containing quercetin(0.5 mg/ml), and high-methoxy pectin significantly enhanced the urinary 
excretion by 1.69 fold in humans (Nishijima et al., 2015). Saura-Calixto investigated in an in 
vitro study that dietary fibre from red grape subjected to digestion treatment containing 73.5 
± 0.8 g /100 g of total dietary fibre and 14.8 ± 0.2 g/100g proanthocyanidins produced more 
phenolic metabolites than non-digestible carob pod containing 15 ± 0.3 g/100g of total 
dietary fibre and 78.3 ± 1.8 g/100g proanthocyanidins based on same amount of non-
extractable proanthocyanidins that are linked to cell wall constituents and not detected by the 
usual analytical procedures (Perez-Jimenez et al., 2013) in two different fibre containing 
products  fermented by gut bacteria from rats (Saura-Calixto et al., 2010). Tamura et al also 
reported that concentrations of quercetin and isorhamnetin and ratios of isorhamnetin / 
quercetin were significantly higher in plasma after feeding a pectin-rutin diet in rats for 14 
days than a cellulose-rutin diet (Tamura et al., 2007a), which suggested that dietary fibre can 
modify metabolism of flavonoids or gut physiological function to enhance bioavailability of 
flavonoids. Resistant starch acting as dietary fibre in the colon, improved urinary excretion of 
equol in ovariectomized mice feed formulated diet with daidzein (0.1%) and resistant starch 
(12%) for 6 weeks with increased proportion of Bifidobacterium spp in faecal bacteria 
(Tousen et al., 2011).  
Other carbohydrates also affect bioavailability of flavonoids. Schramm and colleagues 
showed that sugar and bread meals increased plasma concentration of flavanols (epicatechin 
& catechin) to 140 % after consumption of cocoa providing 0.125 g/kg body weight of 
flavanol in subjects (Schramm et al., 2003).  
1.5.3 Fat 
Fat also influence the bioavailability and metabolism of flavonoids. A higher content of fat in 
flavonoid enriched food tended to enhance the bioavailability of flavonoids. Cream is high in 
fat. Mullen and colleagues reported that cream delayed Tmax of pelargonidin glucuronide in 
plasma from 1.1 ± 0.4 to 2.4 ± 0.5 h after the consumption of strawberries containing 222 
µmol of pelargonidin-3-O-glucoside, and there was a lower Cmax (227 ± 35 nmol/L) 
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compared to that without cream (274 ± 24 nmol/L). Lower 0–2 h urinary excretion of total 
anthocyanins was found after intake of the strawberries with cream. The 24h overall 
excretion of anthocyanins was not significantly different after ingestion strawberries with 
cream or without cream, which delayed gastric emptying and extended mouth to caecum 
transit time (Mullen et al., 2008b). In an in vitro study, Ortega reported significantly higher 
procyanidins (monomers and dimers) after digestion of cocoa liquor containing ~50 % fat 
than cocoa powder containing ~15 % fat through GI digestion by using an in vitro digestion 
model, both of which contained similar amount of phenolic compositions (Ortega et al., 
2009b). It indicated that higher fat reduced the loss of flavonoids under gastrointestinal 
digestion conditions. In animal studies, plasma quercetin metabolites were also enhanced 
after administration of quercetin (30 μmol/kg body weight) with a diet containing 17 % fat 
compared with 3% fat in pigs, whereas they were similar compared with meal containing 32 
% fat (Lesser et al., 2004).  
On the other hand, different types of fatty acids influenced the bioavailability of flavonoids. 
A diet rich in medium-chain fatty acids (162.8 fat/kg diet), not long chain fatty acids 
significantly enhanced the absorption of quercetin compared with the standard diet (16.7 g 
fat/kg diet), and delayed Cmax of quercetin in pigs after supplementation of  30 mmol 
quercetin/kg body weight (Lesser et al., 2006). In an animal study, plasma quercetin 
metabolites were increased in rats after 2 weeks ingestion with diet contained soybean oil (> 
4.6 % (w/w)), fish oil or beef (9.5 % lipid content) with 1.0 g of onion powder (Azuma et al., 
2003). 
1.6 Individual bioavailability- human factors 
The bioavailability of flavonoids may depend on the ethnic origin, gender and age of the host. 
Ethnicity has been investigated in several previous studies. A higher maximum concentration 
in plasma and area under the plasma concentration-time curve of genistein and daidzein were 
found in Asians than in Caucasians (3.7 vs. 2.4 and 43.7 vs. 30.1 ng/ml per h per kg BW; 2.9 
vs. 1.7 and 29.2 vs. 19.6 ng/ml per h per kg BW) after an acute intake of soya-based cheese 
(45.97 mg isoflavones), and 10 day daily consumption of soya-based cheese significantly 
increased these values in Caucasians, but not that of daidzein in Asians (Vergne et al., 2009). 
In an in vitro fermentation study, daidzein was more degraded by gut bacteria from Asians 
than Caucasians (0.25 mol/L ± 0.03 mol/L vs. 0.20 mol/L ± 0.03 mol/L in phases I, and 0.21 
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mol/L ± 0.02 mol/L vs. 0.12 mol/L ± 0.03 mol/L in phases II) after 24 h incubation of 
daidzein and genistein at a concentration of 100 mol/L in brain heart infusion culture medium 
(600 mol/L) (Zheng et al., 2003b). In another in vitro study, there was higher production of 
phenolic acids by gut bacteria from Indian participants than Caucasian subjects (9.4 ± 4.4 
µg/ml vs. 4.1 ± 3.5 µg/ml) at 6 h of fermentation (Alkhaldy et al., 2012b).  .  
In terms of  age, there was higher excretion of phenolic acids in older people 54-75 y than 
younger people 23-43 y (23.4 ± 31.7 vs. 227.4 ± 72.3µg/day after a high polyphenol diet 
(Alkhaldy et al., 2012b). In addition, Erlund et al reported that the  0-24 h area under the 
plasma concentration time curve of quercetin was higher in women than men (1946 µg·h/L 
vs. 678 µg·h/L) after intake of quercetin aglycone and rutin equivalent to 50 mg dose of 
quercetin (Erlund et al., 2001b). The rate of urinary excretion of daidzein and genistein was 
39 % and 44 % higher respectively, and the total amount of urinary total isoflavonoids and 
metaboliteswas higher (32%) in children (3-12y old)  than in adults over 12 h after intake of 
soya nuts containing 0·615 mg total isoflavones/kg (Halm et al., 2007). 
Gender also affected the bioavailability of flavonoids. Quercetin in plasma was higher in 
women from 0 to 24 hours (1946 µg · h/L) than in men (678 µg · h/L) after ingestion of 50 
mg quercetin aglycone and rutin, expressed as quercetin equivalents (Erlund et al., 2001a). 
1.7 Other factors 
Various other factors have been suggestd to affect the bioavailability and absorption of 
dietary flavonoids, such as food sources, dose, solubility and characteristics of flavonoids. 
Brett and colleagues revealed no different absorption and excretion of flavanone through 
intake of orange fruits and orange juice from concentrate (Brett et al., 2009). Charron et al. 
reported that plasma anthocyanin decreased with intake dose of total anthocyanins from 76 to 
380 µmol through consumption of carrot juice from 50 to 250 mL, and Cmax of nonacylated 
anthocyanins was 4 times higher than that of acylated anthocyanins so that acylated 
anthocyanins had lower bioavailability of acylated anthocyanins compared with non-acylated 
anthocyanins from purple carrots juices (Charron et al., 2009). Lower solubility of hesperidin 
in orange juice reduced urinary excretion of hesperetin metabolites and the Cmax in plasma 
from humans after intakes of orange juices (Vallejo et al., 2010a). Krogholm showed that 
urinary excretion of naringenin and hesperetin (14.2 % and 22.6 % of intake) was higher than 
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quercetin (1.5 % of intake), Cmax of naringenin (0.25 µM) was significantly higher than that 
of quercetin and hesperetin (0.15 µM and 0.18 µM), and Tmax of quercetin and naringenin 
(3.6 ± 1.6 h) was earlier than that of hesperetin (4.9 ± 1.4 h) after consumption of a 
hesperetin, naringenin and quercetin mixed juice (Krogholm et al., 2010). In addition, urinary 
excretion of hesperidin metabolites was higher (12.0 %) than (epi)gallocatechin metabolites 
(6.2 %) after consumption of a flavonoids mixed juice containing green tea flavan-3-ols, 
grape seed and pomace procyanidins, apple dihydrochalcones, procyanidins and chlorogenic 
acid, citrus flavanones and grape anthocyanins (Borges et al., 2010). 
1.8 Gut microbiota 
There are up to 10
14
 total bacteria, more than 1000 different species in the human intestinal 
tract (Rajilić-Stojanović and de Vos, 2014). 99 % of the gut bacteria belongs to a few phyla, 
the main ones being Bacteroidetes and Firmicutes, whereas Actinobacteria, Proteobacteria 
and Verrucomicrobia are minor constituents (Lozupone et al., 2012, Eckburg et al., 2005, 
Guarner and Malagelada, 2003, Suau et al., 1999). The gut microbiota is individually 
different and modified over the whole life by diet, life-style, disease and antibiotic use, but its 
composition usually remains relatively stable (Nicholson et al., 2012, Moore and Moore, 
1995).  
The gut bacteria have been widely investigated for their interactions with food and flavonoids 
(Figure 1-7). Non-digestible carbohydrates, such as non-starch polysaccharides, resistant 
starch and oligosaccharides that are resistant to gastric acidity and enzymes (Dhingra et al., 
2012), can be fermented into short chain fatty acids by gut microbiota (Crittenden et al., 
2002) affecting the pH in the colon (Brøkner et al., 2012) which may affect the metabolism of 
flavonoids (Mansoorian et al., 2015). 
Hawksworth detected β-glucosidase activity in Bacteroides, Bifidobacteria, and Lactobacilli 
in in vitro cultures (Hawksworth et al., 1971), these enzymes can degrade flavonoids into 
their aglycone. Rutin, hesperidin, naringin, poncirin and baicalin were degraded by gut 
bacteria isolated from human faeces with activity of α-rhamnosidase and β-glucosidase or 
endo-β-glucosidase (Kim et al., 1998). In addition, Escherichia coli HGH21 and a gram-
positive strain HGH6 isolated from human faeces cleaved daidzin and genistin into daidzein 
and genistein (Hur et al., 2000). Gut bacteria are responsible for cleavage C-ring of 
  
 
25 
flavonoids. Clostridium scindens and Eubacterium desmolans degraded  20 ~ 25 % of 
naringenin during in vitro incubation at 37°C for from 4 h to 7 days (Winter et al., 1989). 
Clostridium cocoides-Eubacterium rectale group transformed (+)-catechin and (-)-
epicatechin into 5-(3’,4’ -dihydroxyphenyl)-γ- valerolactone, 5-phenyl- γ -valerolactone and 
phenylpropionic acid by using batch-culture fermentation (Tzounis et al., 2008).     
 
Figure 1-7 Interactions between diet / flavonoids, metabolites and health 
        
Flavonoids and their metabolites may also modulate the gut microbial composition (Hervert-
Hernández and Goñi, 2011). (+)-Catechin stimulated growth of Clostridium coccoides–
Eubacterium rectale group, Bifidobacterium spp. and Escherichia coli (E.coli), and inhibited 
growth of C. histolyticum group, while (−)-epicatechin only increased C. coccoides–
Eubacterium rectale group through incubation of human gut bacteria with ( − )-epicatechin or 
(+)-catechin (Tzounis et al., 2008). Lactobacilli and Bifidobacteria were increased in faeces 
of rats by feeding 1 mg of resveratrol/kg/day for 25 days, and this also reduced the colitis 
caused by 5% dextran sulfate sodium over the last 5 days, reducing systemic and colonic 
inflammatory markers and cytokines (Larrosa et al., 2009). Bacteroides spp., Clostridium 
spp.were inhibited by incubation with freshly brewed thick Yunnan Chinese tea containing 
epicatechin, catechin, 3-O-methylgallic acid, gallic acid and caffeic acid (C. perfringens and 
C. difficile), Bifidobacterium spp., Lactobacillus spp., E. coli and Salmonella typhimurium, 
but did not affect growth of Clostridium spp., Bifidobacterium spp. and Lactobacillus sp.by 
in vitro incubation with 28 common pathogenic, commensal and probiotic intestinal bacteria 
(Lee et al., 2006). Ellagitannins strongly inhibited the growth of Staphylococcus bacteria 
cultured aerobically at 37 °C on nutrient agar (Puupponen‐Pimiä et al., 2005).  
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Fruits, vegetables, and their products containing polyphenols influence the composition of the 
colonic microbiota. A human intervention study revealed that Enterococcus, Prevotella, 
Bacteroides, Bifidobacterium, Bacteroides uniformis, Eggerthella lenta, and Blautia 
coccoides–Eubacterium rectale groups significantly increased in faeces of men after 4 week 
daily consumption of red wine (Queipo-Ortuño et al., 2012). In addition, 6 weeks daily 
consumption of a wild blueberry drink (25 g of wild blueberry powder in 250 mL of water) 
significantly increased Bifidobacterium spp. and L. acidophilus group in men faeces 
(Vendrame et al., 2011). There were several in vitro studies also showing the effects of 
polyphenol enriched fruits on proliferation of gut bacteria. Growth of C. perfringens, C. 
ramosum, S. aureus, and C. clostridioforme were inhibited, whereas Bifidobacterium breve 
and Bifidobacterium infantis were increased by incubation with commercial pomegranate 
peel extract (0.01% (v/v)) containing19% ellagitannins as punicalagins and punicalins, 4% 
free ellagic acid, and 77 % oligomers composed of 2-10 repeating units of gallic acid, ellagic 
acid, and glucose in different combinations in broth or /and agar (Bialonska et al., 2009). 
Purple and red vegetable and fruit juices (180 mL) at 1:2 to 1:16 dilutions and tea at  1:28 to 
1:32 dilutions with single or double-strength trypticase soy broth inhibited growth of S. 
epidermidis and K. pneumoniae in 96-well microtiter plates with 20 mL innoculum  (Lee et 
al., 2003). Lactobacillus spp. and Bifidobacterium spp. increased in faecal samples of women 
after 4 weeks consumption of a high cocoa flavanol drink every day (494 mg) compared with 
a low cocoa drink (29 mg) (Tzounis et al., 2011). The impact of other constituents of these 
fruits and vegetable juices on the bacteria should be considered to ensure the effects are due 
to the flavonoids alone. 
1.9 Flavonoids and risk of disease  
1.9.1 Mechanism of flavonoid bioactivity-antioxidant actions 
Flavonoids are thought to play a role in protection against disease. Flavonoids as antioxidants 
can scavenge free radicals and chelate metal ions (Cook and Samman, 1996b). A catechol 
group in ring B determines the radical-scavenging capability of flavonoids, where electron 
donation is easier (Bors et al., 1990). A 3 hydroxyl group in the heterocyclic ring and 
polyhydroxylation of A and B aromatic rings of flavonoids enhance antioxidant and free 
radical scavenging functions (Sichel et al., 1991).  
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Dietary flavonoids have been shown to protect against oxidative stress and inflammation and 
have been suggested to reduce risk of  chronic diseases to play an important role in human 
health (Tapiero et al., 2002) (Table 1-5). Naringin (0.03, 0.1, 0.3, and 1 mM) increased H2O2-
induced cytotoxicity and inhibited chromatin condensation and DNA damage induced by 
H2O2 in mouse leukemia P388 cells (Kanno et al., 2003). (-)-epigallocatechin gallate, 
quercetin, rutin and hesperetin (1–50 mM) inhibited LDL oxidation, and inhibited HUVEC 
nuclear condensation and fragmentation induced by oxidized LDL in human endothelial cells 
(Jeong et al., 2005). In addition, epigallocatechin gallate and (+)-catechin, quercetin, 
myricetin, rutin, naringenin, hesperetin, luteolin and apigenin at 1–50 mM increased anti-
apoptotic Bcl-2 expression, and reduced Bax expression and caspase-3 cleavage in human 
endothelial cells stimulated by oxidized LDL potentially against for atherosclerotic disease 
(Jeong et al., 2005). Apigenin at 20, 40 μM reduced LPS-induced expression of nitric oxide 
synthase, cyclooxygenase-2, expression of IL-1β, IL-2, IL-6, IL-8, and TNF-α, and AP-1 
proteins (c-Jun, c-Fos, and JunB) in human lung A549 cells (Patil et al., 2015). Apigenin, 
luteolin and genistein (50 μM) reduced platelet aggregation induced by arachidonic acid and 
collagen related to platelet responses (Guerrero et al., 2005). Flavonoids also have shown 
inhibitory properties against viruses. Epicatechin (35 μM), epicatechin-gallete (50 μM), 
genistein (50 μM), naringenin (50 μM) and quercetin (50 μM) inhibited virus-induced 
cytopathic effect, and catechin, epigallocatechin, epigallocatechin gallate, naringenin, 
chrysin, baicalin, fisetin, myricetin, quercetin, and genistein at less than 100 μM moderately 
inhibited growth of HSV-1 virus (Lyu et al., 2005).  
However, the studies above used parent compounds and aglycones which are not absorbed 
intact or when absorbed are at much lower concentrations. Thus much lower physiological 
concentrations are seen after ingestion of food and juices. For example, the Cmax of hesperidin 
metabolites was 922 nM after the consumption of orange juice (Mullen et al., 2008a) and the 
Cmax of total catechins, EGCG, ECG, EGC and  EC were  461.8 ± 27.4 nM,  178.9 ± 12.7 
nM, 147.3 ± 11.4 nM, 86.5 ± 5.1 nM, 48.2 ± 3.8 nM after the consumption of green tea 
(James et al., 2015)  Futhermore daidzein aglycones in plasma were 7.7 ± 1.7 nM at 1.5 h and 
14.5 ± 3.3 nM at 3.0 h, and genistein was 6.0 ± 4.2 nM at 1.5 h and 5.2 ± 3.4 nM at 3.0 h 
after consumption of sautéed onion and tofu (Nakamura et al., 2014). Thus the data generated 
may not be relevant to the physiological effects of dietary flavonoids.    
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Therefore the majority of flavonoids are not absorbed intact as the parent compound but are 
hydrolysed and conjugated, or catabolised into smaller molecular compounds, such as 
phenolic acids, and then these metabolites are distributed to organs and circulated through 
blood stream, finally eliminated into urine. The bioactive properties of these metabolites need 
to be demonstrated at physiological levels. There are few studies to investigate this. Spencer 
et al showed that epicatechin-5-O-β-D- and epicatechin-7-O-β-D-glucuronides did not inhibit 
peroxide-induced loss in neuronal or fibroblast viability, and caspase-3 activation in both 
cells, in contrast with 3′-O-methyl epicatechin and epicatechin (Spencer et al., 2001). 
However, epicatechin and 3′-O-methyl epicatechin have been shown to elicit cytoprotective 
effects in fibroblasts(Spencer et al., 2001). Concentrations of 26 phenolic compounds 
(benzoic acid, salicylic acid, 4-hydroxybenzoic acid, protocatechuic acid, gentisic acid, gallic 
acid, syringic acid, cinnamic acid, caffeic acid, sinapic acid, dihydrocaffeic acid, phloretic 
acid, 5-methoxysalicylic acid, vanillic acid, p-coumaric acid, m-coumaric acid, ferulic acid, 
4-hydroxyhippuric acid, 3-hydroxyhippuric acid, 3-hydroxyphenylacetyl glycine, 3-
hydroxyphenylpropionyl glycine, 4-hydroxyphenylpropionyl glycine, hippuric acid, 
pyrogallol, catechol, resorcinol) impacted neither platelet aggregation nor activation at the 
concentration less than 50 μmol/L (Ostertag et al., 2011). However, these studies have still 
not investigated their effects at the physiological conditions. Thus, it is essential to explore 
profile and content of flavonoids metabolites, as well as factors affecting concentrations of 
metabolites derived from polyphenols in our diet to provide insight for experimental and 
clinical studies.  
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Table 1-5 Mechanisms of flavonoids in reducing risk of diseases 
References Flavonoids Actions Treatment Results 
(Jeong et al., 2005) 
 
 
(-)-epigallocatechin gallate, 
quercetin, rutin and hesperetin 
(1–50 mM) 
Antioxidation of LDL, and 
induced oxidative stress and 
oxidized LDL-triggered 
atherogenesis 
Cu2+ induced human umbilical 
vein endothelial cells (HUVEC) 
Inhibited LDL oxidation, 
increased anti-apoptotic Bcl-2 
expression, and reduced Bax 
expression and caspase-3 
cleavage stimulated by oxidized 
LDL. 
(Kanno et al., 2003) 
 
 
Naringin (0.03, 0.1, 0.3, and 1 
mM) 
Antioxidant and anti-apoptopic 
properties 
H2O2-induced mouse leukemic 
P388 cells 
Reduced H2O2-induced 
cytotoxicity and inhibited 
chromatin condensation and 
DNA damage 
(Patil et al., 2015) 
 
 
 
Apigenin (20, 40 μM) 
Anti-inflammation 
lipopolysaccharide (LPS)-
induced human lung A549 cells 
Inhibited nitric oxide synthase, 
cyclooxygenase-2, expression of 
IL-1β, IL-2, IL-6, IL-8, and 
TNF-α), and AP-1 proteins (c-
Jun, c-Fos, and JunB). 
(Guerrero et al., 2005) 
 
Apigenin and genistein (50 μM) Antiplatelet 
Arachidonic acid and collagen-
induced platelet 
Reduced platelet aggregation 
and TxA(2) generation linked to 
platelet responses 
(Lyu et al., 2005) 
 
EC, ECG, galangin, and 
kaempferol Antivirus HSV-1 Inhibited  
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1.9.2 Epidemiological studies in consumption of flavonoid-rich food  
The association between flavonoids and disease has been investigated in several 
epidemiological studies. These studies show positive or neutral associations between 
flavanone or flavanone-rich food and health benefits. The details are illustrated in Table 1-6. 
Over the past decades, flavonoid intake has been linked to reduced risk of cardiovascular 
disease. Cassidy et al reported that anthocyanin and flavanones intake reduced the risk of 
hypertension in a 14 y follow-up cohort study (Cassidy et al., 2011). An intake of 80 g/day 
fruits was associated with 6–7 % lower risk of CVD and CHD mortality, and the highest 
intake of grapes and citrus reduced the risk of CVD and stroke compared with non-consumers 
(Lai et al., 2015). Ponzo et al. also showed  an inverse association of intakes of flavanones, 
flavan-3-ols, anthocyanidins and flavanones with CVD risk (Ponzo et al., 2015).  Mink et al 
also observed an inverse association between flavanone intake and CHD risk in the  highest 
intake group  compared with the  lowest intake group (Mink et al., 2007b). Mursu et found 
that the highest intake group of flavanone and flavone had an inverse correlation with risk for 
CVD death after multivariate adjustment (Mursu et al., 2008b). Tavani et al found lower non-
fatal acute myocardial infarction (AMI) in the highest intake group of anthocyanidins, 
compared with the lowest intake, and flavanone intake had similar effect after alcohol 
adjustment (Tavani et al., 2006). These studies suggested potential benefits of flavanone or 
flavanone rich flood, especially citrus fruits /juices intake in the risk of human cardiovascular 
diseases. 
However, some studies found the association only with total flavonoids intake. The 18 % 
lower risk of fatal CVD was associated with the highest intake of total flavonoids in men and 
women (McCullough et al., 2012). The highest intake of flavonoids reduced 46 % CVD risk 
compared with the lowest intake of flavonoids (Tresserra-Rimbau et al., 2014). In addition, a 
lower risk of all-cause, CVD, and cancer mortality was found  in the highest intake of total 
flavonoid intake(Ivey et al., 2015).  
There are some studies revealing their effects in cancer risks. The lower incidence of ovarian 
cancer was found in the highest intake of flavanol and flavanone compared with in the lowest 
group (Cassidy et al., 2014). However, there are several studies showing no association 
between flavanone intake and the risk of cancers. For instance, the highest intake of total 
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flavonoid, flavonol and flava-3-ol reduced risk of the lung cancer, but no effect was seen for 
flavanone intake (Mursu et al., 2008a).  
Risk of type-2-diabetes has inversely been associated with flavanone intake. Higher urinary 
excretion of hesperetin reduced the risk (Sun et al., 2015). Citrus fruits, especially orange 
juice, tended to decrease plasma concentration of  IL-18 (proinflammatory cytokines related 
to type 2 diabetes incidence) in women (Landberg et al., 2011). Wedick et al also reported 
that the intake of flavones and flavanones slightly reduced type 2 diabetes risk (Wedick et al., 
2012). 
Flavanone intake also affected cognitive functions. In addition, women had greater healthy 
aging when the highest intake of flavones, flavanone, anthocyanin, and flavonol compared 
with the lowest intake (Samieri et al., 2014). Butchart et al. reported an association between a 
higher IQ and intake of flavones and flavanones at age 11 years, the effects of citrus fruit 
consumption on mini-mental state examination, verbal fluency and speed tests in older 
people, as well as association between flavanones and verbal fluency in later life (Butchart et 
al., 2011). However, flavanone intake was not found to reduce risk of Parkinsons Disease, but 
total flavonoid intake affected the incidence in men (Gao et al., 2012). 
Diet, nutritional status, and lifestyle are comprehensive factors to affect incidence of chronic 
diseases and cancers (Edmands et al., 2015). Epidemiological studies have revealed 
inconsistent associations of flavanone intake and chronic diseases. The dietary habits can be 
very varied. For instance, the main flavonoid intakes are different across countries. 
Proanthocyanidins (48.2 %) are the main sources along with flavan-3-ol monomers (24.9 %) 
in non-Mediterranean (MED) countries, while proanthocyanidins (59.0 %) were the main 
flavonoids ingested in MED countries. even though there were no differences in total 
flavonoid intake between non-MED countries (373.7 mg/d) and MED countries (370.2 mg/d).  
Tea (25.7 %) and fruits (32.8 %) were main sources of flavonoids in non-MED regions, while 
fruits (55.1 %), wines (16.7 %) and tea (6.8 %) in MED regions.(Zamora-Ros et al., 2013). In 
this study, the variability in the detailed intakes of flavonoids and metabolites might 
potentially explain the variation in outcomes of health in clinical studies and epidemiology 
studies.  
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Table 1-6 Flavanone or orange juice intake and diseases on cohort studies 
Diseases Reference Hypothesis Methods Results Comments 
CVD, CHD mortality (Lai et al., 2015) 
The intake of polyphenol 
in total fruit and fruit 
subgroup is linked to 
reduced  CVD mortality 
 
30,458 women (aged 35–69 
years) were recruited and 
completed FFQ providing 
information about 600 diet, 
health and lifestyle variables. 
During the mean follow-up 
period of 16.7 years from 1995–
1998, fatal CVD deaths were 
recorded, and survival was 
analysed by using participants 
free from history of CVD at 
baseline. 
80 g/day intake of total fruit 
reduced 6–7 % risk of CVD 
and CHD mortality. The 
highest intake of grapes and 
citrus significantly lowered risk 
of CVD and stroke respectively 
compared with non-consumer. 
 
The cohort study was only 
conducted in women. 
Polyphenol profiles should 
be introduced to evaluate 
association between 
flavanone intake and CVD 
mortality. 
All-cause, CVD, 
cancer mortality 
(Ivey et al., 2015) 
Flavonoid intake is 
associated with lower 
risk of mortality from all 
causes 
1063 women aged over 75 y 
were recruited and followed for 5 
years. Two estimates of 
flavonoid intake (total 
flavonoidUSDA and total 
flavonoidPE) were used to assess 
flavonoid intake. The association 
between flavonoid risk and all-
cause, cancer, and cardiovascular 
mortalities was assessed. 
High intake of total flavonoid 
was associated with a lower 
risk of 5-y all-cause, 
cardiovascular disease and 
cancer mortality. 
Only the intake of total 
flavonoids was used for 
assessment. There is no 
information about 
attribution of specific 
flavonoid subclasses to 
reduce mortality risk. The 
different outcomes based 
on two databases provided 
an insight for further 
epidemiological studies. 
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CVD mortality 
(Tresserra-
Rimbau et al., 
2014) 
The intake of total 
polyphenol was 
associated with reduced 
myocardial infarction, 
stroke or death from 
cardiovascular causes 
7172 participants were followed 
for 4.3 year and a 137-item FFQ 
at baseline and yearly thereafter 
was used for assessment of 
flavonoid intake. Hazard ratios 
were estimated by using a time-
dependent Cox proportional 
hazards regression with updated 
diet and covariates information. 
There was a 46 % lower risk of 
CVD in the highest flavonoid 
intake group compared with 
the lowest flavonoid consumer. 
The intake of flavanols, lignans 
and hydroxybenzoic acids had 
the strongest inverse 
associations with CVD risk. 
In this study, The CVD 
risk was not associated 
with flavanone intake.  
CVD mortality 
(Tresserra-
Rimbau et al., 
2013) 
The intake of flavonoid 
was inversely associated 
with the cardiovascular 
(CV) risk 
1,658 individuals were recruited 
between 2001 and 2003, were 
followed for 12 years. 
Anthropometric, laboratory 
measurements, medical history 
and the vital status were 
collected at baseline and during 
2014. The Framingham risk 
score was used to evaluate CV 
risk. 
The lowest intakes of total and 
all subclasses of flavonoids, 
but isoflavones, were linked to 
the 2014 CV risk score and 
increased the risk score from 
baseline. Flavanones, flavan-3-
ols, anthocyanidins had an 
inverse correlation with 
incident CV events. Flavan-3-
ols, anthocyanidins and 
flavanones were linked to 
reduce morality of all-cause. 
Food-frequency 
questionnaire completed 
from baseline was prone to 
cause bias, due to whether 
participants have changed 
their diets or not during the 
12 years. 
CVD,  CHD mortality 
(Mink et al., 
2007a) 
Flavonoid intake was 
associated with reduced 
risk of cardiovascular 
disease. 
34,489 postmenopausal women 
participated to complete FFQ and 
were followed over 16 years. 
Intakes of total flavonoids and 
flavonoid subclasses were 
Anthocyanidins intake was 
significantly associated with 
CHD, CVD, and total mortality 
after adjustment for all of non-
dietary confounders, and 
7 subclasses of flavonoid 
were included to evaluate 
flavonoid intake. The 
observation was achieved 
from postmenopausal 
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assessed. Proportional hazards 
rate ratios (RR) were calculated 
for assessment of CVD, CHD, 
stroke, and total mortality. 
flavonones intake associated 
with CHD. Consumption of 
apples, pears, and red wine 
were associated with reduced 
mortality of CHD and CVD. 
Consumption of bran, 
strawberries, and chocolate 
associated with mortality of 
CVD, and consumption of 
grapefruit was associated with 
lower mortality of CVD. 
women. Sampling could be 
enlarged for all of 
population to identify 
cardio protective effects of 
flavonoids intakes. Food 
source should be further 
studied because of larger 
source of flavanone intake 
from orange and orange 
juice. 
Hypertension 
(Cassidy et al., 
2011) 
Habitual flavonoid intake 
is related to hypertension 
incident 
46,672 women and 23,043 men 
were followed for 14 years. 
Food-frequency questionnaires 
were collected every 4 years. 
The highest anthocyanin intake 
reduced hypertension risk by 8 
%. Flavone (apigenin), flava-3-
ol (catechin) intakes reduced 
hypertension risk separately by 
5% for all participants and by 
6% for participants over 60 y. 
Flavanone intake was not 
associated with lower risk 
of hypertension. 
CVD, Stoke 
(Mursu et al., 
2007) 
The intake of five 
flavonoid subclasses 
(flavonols, flavones, 
flavanones, flava-3-ols 
and anthocyanidins) is 
associated with reduction 
of ischaemic stroke and 
CVD mortality. 
1950 eastern Finnish men 
without CHD and stroke aged 
42-60 years were followed for 
15.2 years. Age, examination 
years, BMI, systolic blood 
pressure, hypertension 
medication, serum HDL- and 
LDL-cholesterol, serum TAG, 
A lower CVD risk was 
associated with the highest 
intake of flavonol and flavan-
3-ol. A lower CVD mortality 
was found in the highest intake 
of flavanone and flavone after 
adjustment for multivariate. 
This study excluded 
women, and onle 4d food 
record from baseline was 
used. The result might exist 
in bias. 
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maximal oxygen uptake, 
smoking, family history of CVD, 
diabetes, alcohol intake, energy-
adjusted intake of folate, vitamin 
E, total fat and saturated fat 
intake were assessed. 
Acute Myocardial 
Infarction 
(Tavani et al., 
2006) 
Intake of flavonoids is 
associated with risk of 
acute myocardial 
infarction (AMI). 
760 patients (580 men and 180 
women) were interviewed 
between 1995 and 2003, and 682 
patients (439 men and 243 
women) were assessed as control 
group. Flavonoids intake was 
assesses based on the US 
flavonoid food composition 
database. Adjusted odds ratios 
(OR) and 95% confidence 
intervals (CI) were calculated by 
using multiple logistic regression 
models. Energy and alcohol 
intake, sociodemographic 
factors, tobaccos were included 
as confounders. 
Highest intake of 
anthocyanidins and flavonols 
reduced AMI risk compared 
with the lowest quintile. 
Higher intake of 
flavanones was only 
associated with the reduced 
risk of AMI after non-
adjustment for alcohol 
intake. Absorption of 
flavonoids might affect its 
protective effects on 
chronic disease. 
Epithelial Ovarian 
Cancer 
(Cassidy et al., 
2014) 
Habitual flavonoid 
subclass intake impacts 
on risk of ovarian cancer 
171,940 participants were 
followed for 16–22 y. Validated 
food-frequency questionnaires 
were collected every 4 y. The 
723 cases of ovarian cancer 
were confirmed during 16-22 
years. The highest group of 
flavonol and flavanone intakes 
The result strongly 
revealed the association 
between flavanone intake 
and reduced risk of ovarian 
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risk of ovarian cancer was 
estimated by using Cox 
proportional hazards models. 
was associated with lower risk 
of ovarian cancer than those in 
the lowest group. Flavanone 
intake had a stronger 
association with serous 
invasive and poorly 
differentiated tumors compared 
with nonserous and less-
aggressive tumors. There was 
no significantly association 
between intake of other 
flavonoids and the risk. 
cancer. Other databases can 
be used to confirm these 
positive effects. 
Cancers 
(Mursu et al., 
2008a) 
High intake of flavonoids 
decreases the risk of 
lung, prostate, and 
colorectal cancer. 
2590 middle-aged eastern 
Finnish men participated and 
were followed for 16.2 years. 
Flavonoid intake, maximal 
oxygen uptake, body weight, 
body mass index, and resting 
systolic blood pressure were 
measured. Blood sample was 
collected. 
62 lung, 138 prostate, and 55 
colorectal cancers were 
reported during follow-up 
period.  Highest intake of total 
flavonoid, flavanols, and flava-
3-ols reduced risk of lung 
cancer, compared to the lowest 
intake. There was no 
association between flavonoid 
intake and the risk of prostate 
and colorectal cancer. 
Women were excluded in 
this study, and 4 days food 
recording might cause bias 
of flavonoid intake on 
humans. 
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Cognitive Function 
(Samieri et al., 
2014) 
Flavonoid intake in 
midlife is relative to 
prevalence of healthy 
aging. 
13,818 women in late 50s 
without chronic diseases were 
recruited in 1984-1986 and were 
followed for 15 y. Healthy aging 
was defined on survival to ≥ 70 y 
with no major chronic diseases 
or major impairments in 
cognitive or physical function or 
mental health. Intakes of 
flavonoid-rich foods were 
retrieved from 2 food-frequency 
questionnaires. 
1517 women achieved healthy 
aging. Women in the highest 
quintile of intake of flavones, 
flavanone, anthocyanin, and 
flavonol at midlife had greater 
odds of healthy aging. 
Oranges, berries, onions, and 
apples were associated with 
increased odds of healthy 
aging. 
The results confirmed 
benefits of favanone 
intakes on cognitive 
function. Case control 
study might provide 
stronger evidence to 
support this association. 
Cognitive Function 
(Butchart et al., 
2011) 
Flavonoid intake is 
related to better cognitive 
function in later life. 
IQ of 1091 men and women born 
in 1936 was measured at age 11 
years. Moray House Test, 
National Adult Reading Test, 
and verbal fluency were 
estimated, and FFQ was 
completed at age of 70 years. 
Total fruit, citrus fruits, apple 
and tea intakes significantly 
associated with better scores in 
cognitive tests before 
adjustment for confounders. 
Better verbal fluency in later 
life was related to flavanone 
intake before adjustment. 
There was an association 
between citrus fruits, 
flavanone intake and 
cognitive function, but 
assessment of flavanoid 
intake was conducted only 
at 11 and 70 years old. It 
needs more works to 
confirm relationship 
between flavonoid intake 
and cognitive function. 
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Parkinson Disease 
(Kuo et al.) 
(Gao et al., 2012) 
Higher intakes of total 
flavonoids and their 
subclasses reduce risk of 
Parkinson disease. 
49,281 men and 80,336 women 
were recruited. Dietary intakes 
were assessed at baseline and 
every 4 years. Tea, berry fruits, 
apples, red wine, and orange / 
orange juice and flavonoids were 
assessed by food composition 
database and FFQ. 
Total flavonoids in the highest 
intake reduced 40% PD risk in 
men after adjustment for 
confounders. There was no 
association in women. 
Anthocyanins intake and 
berries decreased PD risk. 
The association between 
total flavonoid intake and 
PD risk was different in 
women and men, which 
might require to be 
considered in studies on 
flavonoid intake and 
diseases. 
Type 2 Diabetes (Sun et al., 2015) 
Urinary excretion of 
flavonoid and phenolic 
acid metabolites is 
estimated to associate 
with T2D risk. 
29,611 subjects (NHSII) aged 
32– 52 y provided from 1996 to 
2001, and 18,743 participants 
aged 53–80 from 2000 to 2002 
were recruited and provided 
blood and urine.  1111 T2D 
cases were identified and 
randomly selected 1 control for 
each case based on age at urine 
sample collection, month of 
sample collection, first morning 
urine (yes or no), race (white or 
other races), and menopausal 
status and postmenopausal 
hormone use (NHSII only). 
Metabolites in urine were 
analysed. 
Higher urinary excretion of 
hesperetin was linked to a 
lower T2D risk, not other 
polyphenols. Markers of 
flavanone intakes (naringenin 
and hesperetin) and flavonol 
intakes (quercetin and 
isorhamnetin) were 
significantly correlated with a 
lower T2D risk during the early 
follow-up period (~4.6 y). 
None of flavonoids was 
associated with T2D risk 
during later follow-up. Flavan-
3-ols and ferulic acid were not 
linked to T2D risk in either 
period. 
It was the first time to use 
flavonoid metabolites for 
evaluation of association 
with diseases risk. The 
measurement of 
metabolites applied 
hydrolysis that is prone to 
under evaluation of the 
association. 
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Diabetes 
(Wedick et al., 
2012) 
 
 
 
Intakes of flavonoid are 
associated with reduced 
risk of type 2 diabetes. 
 
 
 
A total of 70,359 women in 
1984-2008, 89201 women in 
1991-2007, and 41,334 men in 
1986-2006 were included. FFQ 
was sent to report their dietary 
food- rich flavonoids. Diabetes 
cases were reported. 
During follow-up, 12,611 
participants were diagnosed 
with type 2 diabetes. Higher 
intakes of anthocyanins 
reduced risk of type-2 diabetes 
after adjustment for age, BMI, 
lifestyle and dietary factors. 
Consumption of flavonoids- 
rich fruits, blueberries, 
strawberries and apples/pears, 
was associated with the risk. 
Flavnone intake was also 
associated with the risk, but not 
after adjustment. 
The association between 
flavanone intake and 
diabetes was not found. 
Misclassification of 
flavonoids or population 
relative to food habits 
caused underestimation. 
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1.9.3 Clinical studies of role of flavanones in disease 
Intervention studies can explore the mechanisms by which flavanone and/or metabolites 
impact on disease, when epidemiologic studies reveal an association between citrus flavanone 
intake and disease risk (Table 1-7). Rangel-Huerta and colleagues showed that urinary 8-
hydroxy-2’-deoxyguanosine, 8-iso-prostaglandin F2α, erythrocyte catalase, glutathione 
reductase activities, body mass index, waist circumference and leptin decreased while 
erythrocyte superoxide dismutase activity increased after 12 weeks daily consumption of high 
polyphenol orange juice (745 mg/d ) compared with low polyphenol orange juice (299 mg / 
d) (Rangel-Huerta et al., 2015a). Constans et al observed a significant association between 
antioxidant effect and plasma hesperetin levels, and reactive oxygen species reduced after 4-
weeks daily consumption of 200 mL blond orange juice, which also tended to reduce 
concentration of endothelial dysfunction biomarkers (sICAM) from 172.1 ± 11.7 ngmL
−1 
to 
168.3 ± 11.0 ngmL
−1
, and increase plasma apoA-I from 1.2 to 1.6 g L
−1
 and apoB from 0.5 to 
1.3 g L
−1
 in men with two cardiovascular risk factors (Constans et al., 2014). However, 
consumption oforange juice or a hesperidin supplement (both providing 320 mg hesperidin) 
did not affect endothelial function, blood pressure, arterial stiffness, cardiac autonomic 
function, platelet activation, and NADPH oxidase gene expression, while plamsa 
concentrations of metabolites increased including eight flavanone metabolites (hesperetin-
glucuronide, naringenin-7-glucuronide, hesperetin-glucuronide, hesperetin-diglucuronide,  
hesperetin-diglucuronide, naringenin-glucuronide, hesperetin and naringenin) and 15 
phenolic metabolites (hippuric acid, dihydroferulic acid, dihydroferulic acid–3-glucuronide, 
4-hydroxyphenylacetic acid, vanillic acid, hydroxyhippuric acid, iso/ferulic acid–
glucuronide, 3- hydroxyhippuric acid, isovanillic acid, 3-hydroxyphenylacetic acid, vanillic 
acid–glucuronide, isovanillic acid–glucuronide, iso/vanillic acid–glucuronide, 4-hydroxy-
benzoic acid, benzoic acid–4 glucuronide) in participants aged 51–69 y (Schar et al., 2015).  
Consumption of orange juice displayed anti inflammatory properties in humans. Dalgard et 
al. observed that C-reactive protein (CRP) was decreased by 11 % and fibrinogen by 3 % 
after 4 weeks consumption of juice containing 250mL orange juice and 250mL blackcurrant 
juice in patients with peripheral arterial disease (Dalgard et al., 2009).   
Consumption of orange juice protected against inflammation induced by meals. Ghanim et al. 
showed that a high-fat, high-carbohydrate meal coupled with orange juice increased plasma 
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glucose concentration, endotoxin, inflammatory indexes (protein expression of NADPH 
oxidase subunit p47phox, phosphorylated and total p38 mitogen-activated protein kinase, 
suppressor of cytokine signaling-3, TLR2 and TLR4 messenger RNA (mRNA) and protein 
expression, mRNA expression of matrix metalloproteinase in circulating mononuclear cells) 
(Ghanim et al., 2010). In addition, serum antioxidant capacity significantly increased by 
around 50 µmol TE/L after consumption of both orange juice or hesperidin and naringenin 
with 28 g of Kellogg's Corn Flakes and 118 mL of 2% milk as a typical, high-carbohydrate 
breakfast in health subjects (Snyder et al., 2011). 
However, immune function was not affected by consumption of orange juice or hepseridin. 
Perche et al found that polymorphonuclear neutrophil cells, B and T lymphocytes, NK cells 
and monocytes, ROS production by stimulated phorbol myristate-acetate, lytic activity of NK 
cells or cytokine production capacity of leukocytes were not affected in well-nourished 
humans after 4 weeks of daily consumption of orange juice containing 292 mg hesperidin or 
isocaloric control beverage with a capsule of hesperidin (292 mg) compared with isocaloric 
control beverage with placebo (starch) (Perche et al., 2014). 
Consumption of orange juice may improve cognitive function. Kean et al observed that better 
global cognitive function and improved global performance and memory were found after 8 
weeks daily consumption of flavanone-rich orange juice (305 mg) compared with low-
flavanone (37 mg) orange-flavored in older adults (Kean et al., 2015b).  
Furthermore, Milenkovic et al. found that 4 weeks consumption of orange juice containing 
292 mg/500 mL of hesperidin up-regulated 1,706 genes and down-regulated 1,716, while 4 
weeks consumption of control drink with 2 capsules of hesperidin (146 mg each) up-
regulated 1,033 genes and down-regulated 786 genes in overweight healthy male blood 
leukocytes compared to 4 weeks of control drink and placebo (starch). Those genes which 
have been shown to be involved in processes of signal transduction, cell adhesion, immune 
response, cell proliferation, chemotaxis and lipid metabolism were mostly downregulated, 
while those which were upregulated were linked to the inflammatory response or the I-
kappaB kinase/NFkappaB (Milenkovic et al., 2011).
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Table 1-7 Orange juice / flavanone and disease risk on intervention studies 
Diseases Reference Hypothesis Methods Results Comments 
Cardiovascular disease (Schar et al., 2015) 
Orange juice or a dose-
matched hesperidin 
supplement affects 
cardiovascular risk 
biomarkers in men at 
moderate CVD risk. 
16 participants aged 51-69 y 
consumed orange juice or a 
hesperidin supplement (320 mg) or 
control. Endothelial function, blood 
pressure, arterial stiffness, cardiac 
autonomic function, platelet 
activation, NADPH oxidase gene 
expression and plasma flavanone 
metabolites were assessed at baseline 
and 5 h postintake. 
Cardiovascular risk 
biomarkers were not changed. 
An acute, randomized, placebo-
controlled crossover trial, 
measurements conducted only at 
baseline and 5 h post intake. Other 
biological parameters in biological 
samples might improve accuracy of 
benefits of flavanone or orange 
juice intake in cardiovascular 
diseases. 
Oxidative stress 
(Rangel-Huerta et 
al., 2015a) 
The intake of high 
polyphenol orange juice 
affects antioxidant 
defence system, 
oxidative stress 
biomarkers, and clinical 
signs of metabolic 
syndrome. 
100 nonsmoking overweight or obese 
subjects participated in the 
randomized, double-blind crossover 
study for two 12-wk periods with a 7-
wk washout period. Enzymatic and 
nonenzymatic blood antioxidant 
defence systems, urinary and plasma 
oxidative stress biomarkers, and 
clinical signs of metabolic syndrome 
were assessed before and after 
interventions. 
Urinary 8-hydroxy-2’-
deoxyguanosine, 8-iso-
prostaglandin F2α, 
erythrocyte catalase, and 
glutathione reductase 
activities decreased, as well as 
body mass index, waist 
circumference and leptin. The 
consumption of high 
polyphenol orange juice 
increased erythrocyte 
Flavanone content in orange juice, 
or flavanone metabolites in 
biological samples were not 
analysed, which caused a 
misevaluation whether orange juice 
flavanone contributed to these 
benefits. 
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superoxide dismutase (SOD) 
activity. 
Cardiovascular disease (Constans et al.) 
Blond orange juice 
containing flavanone 
affects antioxidant 
markers, cardiovascular 
biomarkers and 
endothelial function 
25 male volunteers with LDL-
cholesterol between 130 and 190 
mg/L over 50 years were recruited in 
this randomized cross-over study. 
200 mL of either blond orange juice 
or control beverage was consumed 3 
times every day for 4 weeks. 
Endothelial function (flow mediated 
dilatation and plasma markers), 
oxidative status, lipid profile and 
inflammatory markers were analysed. 
Improved antioxidant effect 
was linked to hesperetin 
plasma levels, while reactive 
oxygen species decreased. 
Endothelial dysfunction 
tended to decrease and plasma 
apoA-I concentration tended 
to increase. 
The results supported effects of 
orange juice hesperetin on 
cardiovascular diseases in subjects 
with risk factors. Sampling can be 
extended to healthy humans and 
females for assessment of 
flavanone in CVD diseases in 
future. 
Endothelial and Vessel 
Function 
(Milenkovic et al., 
2011) 
Chronic consumption of 
orange juice influence 
the gene expression 
profile of leukocytes and 
hesperidin contribute to 
nutrigenomic effects of 
orange juice. 
24 overweight men at age of 50-65 
years were divided into three groups 
to consume control drink with 
placebo, control drink with 
hesperidin, or orange juice for 4 
weeks in a randomized, controlled, 
crossover study. Fasting blood 
samples were collected after 4-week 
dietary intervention. Global gene 
expression profiles were estimated by 
Leukocyte gene expression 
was affected after 4-week 
orange juice and hesperidin 
intakes, which are related to 
chemotaxis, adhesion, 
infiltration of circulating cells 
to vascular wall and lower 
lipid accumulation. 
It was first to study effect of orange 
juice and hesperidin on human 
vascular function at the molecular 
level. It is a suggestive direction to 
understand exact effect of 
flavonoids on human diseases. 
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human whole genome cDNA 
microarrays. 
Arterial Inflammation 
(Dalgard et al., 
2009) 
Both orange and 
blackcurrant juice 
reduce levels of 
inflammatory markers in 
patients with CVD. 
48 patients with peripheral arterial 
disease (PAD) participated in the 
block-randomised, 2×2 factorial 
crossover trial with two intervention 
periods of 4 weeks and one wash-out 
period of 4 weeks. 250mL orange and 
250mL blackcurrant juice with 
vitamin E; juice with placebo-vitamin 
E; placebo with vitamin E; placebo 
with placebo- vitamin E were 
consumed for 4 weeks. Venous blood 
samples were collected, 3d apart, at 
baseline and at the end of each 
intervention period. C-reactive 
protein (CRP) and IL-6 
concentrations were measured. 
Juice reduced C-reactive 
protein (CRP) by 11% and 
fibrinogen by 3%. 
This study supported effects of 
orange juice on patients. Healthy 
subjects can be considered to 
extend the effect of fruit juice in 
population. 
Inflammation and 
Oxidant Stress 
(Ghanim et al., 
2010) 
Orange juice affects 
high-fat, high-
carbohydrate (HFHC) 
meal-induced 
inflammation and 
30 healthy subjects divided into 3 
groups consuming water, 300 kcal 
glucose or orange juice with a 900-
kcal HFHC meal. Blood were 
collected before and 1, 3, 5 h after 
Orange juice with meal 
significantly reduced protein 
expression of the NADPH 
oxidase subunit p47(phox), 
phosphorylated and total p38 
Orange juice was evidenced to 
display its postprandial effects. 
Flavanone and their metabolites 
could provide more information 
about their anti-inflammation and 
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oxidative stress and the 
expression of plasma 
endotoxin and Toll-like 
receptors. 
intaking. Circulating mononuclear 
cells (MNCs) were isolated. ROS-
generation was measured by 
chemiluminescence. Total RNA was 
isolated and real-time reverse 
transcriptase polymerase chain 
reaction was measured. Endotoxin, 
serum MMP-9, plasma-glucose and 
insulin concentration were measured. 
mitogen-activated protein 
kinase, and suppressor of 
cytokine signaling-3; TLR2 
and TLR4 messenger RNA 
(mRNA) and protein 
expression; mRNA expression 
of matrix metalloproteinase 
(MMP)-9 in MNCs; and 
plasma concentrations of 
endotoxin and MMP-9, and 
generation of reactive oxygen 
species 
autoxidation. 
Blood Oxidant Stress (Snyder et al., 2011) 
Orange juice flavonoids 
reduce postprandial 
oxidation. 
16 male and female participants were 
divided into 4 groups: placebo 
(ascorbic acid) with sugar and 
sucrose; placebo (ascorbic acid and 
sugar mixture) with hesperidin; 
placebo (ascorbic acid and sugar 
mixture) with naringenin and 
luteolin; fresh-squeezed navel orange 
juice. Serum oxygen radical 
absorbance capacity (ORAC), total 
plasma phenolics (TP), and serum 
ORAC and LO lag time 
significantly increased after 
consumption of orange juice 
and placebo with hesperidin, 
lutelin and naringenin. 
This study confirmed serum 
antioxidant capacity of flavonoids 
in orange juice. 
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lipoprotein oxidation (LO) were 
measured before and 1, 2, and 3 h 
after intervention. 
Cognitive benefits (Kean et al., 2015b) 
Daily consumption of 
flavanone-rich orange 
juice benefits cognitive 
function in healthy older 
adults. 
A crossover, double-blind, 
randomized trial was conducted. 37 
healthy older adults daily consuming 
high-flavanone orange juice or a 
placebo for 8 wk. Cognitive function, 
mood, and blood pressure were 
assessed at baseline and after 
treatments. 
Global cognitive function was 
significantly improved after 
8-wk consumption of 
flavanone-rich juice compared 
with the low-flavanone 
control. Mood and blood 
pressure was not significantly 
affected. 
The results supported benefits of 
flavanone rich orange juice in 
cognitive function. Flavanone 
metabolites might provide more 
accurate evdence. 
Immune function (Perche et al., 2014) 
Orange juice and its 
major polyphenolic 
compound hesperidin 
affect immune cell 
functions. 
24 healthy participants randomised 
for daily consumption of 500 mL 
orange juice, hesperidin, or placebo. 
Fasting bloods were taken at baseline 
and at the end of each 
intervention.Excreted cytokine, lytic 
activity of NK cells, and reactive 
oxygen species were assessed. 
PMN, B and T lymphocytes, 
NK cells and monocytes, 
ROS production, lytic activity 
of NK cells or cytokine 
production capacity of 
leukocytes were not affected. 
This study is inconsistent to other 
studies about orange juice intake in 
immunological function. Subjects 
(healthy or patients, male or 
female, active or inactive) or 
extended intervention period should 
be further studies to achieve the 
hypothesis. 
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1.9.4 Phenolic acids and diseases 
In comparison with flavonoids, phenolic acids as metabolites from flavonoids have been little 
studied for their benefits in humans. The health effects of phenolic metabolites are mostly 
attributed to experimental studies linked to several chronic diseases by searching PubMed 
targeting specific phenolic acids and ‘disease’ or ‘cancer’, there were eight relevant papers 
(Table 1-8). 4-hydroxybenzoic acid, isovanillic acid, isovanillic acid -glucuronide, vanillic 
acid-glucuronide, protocatechuic acid-3-sulfate, and benzoic acid sulfate significantly 
reduced secretion of pro-inflammatory cytokine TNF-α, and IL-1β secretion was inhibited by 
4-hydroxybenzoic acid at physiological concentrations in human THP-1 monocytic cells 
stimulated by lipopolysaccharide (Gesso et al., 2015). 3, 4-dihydroxybenzoic acid 
(protocatechuic acid) increased caspase-3 and caspase-8 activities, and decreased intercellular 
adhesion and concentration of interleukin IL-6 and IL-8 in human breast cancer, lung cancer, 
HepG2, cervix HeLa, and prostate cancer cells (Yin et al., 2009). Kampa and his colleagues 
also found anti-proliferation activity of 4-hydroxybenzoic acid in T47D human breast cancer 
cells (Kampa et al., 2004). It also increased activity of peroxisome proliferator–activated 
receptor-γ that controls glucose and lipid metabolism, and adiponectin and GLUT4 levels in 
human omental adipocytes (Scazzocchio et al., 2011). In addition, protocatechuic acid 
reduced IL-6 protein levels in ox LDL-stimulated and CD40L-stimulated vascular endothelial 
cells, and protocatechuic acid-4-sulfate decreased CD40L-stimulated vascular endothelial 
cells (Amin et al., 2015). Similarly, the anthocyanin and its metabolites reduced production 
of VCAM-1 protein, 3-O-methylgallic acid and 3, 4-dihydroxyphenylacetic acid respectively 
at the concentration of 260 µM and > 400 µM significantly inhibited proliferation of HCT116 
colon cancer cells (Henning et al., 2013). 3, 4-dihydroxyphenylacetic acid also attenuated 
proliferation of prostate cancer cells (LNCaP) at135 µM and colon cancer cells (HCT116)  at 
90 µM, and had more inhibitory effect on colon cancer cells compared with normal intestinal 
epithelial cells (IEC6) (Gao et al., 2006b). 3, 4-dihydroxyphenylacetic acid and 4-hydroxyl-
phenylacetic acid at 2 mM have been shown to have anti-platelet aggregation activity in 
cancer cells (Kim et al., 1998). 3-hydroxybenzoic acid and 3-(3´-hydroxyphenyl) propionic 
acid inhibited aggregation of β-amyloid peptides into neurotoxic β-amyloid, linked to 
Alzheimer’s disease neuropathogenesis (Wang et al., 2015). 
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Table 1-8 Phenolic acids and diseases and cancers 
Related disease Sources Phenolic acids Results 
Alzheimers Disease (Wang et al., 2015) 3-hydroxybenzoic acid  
3-(3´-hydroxyphenyl)propionic acid 
The aggregation of β -amyloid peptides 
into neurotoxicamyloid was decreased in 
in vitro incubation of Aβ1–42 peptides 
(25 µM) 
Vascular Disease (Amin et al., 2015) Protocatechuic acid  IL-6 protein levels in oxLDL stimulated 
vascular endothelial cells was reduced 
Protocatechuic acid-4-sulfate IL-6 protein production was reduced In 
CD40L-stimulated cells 
Diabetes (Scazzocchio et al., 2011) Protocatechuic acid 
 
Increased adipocyte glucose uptake and 
GLUT4 membrane translocation, nuclear 
PPARγ activity, adiponectin and GLUT4 
expressions, and prevented against 
pathology associated with insulin 
resistant. 
Monocytic Leukemia (Gesso et al., 2015) Isovanillic acid,  
Isovanillic acid-glucuronide,  
Vanillic acid-glucuronide, Protocatechuic 
acid-3-sulfate,  
Benzoic acid-sulfate, 
4-Hydroxybenzoic acid  
Protocatechuic acid 
TNF-β secretion of human monocytic 
cells (THP-1) stimulated by LPS was 
reduced. 
4-Hydroxybenzoic acid IL-1β secretion of human monocytic cells 
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(THP-1) stimulated by LPS was reduced. 
Cancers (Yin et al., 2009) Protocatechuic acid 
 
 
Human breast cancer MCF7 cell, lung 
cancer A549 cell, HepG2 cell, cervix 
HeLa cell, and prostate cancer LNCaP 
cell, breast MCF10A, lung IMR-90, and 
prostate PrEC cells viability, 
mitochondrial membrane potential, and 
Na
+
-K
+
-ATPase activities were reduced, 
while lactate dehydrogenase leakage, 
caspase-3 activity (2-8 μmol/L), DNA 
fragmentation in cancer cell were 
increased. Cell adhesion, vascular 
endothelial growth factor (IL-6 and IL-8) 
was inhibited at 2-8 μmol/L. 
(Kampa et al., 2004) Caffeic acid, ferulic acid, protocatechuic acid, 
3, 4-dihydroxyphenylacetic acid, sinapic acid 
and syringic acid 
Growth of breast cancer cells was 
inhibited.  
 3, 4-dihydroxyphenylacetic acid Nitric oxide synthase of breast cancer 
cells was reduced. 
(Gao et al., 2006a) 3, 4-dihydroxyphenylacetic acid Proliferation of the prostate and colon 
cancer cells were inhibited, and colon 
cancer cells were inhibited more than 
normal intestinal epithelial cells. 
(Kim et al., 1998) 3, 4-dihydroxyphenylacetic acid, 4-
hydroxylphenylacetic acid 
Inhibited platelet aggregation of human 
stomach cancer cells (SNU-1), human 
colon cancers (SNU-C4), mouse 
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lymphoid neoplasma cells (P-388D1), 
mouse lymphocytic leukemia cells (L-
1210), human hepatoblastoma cells 
(HepG2), human lung cancer cells (A549) 
and Macacus' rhesus monkey kidney cells 
(MA-104), quercetin and ponciretin were 
more effective on cytotoxicity for tumor 
cell lines. 
 2, 4, 6-trihydroxybenzaldehyde Cytotoxic activities on human stomach 
cancer cells (SNU-1), human colon 
cancers (SNU-C4), mouse lymphoid 
neoplasma cells (P-388D1), mouse 
lymphocytic leukemia cells (L-1210), 
human hepatoblastoma cells (HepG2), 
human lung cancer cells (A549) and 
Macacus' rhesus monkey kidney cells 
(MA-104) 
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1.10 Flavonoids, health effects and exercise 
Flavonoids have been widely studied to explore their beneficial effects in athletes and sports. 
Endurance capacity and VO2 max were increased during a cycling test by 13.2 % and 3.9 % in 
healthy untrained volunteers  supplementing quercetin (500 mg) twice daily for 7 days (Davis 
et al., 2010). The increase in F2-isoprostanes induced by exercise was significantly attenuated 
in athletes after supplementing 120 mg resveratrol and 225 mg quercetin for 6 days and 240 
mg resveratrol and 450 mg quercetin on day 7 (McAnulty et al., 2013). This indicated that 
flavonoid supplements can reduce lipid peroxidation induced by exercise. In addition, blood 
lactate concentration decreased by 27 % in overweight, middle-aged women conducting 1 h 
aerobic training 3 times a week for 3 months and consumed 500 mL/d of orange juice 
compared with control group who did not drink orange juice, which revealed that 
consumption of orange juice was potential to attenuate muscle fatigue and enhance exercise 
performance (Aptekmann and Cesar, 2010). Furthermore, the inhibitory effects of flavonoid 
intake on muscle force loss, muscle damage and oxidative stress biomarkers (creatine 
phosphokinase , lactate dehydrogenase and malondialdehyde ) induced by exercise, was 
confirmed in mice by feeding catechin for 8 weeks (Haramizu et al., 2011).  
However, the effect of physical activity on the bioavailability and absorption of dietary 
flavonoids has been rarely investigated. In a cross sectional study, it was found that 24 h 
urinary excretion of naringenin, eriodictyol, and hesperetin metabolites were 92 %, 88 %, and 
53 % higher in very well trained athletes than in sedentary individuals after ingestion of 
aronia-citrus juice (a mixture of citrus juice (95 %) with 5 % of Aronia. Melanocarpa juice 
containing 86.1 mg of flavanone per 400 ml) (Medina et al., 2012). 
Gut bacteria is associated with metabolism of polyphenols in the colon. The gut microbiota 
could be modified by frequent physical activity, which also influences bowel movements 
(Zheng et al., 2003a, Holdstock et al., 1970). Clark et al reported that there were 48 bacterial 
taxa in significantly greater abundance in athletes than in high BMI (> 28) controls excluding 
Bacteroidetes, and 40 taxa excluding Lactobacillaceae, Bacteroides and Lactobacillus than 
lower BMI (< 25) controls by measuring 16S rRNA of fresh stool samples (Clarke et al., 
2014).  An animal study revealed  different TGGE profiles of gut bacteria 16S rRNA from 5 
of 7 male rats which accessed voluntary wheel-running exercise for 5 weeks compared with 7 
male rats without exercise for 5 weeks, where another two rats subjected to the exercise had 
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different TGGE profiles from others  (Matsumoto et al., 2008). If the bacteria change with 
exercise then the flavanone metabolism in the gut may also change.   
Intensive exercise has also been illustrated to prolong gut transit time that might affects the 
timing and amount of dietary flavonoids reaching the colon for bacterial degradation and 
further absorption(Brouns and Beckers, 1993, Spencer and Crozier, 2012). In addition, many 
gastrointestinal hormone related to motility, metabolism and absorption functions have been 
reported to change by increased physical activity (O'connor et al., 1995).  
Absorption of flavonoids involves epithelial brush border membrane transporters, such as Na-
dependent GLUT-1, and UDP-glucuronosyl transferase (Gee et al., 1998, Henry-Vitrac et al., 
2006). However, Piatkowski et al reported that 8-week treadmill running did not affect UDP-
glucuronosyl transferase, beta-glucuronidase, and glutathione-S-transferase in young and 
middle-aged male rats (Piatkowski et al., 1993). 
In addition, physiological functions of gastrointestinal intestine tract have been linked to 
absorption or/and rate of drug and flavonoids, such as gastric emptying and gut transit time 
(Clements et al., 1978, Mullen et al., 2008a, Mullen et al., 2008b, Mullen et al., 2009a). In 
addition, marathon runners had faster gastric emptying than sedentary subjects (67.7 min vs. 
85.3 min) measured by recording stomach radioactivity of an isotope marker (human serum 
albumin), which was injected into a raw egg for making an omelette (Carrio et al., 1989).  
Koffler and his colleagues found that whole bowel transit time was significantly shortened 
from 41 ± 11 h to 20 ± 7 h in 7 healthy sedentary males through 13-wk (3 d
.
wk
-1
) body 
strength training program by using keiser K-300 variable resistance machines, whereas mouth 
to cecum transit time was not influenced (1.83 ± 0.32 hr vs. 1.40 ± 0.25 hr) (Koffler et al., 
1992).  
Gastrointestinal hormones might be related to intestinal physiological functions. Peptide YY 
delayed gut transit time from 67 ± 4 mins to 94 ± 7 mins and 192 ± 9 mins, and prolonged 
gastric emptying from 37 ± 8 mins to 63 ±10 mins and 130 ±12 mins when subjects received 
low dose of infusion at 0.4 pmol/kg/min dose (50 ml), and high dose infusion at 1.1 
pmol/kg/min (50 ml) (Savage et al., 1987). Naslund and his colleagues supposed that peptide 
YY was responsible for intestinal motility and glucagon-like peptide -1 dominated early 
gastric emptying (Naslund et al., 1998). The gastrointestinal hormones (vasoactive intestinal 
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polypeptide, gastrin, secretin, pancreatic polypeptide, neurokinin A, pancreastatin, and 
glucagon-like peptide 1) were significantly increased after a 30 min race in 26 marathon 
runners (O'connor et al., 1995).   
In addition, metabolites are circulated through blood stream in the body. However, blood 
flow required for exercising muscle and lung is diverted away from the GI tract and tissues 
(Duncker and Bache, 2008, Flamm et al., 1990, Khazaeinia et al., 2000). Cycling decreased 
blood flow in the spleen, kidney and liver by 46 %, 24 % and 18 % whereas blood flow 
increased in active muscle (leg) by 50 % in humans (Flamm et al., 1990). In comparison with 
resting, renal blood flow was decreased by 53.4 %, 17.5 % and 21.1 % respectively 
immediately, 30 min and 60 min after cycling in six males (Suzuki et al., 1996).  
However, forearm blood flow was 64 % higher in athletes than sedentary people by using 
capacitance plethysmography (Ebeling et al., 1993). There was a marginally significantly 
lower hepatic blood flow (15.6 mL/min/kg vs. 18.2 mL/min/kg) in participants undertaking 
16 weeks exercise (40 min treadmill walking, stairclimbing, or combination three times per 
week) compared with subjects without exercise (Pollock et al., 1995). In addition, biliary 
excretion of endogenous bile acids and reduced and oxidized glutathione were increased 
respectively by 190 % and 173 % respectively in female rats with 6 weeks running exercise 
compared with sedentary rats (Watkins et al., 1994). Therefore, physical activity modified gut 
physiological function, gut bacteria and circulatory system that potentially influence 
bioavailability of flavanone so that induce variable benefits in humans by the intake of 
dietary flavonoids.  
1.11 Aim of thesis  
Based on the review of the literature above, it is clear that flavanones and flavanone-rich food 
constitute an integral part of the diet and may enhance human health. However, many factors 
could cause inconsistent effects, such as food sources, food matrix, age, ethnicity and 
physical activity. On the other hand, although the bioactive properties of flavanone have been 
reported in several studies flavanone bioavailability is low in humans. The impact of 
metabolites and phenolic acids produced in the body may be more important. Flavanone 
metabolites are more complex than the ingested parent flavanone, and possible synergistic or 
antagonistic effects can not be ignored. Thus in this thesis, factors affecting the bioavailablity 
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and metabolism of orange juice flavanones, including food source, food matrix and physical 
exercise, were considered to investigated in order to enhance their beneficial effects in 
humans. 
    The following hypotheses were to be tested: 
1 The release and stability of of flavanones in orange juice and their degradation 
by gut bacteria in the gastrointestinal tract are influenced by the source and 
formulation of the juice. 
2 Full fat natural yoghurt affects the stability and gut bacterial metabolism of 
flavanone in orange juices in in vitro models of  the gastrointestinal tract 
3 Physical exercise affects the bioavailability and metabolism of orange juice 
flavanones in healthy sedentary humans 
    To investigate these hypotheses, the following studies were conducted: 
1 Smooth orange juice and orange juice ‘with bits’ from six different brands 
were analysed to assess the variability in flavanone content between brands and the 
impact of inclusion of pulp ‘bits’(chapter 3) 
2 The metabolism of flavanones was investigated in smooth orange juice and 
orange juice ‘with bits’ using stimulated GI digestion and fermentation models 
(chapter 3) 
3 Full fat natural yoghurt (no live bacteria) was incubated with smooth orange 
juice and orange juice ‘with bits’ to investigate any differences in metabolism of 
orange juice flavanone in an in vitro model of the upper GI tract and colonic 
fermentation model (chapter 4) 
4 To investigate the mechanism by which yoghurt may influence flavanone 
metabolism, the fate of orange juice flavanones in models of the upper GI tract were 
compared in the presence of Full fat natural yoghurt (no live bacteria), probiotic 
yoghurt (live bacteria) and fruit yoghurt (no live bacteria but additional  polyphenols 
from the fruit) (chapter 4). Raftiline and glucose were used to investigate the effect of 
inclusion of different types of fermentable non digestible carbohydrates (dietary fibre) 
on colonic metabolism of hesperidin by gut bacteria (chapter 5) 
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5 A 4 week physical exercise intervention study was conducted to assess 
bioavailability and metabolism of orange juice flavanone in previously healthy 
sedentary humans (chapter 6) 
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CHAPTER 2 General Methods 
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2.1 Introduction 
As discussed in chapter 1, it is essential to understand the metabolism and bioavailability of 
dietary flavonoids which may determine thebeneficial effects of dietary polyphenols in the 
host. Thus, it is important to consider factors that may affect bioavailability of orange juice 
flavanone by interactions between dietary flavonoids (flavanone) and the food matrix, and 
physical activity which m act through physiological, metabolic and absorptive processes. 
This chapter covers the common methods used throughout the whole thesis. More specific 
methods will be described in the individual chapters. 
Advanced analytical equipment, such as HPLC-PDA, HPLC-MS and GC-MS were used in 
this thesis to measure polyphenols and their metabolites. The total phenol content and 
antioxidant capacity of orange juices and biological samples (plasma, urine,) were also 
measured using colorimetric assays. Hesperidin, narirutin, total phenol, total flavonoid 
content, and antioxidant capacity were measured in a range of orange juices. Flavanone 
metabolites, phenolic acids, total phenols and antioxidant capacity, pH were measured in the 
in vitro models of the GI tract. In the human studies, flavanone metabolites in plasma and or 
urine were measured. These methods are detailed below (Figure 2-1). 
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Figure 2-1 Flow of studies in this thesis and the factors studied 
The factors affecting bioavailability of orange juice flavonoids were tested in different models, 
including food source, food matrix, people and physical exercise, the final boxes are the analysis 
done on samples in this thesis. NDC: Non-digestible carbohydrates.  
2.2 Orange Juices 
The orange juices used in this thesis were purchased from local supermarkets in Glasgow: 
Tropicana Company, Leicester, U.K; Innocent, Innocent Ltd, London, U.K; Sainsbury’s own 
brand orange juice, Sainsbury's Supermarkets Ltd, London, U.K; Tesco own brand orange 
juice, Tesco Stores Ltd., U.K; Morrison’s own brand orange juice, Wm Morrison 
Supermarkets PLC, Bradford, U.K; Waitrose own brand orange juice, U.K. These companies 
all produce smooth orange juice and a corresponding orange juice ‘‘with bits’’. The term 
‘‘with bits’’ is used by these manufacturers to describe the inclusion of pulp in the juice. The 
actual content of the ‘bits’ (pulp) in orange juices was not clear.  However orange pulp has 
been reported to be 9.8 % of proteins, 2.4 % of lipids, 2.7 % of ash contents, 9.3 % of total 
carbohydrates and 74.9 % of total dietary fibre content 54.8 % (insoluble dietary fiber and 
20.1 % soluble dietary fibre) (Larrea et al., 2005). We had the dietary fibre content of the 
juices used in this thesis measured by the AOAC method (Prosky et al., 1988) (The analysis 
of dietary fibre was conducted by Prof Kofi E Aidoo at School of Health and Life Science, 
Glasgow Caledonian University) There was much less fibre than that reported above (see 
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chapter 3). The juices used were 100 % squeezed, not from concentrate. Tropicana orange 
juices were purchased in April of 2013, Sainsbury’s, Tesco and Innocent orange juices were 
purchased in August of 2013, Waitrose and Morrison’s orange juices were obtained in March 
of 2014.   
2.3 In vitro gastrointestinal digestion and fermentation 
model 
The model to simulate gastric and small intestinal digestion was adapted from Gil-Izquierdo 
with some modifications (time and orange juice volume shown below) (Gil-Izquierdo et al., 
2003). This in vitro procedure consisted of two sequential steps: an initial gastric phase: 
pepsin / HCl (pH 2) for 1 h and a small intestinal phase: pancreatin enzymes/bile salts pH 7 
for 6 h. Orange juice (40 mL) was used for gastric and small intestinal digestion, and then 
colonic fermentation based a proportion of 250 mL orange juice reaching colon consumed by 
subjects in Mullen’s study (Mullen et al., 2008a). 
2.3.1 Gastric phase 
The sample was incubated for 1 hour at 37 °C in a shaking water bath at 100 stokes/min with 
pepsin (from porcine gastric mucosa, EC 3.4.23.1, Sigma, Steinheim, Germany). For the 
gastric phase digestion, orange juice was adjusted to pH 2 by adding concentrated HCl (5 M), 
and pepsin added (0.32 % w/v) in 0.1 M HCl in cap-sealed bottles, and then incubated in a 37 
°C shaking water bath at 100 stokes/min for 1 h. 
2.3.2 Small intestinal phase 
After the gastric phase, the orange juice digesta was neutralized with NaHCO3 before adding 
pancreatin (4 g/l; from porcine pancreas, Sigma, UK) and bile extract (25 g/l; containing a 
mixture of sodium cholate and sodium deoxycholate, Sigma, UK) in 0.1 M NaHCO3. 
Digestion was performed at 37 °C for 6 h in a shaking water bath at 100 stokes/min. During 
the intestinal digestion, cellulose dialysis tubing (molecular weight cut-off 0.1-0.5 kDa, 
Sigma) was used to allow carbohydrates, fatty acids and peptides to pass through the dialysis 
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membrane into a 5L beaker filled with 5 L of distilled water. At the end of the small intestinal 
digestion with cellulose dialysis tubing, digestas were collected and subjected to freeze 
drying to remove water for colonic fermentation by using Freeze Dryer (Edwards Micro 
Modulyo.) 
For evaluation of  stability/ release of hesperidin and narirutin in orange juice during this 
stage, the digesta was not incubated with the dialysis membrane in order to avoid loss of 
flavanones released (Bermúdez-Soto et al., 2007). Aliquots (1.5 mL) were taken before and 
after the pepsin digestion, 2 h, 4 h and 6 h during the pancreatin / bile acids digestion, and 
quickly stored at -80 °C until analysis.  
2.3.3 Colonic phase 
After collection of digesta from the dialysis membrane tubing, digesta was freeze-dried by 
using Edwards Micro Modulyo Freeze Dryer. The residues were stored at - 80 °C until 
colonic fermentation.   
2.3.3.1 Faecal sample collection 
Faecal samples were collected from Caucasian volunteers who had a normal diet, were non-
smokers, had no digestive diseases, no food allergies, and had not received antibiotics for at 
least 6 months before the study. The volunteers followed a low-polyphenol diets avoiding 
fruits, vegetables, tea, coffee, wine and wholemeal foods for 2 days before providing a faecal 
sample (Appendix-3). The faecal sample was collected in a plastic box containing an 
AnaeroGen sacket (Oxioid, Basingstoke, Hampshire, UK) to generate anaerobic conditions, 
and processed within 1-2 h of passage. 
2.3.3.2 In vitro fermentation with human colonic bacteria 
The fermentation medium was prepared as described by Jaganath (Jaganath et al., 2009) . In 
brief, 2 g of tryptone was mixed in 400 mL of distilled water and 100 µl of micromineral 
solution consisting of 13.2 g of CaCl2
. 
2H2O, 10 g of MnCl2
. 
4H2O, 1 g of CoCl2
. 
6H2O, 8 g of 
FeCl3
. 
6H2O, and distilled water up to 100 ml, 200 ml of buffer solution (2 g of NH4HCO3, 
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17.5 g of NaHCO3, and distilled water up to 200 ml), 200 ml of macromineral solution (2.85 
g of Na2HPO4, 3.1 g of KH2PO4, 0.3 g of MgSO4
.
7H2O, and distilled water up to 200 ml), 
and 1 mL of 1 % (w/v) of resazurin solution (a redox indicator). The medium was adjusted to 
pH 7 using 6 M HCl, boiled, and allowed to cool under oxygen-free nitrogen (OFN) to 
remove oxygen. Reducing solution (312 mg of cysteine hydrochloride, 2 mL of 1 M NaOH, 
312 mg of Na2S
. 
9H2O, and distilled water up to 50 ml) was added at 0.5 ml / 10 ml of 
medium after which the solution was purged with OFN until anaerobic conditions were 
obtained. 
Fresh faeces were homogenized with sodium phosphate buffer (pH = 7) to obtain 32 % faecal 
slurry. Faecal slurries were then strained through a nylon mesh to remove particulate 
materials. Strained slurry (5 ml) was added to the mixture of fermentation medium and 
reducing solution. Each batch culture consisted of slurry mixture (50 ml) with digested 
orange juice powder, or hesperidin, or hesperidin plus 0.5 g glucose, or hesperidin plus 
raftilne. No substrates were added for the controls. The amount of hesperidin (10 µg) was 
based on the levels of orange juice consumed by subjects in chapter 3.   
The 50 ml fermentation bottles were sealed air-tight with polyethylene caps and flushed with 
OFN before incubation in a 37 °C shaking water bath at 60 stokes/min and protected from the 
light by a metal cover on the top of the water bath. The fermentation bottles were incubated 
for 24 h in duplicate. Aliquots of the fermentation fluid (8 ml) were collected at 0, 2, 4, 6, 24 
h, and stored at -80 °C until analysis. pH was measured at 0, 2, 4, 6, 24 h by an auto 
calibrated portable digital pH meter model (Hanna pH20instruments, USA).  
2.4 Analysis of flavanones in orange juice 
Orange juice (1 mL) was mixed with 1 ml of methanol for 10 min by using an Ultraturrax 
homogenizer (Fisher Scientific, UK). The mixture was centrifuged at 4500 g at 4 °C for 10 
min. The pellet was extracted with 0.5 mL of methanol for 10 min, and then centrifuged at 
4500 g at 4 °C for 10 min in duplicate. The extracts were centrifugally evaporated under 
vacuum at room temperature using a Thermo Speedvac concentrator. The residue was 
resuspended with 25 μl of methanol and made up to 1 mL with 0.1 % formic acid for 
analysis. 
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2.4.1 Determination of total phenolic compounds 
Total phenolic compounds were determined by using the Folin-Ciocalteau method (Singleton 
and Rossi, 1965). The above extracts (20 µl) were added and mixed with 100 µl of Folin-
Ciocalteu’s reagent (1:10) and 70 µl of distilled water in 96-well plates in triplicate. After 5 
min, 70 µl of sodium carbonate solution was added. The samples were incubated for 2 h and 
then read at 765 nm by using a Multiskan spectrum plate reader (Thermo Fisher Scientific 
Inc., Stafford ST, UK). Gallic acid was used for the standard curve ranging from 50 to 800 µg 
/ ml. All results were expressed as grammes gallic acid (g GAE) / ml orange juice. 
2.4.2 Determination of total flavonoids  
Total flavonoids were determined by using the spectrophotometric method based on the 
production of complex compounds of flavonoids with aluminium chloride (Chang et al., 
2002). The extracts (100 µl) were added into 96 well plates. Aluminum chloride solution (10 
%, 60 µl) and potassium acetate (30 µl), distilled H2O (95 µl) were then added. After 
incubation at room temperature for 30 min, the absorbance of the reaction mixture was 
measured at 415 nm. Total flavonoids were expressed as mg/ml quercetin equivalent (QE). 
Total flavonoid content was calculated with respect to a quercetin standard curve ranging 
from 50 to 200 μg/ mL. 
2.4.3 Determination of antioxidant capacity (FRAP) 
Antioxidant capacity was determined by FRAP assay in a redox-linked colourimetric 
reaction. The method is based on the reduction of ferric (Fe
3+
) to ferrous (Fe
2+
) ion at low pH. 
This causes the formation of a blue colored ferrous-tripyridyltriazine (Fe
2+
-TPTZ) complex, 
which absorbs at 593 nm. Orange juice (25 µl) was incubated with 225 µl FRAP reagent for 4 
min in 96-well plates in triplicate. Samples were read at 593 nm by using the Thermo 
Multiskan spectrum plate reader (Thermo Fisher Scientific Inc., Stafford ST, UK). Aqueous 
solutions of known Fe
2+
 concentration (0.2 to 1 mmol/l; FeSO4∙7 H2O) were used as the 
standard curve and all results are expressed in mmol Fe
2+
 equivalents (TE) per litre (mM). 
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2.5 Analysis of digesta, faecal samples or urine  
2.5.1 Urine 
In this thesis, urine was directly injected into HPLC-MS after centrifugation at 13,000 rpm at 
4 °C for 10 min. Supernatants were injected into HPLC-MS for analysis. 
2.5.2 Extraction of digested and faecal samples for flavanone and 
total phenols analysis 
The polyphenols were extracted by using methanol or ethyl acetate (Mullen et al., 2008a, 
Mullen et al., 2009a). Samples were thawed and homogenized with a Disruptor Genie 
(Scientific Industries, UK). Sample (1 mL) and methanol (1 mL) containing 1% formic acid 
were added to the glass tube and vortexed for 10 min at room temperature. The mixtures were 
centrifuged at 13,000 rpm at 4 °C for 10 min. Supernatants were collected, and pellet was 
mixed with 0.5 ml of methanol and vortexed for 10 min and centrifuged at 13,000 rpm at 4 
°C for 10 min in duplicates. Supernatants were combined and homogenized, and aliquot (1.5 
mL) was centrifugally evaporated under vacuum at room temperature using a Thermo 
Speedvac concentrator. Residues were then resuspended with 25 μl of methanol and 475 μl of 
0.1% formic acid, and centrifuged at 13,000 rpm at 4 °C for 5 min until analysis by HPLC-
PDA. 
2.5.3 Extraction of digesta and faecal samples for phenolic acids 
analysis 
Phenolic acid extraction, derivatisation and analysis were performed by using the method 
from Combet (Combet et al., 2011). Each faecal sample and calibration standard (0.5 ml) 
were mixed with 30 µl of 2, 4, 5-trimethoxycinnamic acid (TMCA) as an internal standard 
and 60 µl of aqueous 1M HCl. Mixtures were vortexed and then placed at 4 °C for 10 min. 
Anhydrous ethyl acetate (1.5 mL) was added to mixtures for 30 s vortex, and then centrifuged 
at 2700 g at 4 °C for 10 min. The upper organic layer was transferred to an amber glass vial 
in a 37 °C aluminium block and dried under a gentle flow of nitrogen. The residue solutions 
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were extracted with 1.5 ml of anhydrous ethyl acetate, and upper layers were transferred to 
the amber vial and dried under a gentle flow of nitrogen. Dichloromethane (DCM) (200 µl) 
was added to rinse walls of the vials and dried under a slight stream of nitrogen. 
Derivatization reagent (50 µl) [N, o-Bis (Trimethylsilyl) trifluoroacetamide (BSTFA) + 10% 
trimethylchlorosilane (TMCS)] was added to the amber vials for derivatisation. The 
headspace was flushed with a gentle flow of nitrogen before sealing. Samples were vortexed 
each 30 min during derivatisation at 70 °C for 4 h. And then anhydrous hexane (350 µl) was 
added to the vials before injection to GC-MS. 
2.5.4 Analysis of digesta and faecal samples for total phenols and 
antioxidant capacity  
Total phenols of the extracts were measured by using the Folin-Ciocalteau method mentioned 
in 2.4.1. Antioxidant capacity was measured by the FRAP assay mentioned in 2.4.3. 
2.6 Identification and quantification of flavanones in 
orange juice by HPLC-PDA 
Samples were injected onto a Thermo Surveyor HPLC system comprising an HPLC pump, 
PDA detector scanning from 250 to 700 nm, and an autosampler cooled to 4 °C (Thermo 
Finnigan, San Jose, CA, USA). Separation was carried out using a 250 × 4.6 mm i.d. 4 μm 
Synergi Max-RP column (Phenomenex, Macclesfield, UK) and eluted from 5 to 50 % 
methanol in 0.1% formic acid within 60 min at a flow rate of 1 ml/min and maintained at 40 
°C. Hesperidin, narirutin, hesperetin and narigenin were identified based on retention times of 
individual authentic standards. Peak area versus concentration was obtained by linear 
regression analysis of concentration at range of 0.1 ng / µl to 300 ng / µl at 290 nm.  
2.7 Identification and quantification of flavanone 
metabolites by using LC-MS 
HPLC-PDA-MS
2
 was used to identify and quantify hesperetin and naringenin metabolites in 
biological samples. Urine was analysed on a surveyor HPLC - PDA - MS
2
 composed of an 
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HPLC pump, a PDA detector, scanning from 200 to 800 nm, and auto-sampler cooled to 4 °C 
(Thermo Fisher Scientific). Reverse-phase separations were carried out by using a 250 × 4.6 
mm i.d. 4 µm Synergi Max-RP column (Phenomenex, Macclesfield, UK) maintained at 40 
°C, and eluted from 25 % - 80 % methanol in 0.1 % aqueous formic acid over 60 min at a 
flow rate of 1ml/min. After passing through the flow cell of the photodiode array detector, the 
column elute was split, and 0.3 ml/min elute was directed to a LCQ Deca XP ion trap mass 
spectrometer fitted with an electrospray interface operating in negative ionization mode for 
hesperetin and narigenin metabolites. The capillary temperature was 325 °C, sheath gas was 
40 units, auxiliary gas was 20 units, and source voltage was 6 kv. Identifications were based 
on full-scan, data-dependent MS scanning from 100 to 800 m/z, MS-MS fragmentation, and 
comparisons of the retention time and absorption λmax with available standards. Hesperetin 
and narigenin metabolites were quantified based on chromatographic peak areas acquired at 
290 nm and expressed relative to standards of hesperetin-7-O-rutinoside and naringenin-7-O-
rutinoside dissolved in methanol at concentrations ranging from 0.1 to 100 ng/µl. Hesperetin 
and naringenin metabolites were quantified as hesperetin-7-O-glucuronide and naringenin-7-
O-glucuronide equivalents. A linear response was obtained for all the standard curves when a 
linear regression analysis was R2 > 0.999. Values were expressed in µM as mean values ± 
SE. Peak identifications were based on full-scan, data dependent MS scanning from 100 to 
800 m/z, MS-MS fragmentation, and comparisons of the retention time and absorption λmax 
with available standards. Limits of detection ranged from 0.1 to 1.0 ng, limits of 
quantification ranged from 1.0 to 5.0 ng, and the precision of the assay (as the coefficient of 
intraassay variation, which ranged from 8.7 % to 9.0 %) were considered acceptable allowing 
the quantification of flavonoids and their metabolites. 
2.8 Identification and quantification of phenolic acids by 
GC-MS 
GC-MS was performed to give high sensitivity and specificity for analysis of phenolic acids. 
Derivatized phenolic acids were analysed using a Trace DSQ single quadruple GC-MS, 
equipped with an AI 300 autosampler (Thermo Finnigan Ltd, Hempstead, Hertfordshire, 
UK). Samples were injected in the split mode with a 25:1 ratio. The injector temperature was 
maintained at 220 °C. The mass spectrometer was used in the positive ionization mode with 
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the ion source and transfer line set at 180 °C and 310 °C, respectively. Separations were 
carried out on a fused silica capillary column (30 m × 0.25 mm i.d.) coated with cross-linked 
5 % phenylmethylsiloxane (film thickness 0.25 µm) (Phenomenex, Macclesfield, Cheshire, 
UK). Helium was the carrier gas with a flow rate of 1.2 ml min
-1
. The column temperature 
was initially set at 40 °C and raised to 160 °C at 20 °C min
-1
, 200 °C at 1.5 °C min
-1
 and 250 
°C at 10 °C min
-1
 to a final temperature of 300 °C at 40 °C min
-1
, held for 5 min. Data 
acquisition was performed in full scan mode (m/z 50 - 470) with ionization energy of 70 eV, 
and analysis was carried out by using Xcalibur software version 2.0 (Thermo Fisher 
Scientific UK,, Hempstead, Hertfordshire, UK). Phenolic acids were identified based on the 
mass spectra and retention time of authentic standards analysed under identical conditions. 
When standards were not commercially available, identification was achieved through the 
integrated National Institute of Standards and mass spectral library 2008 (Scientific 
Instruments Services Inc., Ringoes, NJ, USA), with a confidence of 70 % or above. 
Calibration curves of the ratio between the target ion of the interested analyte and of the 
internal standard (m/z 279) at concentrations ranging from 3-40 mg ml
-1
 were computed (R
2
 
>0.95).  
Standards: 3-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, 4-
hydroxyphenylpropionic acid, 3, 4-dihydroxyphenylacetic acid, 3-(3, 4-dihydroxyphenyl) 
propionic acid, 4-hydroxy-3-methoxy-phenylpropionic acid  (dihydrofeulic acid) were 
purchased from Sigma-Aldrich Co Ltd (Poole, Dorset, UK) or Alfa Aesar (Karlsruhe, 
Germany). The internal standard was 2, 3, 5-trimethylcinamic acid. 
2.9 Data analysis 
Analyses of orange juices in chapter 3 were carried out in triplicate, and data was presented 
as mean values with standard deviation. All data was assumed to be normally distributed and 
independent t-test or ANOVA were employed to test for differences between smooth orange 
juice and orange juice with bits, and significant differences were defined as p < 0.05.  
For orange juice flavanones and or phenolic in digestive fluids and faecal samples, data are 
presented as mean values with standard error. The unit used for the upper GI digestion was 
based on total amount of flavanone or total phenols in the digestive fluids expressed as 
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mg/250ml, and used for the fermeantion was based on concentration of flavanone or  total 
phenols in faecal sample expressed as µM. All data were assumed to be normally distributed; 
t-tests or ANOVA tests with post hoc Tukey-HSD was used to determine significant 
differences defined as p < 0.05. 
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Chapter 3 Metabolism of orange juice flavanone from 
different sources in the in vitro gastrointestinal tract 
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3.1 Introduction 
Flavonoids and flavonoids enriched foods, have been reported to have antibacterial (Lee et 
al., 2003), anti-inflammatory (Coelho et al., 2013), and to inhibit lipid peroxidation (Cesar et 
al., 2010, Constans et al., 2014) and reduce the risk of chronic diseases (Bahorun et al., 2012)  
including type-2-diabetes (Jacques et al., 2013), Parkinson disease (Gao et al., 2012) and 
some cancers (Zamora-Ros et al., 2014). Consumption of orange juice or flavanones 
modulated inflammatory markers (Coelho et al., 2013), enhanced cognitive function (Kean et 
al., 2015a), reduced diastolic blood pressure (Rangel-Huerta et al., 2015b) and improved 
postprandial microvascular endothelial reactivity (Morand et al., 2011), and increased 
antioxidant capacity (Constans et al., 2014, Vinson et al., 2002), inhibited bone loss and 
decreased serum and hepatic lipids (Chiba et al., 2003) in humans. 
According to the Phenol-Explorer database, orange juice (150 ml) contains 90 mg of 
flavanones (Neveu et al., 2010).  Hesperidin constitutes 90 % of the flavanones in orange 
juice, followed by narirutin (Manach et al., 2003, Abad-García et al., 2012). In the juice, they 
are mainly present as glycosides (Rangel-Huerta et al., 2015b).  However, flavanone 
metabolites and phenolic metabolites can be absorbed into the circulatory system after 
deglycosylation and degradation of the parent compounds by intestinal enzymes or colonic 
bacteria (Manach et al., 2005, Crozier et al., 2010, Pereira-Caro et al., 2014a, Roowi et al., 
2009b).  
A human study observed ~ 30 % of hesperidin intake was recovered in ileal fluid 0–24 h after 
consumption of a polyphenol-rich juice by ileostomists (Borges et al., 2013). In an in vitro 
study, 63 % of hesperidin was transformed to the corresponding chalcone during in vitro 
simulated pancreatin-bile digestion (Gil-Izquierdo et al., 2001). Aglycones are conjugated  
into glucuronides, sulfates and sulfoglucuronides by the  intestine epithelium cells and in the 
liver,  or degraded to phenolic acids by gut bacteria in the colon (Kim et al., 1998, Khan and 
Dangles, 2014, Roowi et al., 2009a). In addition, the plasma concentration of flavonoids has 
been highly studied. The maximum concentrations of hesperetin metabolites were 0.9 – 2.2 
µmol/L after consumption of orange juice or hesperidin (Mullen et al., 2008a, Manach et al., 
2003, Erlund et al., 2001c). Conjugated metabolites with a glucuronide, sulfate, or methoxy 
moiety have been detected and characterised in the stomach, intestine, liver, heart, kidney, 
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spleen, pancreas, prostate and bladder by using animal models (Suganuma et al., 1998, Chang 
et al., 2000, Kim et al., 2000).  
 Bacteroides, bifidobacteria, and lactobacilli have the highest enzymatic activity of β-
glucosidase, α-rhamnosidase and β-glucuronidase (Steer et al., 2003, Turner, 2008). 
Clostridium, Eubacterium genera, and beneficial generes bifidobacteria and lactobacilli are 
involved in metabolism of flavonoids via ring-cleavage, decarboxylation, demethylation, and 
dehydroxylation reactions in the human intestinal tract (Selma et al., 2009, Aura, 2008). 
Clostridium genus, Clostridium cocoides and Eubacterium rectaleare are responsible for C-
ring cleavage (Winter et al., 1989, Tzounis et al., 2008). It has been thought that fibre 
enriched products may modify the composition and content of gut microbiota, in turn 
impacting on the metabolism of flavonoids. In an in vitro study, hydroxyphenylacetic acid, 
hydroxyphenylvaleric acid and two isomers of hydroxyphenylpropionic acid were produced 
at a higher amount by fermentation with extractable proanthocyanidins than with red grapes 
which contained dietary fibre (Saura‐Calixto et al., 2010). In addition the polyphenol rich 
foods may affect the growth of the bacteria. Cherry, pomegranate, raspberry, and strawberry 
inhibited growth of Staphylococcus epidermis, Klebsiella pneumonia, Staphylococcus spp., 
Salmonella spp., Helicobacter pylori, and Bacillus cereus (Lee et al., 2003, Puupponen‐
Pimiä et al., 2005). What is more, pomegranate peel extract inhibited growth of C. 
perfringens, C. ramosum, S. aureus, and Clostridium clostridioforme, but significantly 
increased number of Bifidobacterium breve and Bifidobacterium infantis (Bialonska et al., 
2009).  
As discussed in section 1.4.2, the bioavailability of flavanones varied considerably after 
consumption of orange juice ranging from 0.8 ~ 16 % in humans after consumption of orange 
juice (Pereira-Caro et al., 2014b, Brett et al., 2009, Bredsdorff et al., 2010, Erlund et al., 
2001c, Silveira et al., 2014, Vallejo et al., 2010c, Tomas-Navarro et al., 2014, Manach et al., 
2003). This may be related to the difference in the content of the fruit or to changes made in 
processing of the juice. One example is a difference in the inclusion of pulp between smooth 
orange juice and orange juice with pulp or ‘bits’ as they are called in UK market, depends on 
product processing. The orange juice, may include segment membranes and other connective 
tissues, and pulp derived from peel by squeezing (Grigelmo-Miguel and Martı́n-Belloso, 
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1998). The pulp  may contain  pectins, cellulose, hemicellulose and lignin as well as small 
amounts of protein, fat and ash (Grigelmo-Miguel and Martı́n-Belloso, 1998).  
The amount of cellular material is variable by differences in the techniques used in orange 
juice processing. Processing of orange juice can reduce the  insoluble dietary fibre content by 
39.1 % from 58.8 % to 32.3 % and increased soluble dietary fibre by 80 % from 20.1 % to 
37.9 % in orange pulp (Larrea et al., 2005). In addition, pulp and orange juice cloud may 
include non-cell wall proteins (50 %), and cell wall fragments (Brat et al., 2003). Flavanones 
can be bound to fibre solid particles by hydrophilic interaction (Manthey and Grohmann, 
1996). The bioavailability of flavanones depends on their digestive stability and the release of 
flavonoids from the food matrix as they pass through the intestine tract (Rubió et al., 2014). 
Various processing of orange juice affected flavanone under the gastrointestinal pH, 
temperature, and enzyme and chemical conditions (Gil-Izquierdo et al., 2003). As a result, the 
interactions of flavanones and these particles in orange juice from different sources might 
affect the metabolism of flavanone in the gastrointestinal tract to render varying levels of 
bioavailability of flavanones in studies. In addition, orange juice of different types might 
have various actions on gut bacteria to modify metabolism of flavanones in the colon. To our 
knowledge, there have been no in vitro studies to investigate mechanisms by which orange 
juice from different sources affect the release and metabolism of flavanones via digestion and 
fermentation in the gastrointestinal tract. Therefore, the aim of this chapter was to examine 
flavanone metabolism by using an in vitro GI model to determine the likely bioavailability 
from different sources in humans (Figure 3-1). 
In this chapter, smooth orange juice and orange juice with ‘bits’ from 6 brands in the UK 
were measured in terms of flavanone content, dietary fibre, total phenols, total flavonoids, 
and antioxidant capacity to compare physical characteristics. The stability and release of 
flavanone and degradation of flavanone were assessed by using stimulated gastrointestinal 
digestion and fermentation to investigate metabolism of flavanone in smooth orange juice and 
orange juice ‘with bits’. In addition, total phenol and antioxidant capacity of digesta and 
faecal incubations were also evaluated. 
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3.1.1 Hypothesis 
To test the hypothesis that the release and stability of of flavanones in orange juice and their 
degradation by gut bacteria in the gastrointestinal tract are influenced by the source and 
formulation of the juice, for example the inclusion of pulp 
1) What is the variability of flavanone content in 6 different brands of smooth orange juice 
and orange juice ‘with bits?’ 
2) Does the presence of ‘bits’affect the flavanone content in the original juice, release of 
flavanones in a model simulating the upper GI tract or the production of phenolic acids in a 
faecal bacteria incubation model? 
 
3.2 Materials and methods 
3.2.1 Chemicals 
Hesperidin and narirutin were purchased from Extrasynthese (Genay, France). HPLC grade 
methanol was obtained from Rathburn Chemicals (Walkerburn, Borders, UK). Formic acid 
was purchased from Riedel-deHaen (Seelze, Germany). Hydrochloric acid, sodium 
bicarbonate, pepsin (from porcine stomach mucosa), pancreatin (from porcine pancrease), 
bile acids (from porcine); tryptone, 2,4,5 – trimethoxycinnamic acid, anhydrous ethyl acetate, 
dichloromethane (DCM), N-methyl-N- (trimethylsily) trifluoracetateamide, N, O-bis 
(Trimethylsilyl) trifluoroaceta mide (BSTFA) + 10 % trimethylchlorosilane (TMCS),prydine. 
CaCl2
.
2H2O, MnCl2
.
4H2O, NH4HCO3, NaHCO3, Na2HPO4, KH2PO4, MgSO4
.
7H2O, cysteine 
hydrochloride, NaOH, Na2S 
. 
9H2O, and resazurin solution were purchased from Sigma-
Aldrich Co Ltd (Poole, Dorset, UK). Ethyl acetate and dichloromethane (DCM) were 
purchased from Rathburn Chemicals Ltd (Walkerburn, Peeblesshire, UK).   
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3.2.2 Orange juice analysis 
Four popular supermarkets were visited to obtain six brands of orange juice. They supply 
smooth orange juice and orange juice ‘with bits’ (ie including pulp), freshly squeezed, not 
from concentrate. Appendix 1 shows ingredients labelled in the bolttles. The juices were 
Tropicana orange juices, Sainsbury’s, Tesco, Innocent, Waitrose and Morrison’s orange 
juices obtained between April of 2013 and March of 2014.   
The content of dietary fibre in each juice was analysed by using AOAC method (Prosky et 
al., 1988) conducted by the School of Health and Life Science, Glasgow Caledonian 
University. Total phenols, total flavonoids and antioxidant capacity were measured as 
described in section 2.4.2, 2.4.2 and 2.4.3. 
3.2.3 In vitro gastrointestinal digestion and fermentation models 
3.2.3.1 Orange juices for in vitro GI digestion and fermentation 
Two types of 100 % pure squeezed orange juice (smooth orange juice and orange juice ‘with 
bits’) used were from Tropicana Company purchased at Tesco Express, Dumbarton Road, 
Glasgow, UK) for the gastrointestinal digestion and fermentation.  
3.2.3.2 In vitro gastrointestinal digestion 
The model to simulate gastric and small intestinal digestion was adapted from Gil-Izquierdo 
(Gil-Izquierdo et al., 2003).  40 ml of orange juice was chosen based on the orange juice 
consumption by humans in chapter 3. In vitro gastrointestinal digestion was conducted as 
described in section 2.3.1. 
Smooth orange juice and orange juice with bits had similar hesperidin content (37.3 mg/100 
ml vs. 40.5 mg/100 ml) and narirutin (4.1 mg/100 ml and 4.9 mg/100 ml), which did not 
confirm results from  previous studies reporting higher amounts of  hesperidin and narirutin 
in pulp enriched orange juice (Table 3-3). This may have been different for just this one 
brand of juice so we purchased examples of all juices which had both smooth orange juice 
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and orange juice ‘with bits’ in local supermarkets. Six brands had smooth orange juice and 
orange juice ‘with bits’ (Appendix 1), these juices were then compared to investigate the 
variation in flavanones between smooth orange juice and orange juice with bits (Table 3-3).  
 
Figure 3-1 Details of the different stages of the simulated gastrointestinal tract model 
 
3.2.3.3 Faecal sample collection 
Six healthy Caucasian volunteers (Table 3-1) who participated in this study had a normal 
diet, were non-smokers, had no digestive diseases, no food allergies, and had not received 
antibiotics for at least 6 months before the study. The volunteers followed a low-polyphenol 
diet avoiding fruits, vegetables, tea, coffee, wine and wholemeal foods for 2 days (details in 
appendix 2) before providing a faecal sample according to information sheet (appendix 2). 
Each faecal sample was collected by subjects in a special plastic box containing an 
AnaeroGen sachet (Oxoid, Hampshire, UK) to generate anaerobic conditions. Faecal samples 
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were processed when brought to the lab. The food has been recorded in dietary record 
(Appendix 4). 
Table 3-1 Body characteristics of participants 
 
Gender Age(years) Height (cm) Weight (kg) BMI 
1 F 22 172 73 24.7 
2 M 21 181 84 25.6 
3 F 27 161 52 20.1 
4 F 21 168 57 20.2 
5 F 23 164 60 22.3 
6 M 26 185 76 22.2 
Mean ± SD 
 
23 ± 2.6 171 ± 9.5 67 ± 12.5 22.5 ± 2.3 
Values are mean ± SD, M: male, F: female, BMI: body mass index. 
3.2.3.4 In vitro fermentation with human colonic bacteria 
The fermentation was conducted as described in section 2.3.3. 
3.2.4 Extraction of hesperidin and narirutin in orange juices 
Orange juice (1 ml) was extracted as described in section 2.9.1. 
3.2.5 Extraction of hesperidin, narirutin, hesperetin, and naringenin 
after in vitro digestion and fermentation  
Samples were thawed and homogenized with a Disruptor Genie (Scientific Industries, UK). 
Extraction was the same as orange juice described in 2.9.1.  
3.2.6 Analysis with HPLC-PDA 
Hesperidin, narirutin, hesperetin and naringenin were analysed by using HPLC-PDA as 
described in section 2.10.  
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3.2.7 Extraction and derivatization of phenolic acids in faecal 
slurries 
Extraction of phenolic acids was done by the methods published by Combet et al.(Combet et 
al., 2011), as described in section 2.5.3. 
3.2.8 Analysis of phenolic acids by GC-MS  
GC-MS analysis was explained in details in chapter 2.12.  
3.2.9 Total phenol measurement for orange juice, digested and 
faecal samples 
Total phenols were measured by using the Folin–Ciocalteau method. See section 2.6 for more 
details. 
3.2.10 Total flavonoids measurement for orange juice 
Total flavonoids were measured by using the spectrophotometric method based on the 
production of complex compounds of flavonoids with aluminium chloride. See section 2.7 for 
more details. 
3.2.11 FRAP assay for orange juice, digesta and faecal samples 
Antioxidant capacity was determined by using FRAP assay in a redox-linked colorimetric 
reaction. See chapter 2.8 for more details. 
3.3.12 Release of NEPP by hydrolysis with driselase and pectinase / 
cellulase 
Enzymatic hydrolysis was conducted by previous studies with some modification (Kang et 
al., 2008, Fry et al., 2001, Shirakawa et al., 2007, Mandalari et al., 2006, Wilkins et al., 
2007). Orange juice (5 ml) was centrifuged at 4500 g for 10 min at 4 °C. Supernatants were 
77 
 
 
 
extracted with or without methanol (2 ml) in 0.1 % formic acid and centrifuged at 4500 g for 
10 min at 4 °C in duplicate. Supernatants were collected in the 10 ml tubes. Extracted pellets 
and non-extracted pellets were incubated individually with 2 %, 1 %, or 0.1 % of pectinase / 
cellulase (pH 4.4) at 37 °C or driselase at 45 °C (pH 5) for 2, 4, 6, 20, and 24 h.  
Aliquots (0.5 ml) were extracted with ethyl acetate (1 ml), and the extracts were centrifugally 
evaporated under vacuum at room temperature using a Thermo Speedvac concentrator. The 
residue was dissolved with 25 μl of methanol and made up to 1 mL with HPLC-grade water 
containing 0.1 % formic acid for analysis. All of experiments were carried out in 
triplicate.Total phenols were measured by using the Folin–Ciocalteau method. See section 2.6 
for more details. 
3.2.13 Statistical analyses 
All data analysis was conducted with SPSS software version 22. Analyses of orange juices 
were carried out in triplicate, and data was presented as mean values with standard deviation. 
, and was assumed to be normally distributed and independent t-test or ANOVA were 
employed to test for differences between smooth orange juice and orange juice with bits, and 
significant differences were defined as p < 0.05.  
For orange juice flavanones and or phenolic in digestive fluids and faecal samples, data are 
presented as mean values with standard error. The unit used for the upper GI digestion was 
based on total amount of flavanone or total phenols in the digestive fluids expressed as 
mg/250ml, and used for the fermentation was based on concentration of flavanone or  total 
phenols in faecal sample expressed as µM. All data were assumed to be normally distributed, 
t-tests or ANOVA tests with post hoc Tukey-HSD was used to determine significant 
differences between smooth orange juice and orange juice with bits (P < 0.05). 
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3.3 Results 
3.3.1 Analysis of orange juices 
Total phenols, total flavonoids, antioxidant capacity (FRAP), hesperidin and narirutin were 
varied by 26.6 %, 36.8 %, 31.6 %, 158.7 % and 72.1 % (Table 3-2). According to type of 
orange juice, OJ bits had higher total phenolic content compared with smooth OJ (225.9 ± 7.5 
µg GAE/ ml vs. 208.4 ± 6.1 µg GAE / ml, p < 0.05) (Table 3-2). However, total flavonoids 
were similar between OJ and OJ bits (81.4 ± 3.8 vs. 93.0 ± 12.1 µg QAE/ml, p = 0.058). 
There was no significant different antioxidant capacity between OJ and OJ bits. Hesperidin 
and narirutin were 32.9 ± 10.3 mg / 100 ml and 5.1 ± 2.4 mg / 100 ml in OJ bits, while 30.0 ± 
9.1 mg / 100 ml and 3.9 ± 1.4 mg / 100 ml in OJ respectively. Hesperidin was correlated with 
total flavonoids in orange juice (Pearson correlation coefficient = 0.67). In addition, the 
antioxidant capacity of orange juice (FRAP) was correlated with hesperidin (Pearson 
correlation coefficient = 0.86). 
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Table 3-2 Total phenolic content (µg GAE/ml), total flavonoids (µg QE/ml), antioxidant capacity (mM Fe
2+
), narirutin (mg/100ml), hesperidin 
(mg/100ml) and total flavanone (mg/100ml) in orange juices 
Brand Type Total Phenols Total flavonoids FRAP ᵠ Narirutin Hesperidin ᵠ 
Tropicana 
Smooth OJ 216.5 ± 12.0 
dghik
 76.8 ± 0.5
dghijkl
 5.9 ± 0.3
 dfl
 4.2 ± 0.2 
ckl
 37.3 ± 1.8
cdefgijkl
 
OJ bits 228.4 ± 5.9 
cdghijk
 86.7 ± 17.1
dghijkl
 6.4 ± 0.4
 d
 4.9 ± 0.3
 cjkl
 40.5 ± 1.6
acghijkl
 
Sainsbury’s 
Smooth OJ 213.5 ± 2.7
bdfghik
 84.9 ± 13.6
dghijkl
 6.0 ± 0.1
 dfl
 2.3 ± 0.1
abjhijk
 34.5 ± 0.5
adefghijkl
 
OJ bits 252.3 ± 6.6 
abcefghijkl
 100.2 ± 15.0
abcefghijkl
 7.4 ± 0.4 
abceghijk
 3.7 ± 0.3
ijk
 40 ± 1.5
acghijkl
 
Tesco 
Smooth OJ 220.9 ± 1.9
dghijl
 79.2 ± 3.3
dghijkl
 6.3 ± 0.5 
d
 3.7 ± 0.1
ijk
 38 ± 0.8
acghijkl
 
OJ bits 226.1 ± 5.9
cdghijl
 78.9 ± 7.7
dghijkl
 6.1 ± 0.6
 acghij
 4.1 ± 0.1
cjkl
 41.9 ± 1.5
acgijkl
 
Innocent 
Smooth OJ 197.2 ± 9.1
abcdefkl
 82.5 ± 5.2
abcdefijl
 4.6 ± 0.3 
dfl
 4.4 ± 0.2
cjkl
 30 ± 1.2
abcdefkijkl
 
OJ bits 199.8 ± 9.6 
abcdefkl
 81.9 ± 3.5
abcdef
 5.0 ± 0.2 
dfl
 5.3 ± 0.1
cdefkl
 37.4 ± 1.9
bcdegijkl
 
Morrison’s 
Smooth OJ 207.8 ± 3.2 
bdefjkl
 86.4 ± 1.2
abcdefg
 5.2 ± 0.1 
dfl
 7.8 ± 0.1
bcdefghkl
 21.5 ± 1.0
abcdefgkl
 
OJ bits 224.0 ± 7.7 
dghijkl
 101.1 ± 7.0
abcdefg
 5.3 ± 0.1
 dfl
 9.6 ± 0.9
abcdefghijl
 21 ± 1.7
abcdefgkl
 
Waitrose 
Smooth OJ 194.5 ± 8.2 
abcdefjk
 78.6 ± 12.9
abcdef
 4.9 ± 0.3 
d
 2.6 ± 0.1
abcghijk
 17.8 ± 0.2
abedefgkil
 
OJ bits 224.6 ± 9.1
dghijk
 108.9 ± 14.6 
abcdefg
 5.2 ± 0.1
 acghij
 2.8 ± 0.4
ahhijk
 18.5 ± 1.3
abedefgkl
 
Mean 
Smooth OJ 208.4 ± 10.7 81.4 ± 3.8 5.5 ± 0.7 3.9 ± 1.4 20.0 ± 9.1 
OJ bits 225.9 ± 16.7
 *
 93.0 ± 12.1 5.9 ± 0.9 5.1 ± 2.4 32.9 ± 10.3 
Data expressed as mean values ± SEM (n = 3). Repeated measures ANOVA test with LSD post hoc was performed to determine difference within orange 
juice, different letters were expressed significantly different within orange juice (p < 0.05), independent t-test was preformed to determine difference from 
Smooth OJ, 
*
 Significantly different from smooth OJ, p < 0.05, Pearson’s correlation analysis was performed for each column, ᵠ significantly correlated with 
hesperidin (correlation coefficient = 0.86).
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The fibre content in the orange juices ranged from 0.1 g / 100 ml to 0.3 g / 100 ml. There was 
no difference between smooth orange juice and orange juice ‘with bits’ (Table 3-3). 
Table 3-3 Total dietary fibre (g/100 ml) in orange juices 
 
OJ OJ bits 
Tropicana 0.1 0.1 
Sainsbury’s 0.1 0.3 
Tesco 0.1 0.2 
Innocent 0.1 0.2 
Morrison’s 0.1 0.2 
Waitrose 0.3 0.2 
Mean 0.1 ± 0.1 0.2 ± 0.1 
Data expressed as mean values, Mean value was calculated based on six orange juice expressed as 
mean values ± SD (n=6), OJ: smooth orange juice, OJ bits: orange juice ‘with bits’.  Fibre measured 
by AOAC method (Prosky et al., 1988) by the School of Health and Life Science, Glasgow Caledonian 
University. 
3.3.2 Stability and release of hesperidin and narirutin during in vitro 
gastrointestinal digestion 
In the gastric phase, hesperidin was higher in orange juice ‘with bits’ than smooth orange 
juice (p < 0.05), while there was no differences of narirutin (Table 3-4). Hesperidin was more 
stable in smooth orange juice than orange juice ‘with bits’ (p < 0.014), while narirutin was 
similar between the two orange juices (Table 3-4).  
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Table 3-4 Contents of hesperidin and narirutin (mg/250 ml) in smooth orange juice and orange 
juice ‘with bits’ in the gastric phase 
 
0 h 1 h 
 
Hesperidin Narirutin Hesperidin Narirutin 
OJ 25.8 ± 2.6 1.7 ± 0.2 28.6 ± 1.3 1.8 ± 0.0 
Recovery (%) -- -- 112.6± 0.1 103.7± 0.1 
OJ bits 33.1 ± 0.6 
*
 1.7 ± 0.0 22.0 ± 0.6 
*
 1.6 ± 0.1 
Recovery (%) -- -- 66.6 ±0.0 97.4 ±0.0 
Values were expressed as mean values ± SE (n=3), Calculation was based on total amount of 
hesperidin or narituitn from 250 ml of orange juice, OJ: smooth orange juice, OJ bits: orange juice 
‘with bits’, 
* 
significantly different from OJ, p < 0.05 (paired t-test). 
After the small intestinal digestion, hesperidin and narirutin were similar between smooth 
orange juice and orange juice ‘with bits’ (Table 3-5). However, there was more hesperidin 
recovery from smooth orange juice than orange juice ‘with bits’ (90.1 ± 6.8 % vs. 67.9 ± 
3.2%, p = 0.062).  
Table 3-5 Contents of hesperidin and narirutin (mg/250 ml) in smooth orange juice and orange 
juice ‘with bits’ under small intestinal condition 
 
2 h 4 h 6 h 
 
Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin 
OJ 20.5 ± 1.6 1.1 ± 0.1 22.2 ± 1.1 1.1 ± 0.1 22.9 ± 0.6 1.0 ± 0.1 
Recovery (%) 81.9 ± 12.0 61.6 ± 5.1 87.4 ± 5.5 62.8 ± 4.2 90.1 ± 6.8 57.7 ± 2.8 
OJ bits 22.0 ± 0.6 1.0 ± 0.1 25.0 ± 1.3 1.0 ± 0.1 22.5 ± 1.3 1.0 ± 0.1 
Recovery (%) 66.6 ± 2.7 60.6 ± 2.2 75.5 ± 3.1 61.5 ± 0.9 67.9 ± 3.2 57.1 ± 3.0 
Values were expressed as mean values ± SE (n=3), Calculation was based on total amount of 
hesperidin or narituitn from 250 ml of orange juice, OJ: smooth orange juice, OJ bits: orange juice 
‘with bits’ 
* 
significantly different from OJ, p < 0.05 (paired t-test). 
Narirutin had a greater decrease when transferred from gastric condition to small intestinal 
condition from 1.8 ± 0.0 mg / 250 mL to 1.1 ± 0.1 mg / 250 mL in smooth orange juice (p < 
0.02) and from 1.6 ± 0.1 mg / 250 mL to 1.0 ± 0.1 mg / 250 mL in orange juice ‘with bits’ (p 
< 0.01). However, total flavanone (hesperidin + narirutin) was was not significantly 
82 
 
 
 
difference between orange juice ‘with bits’ and smooth orange juice before and after the 
upper GI digestion (Table 3-6). 
Table 3-6 Contents of total flavanone (hesperidin + narirutin) (mg/250 ml) in smooth orange 
juice and orange juice ‘with bits’ during the GI digestion 
 0 h 1 h 2 h 4 h 6 h 
OJ 27.5 ± 2.7 30.3 ± 1.2 21.6 ± 1.6 23.3 ± 1.1 23.9 ± 0.9 
OJ bits 34.8 ± 0.6 23.7 ± 0.6 
*
 23.1 ± 0.6 26.1 ± 1.4 23.5 ± 1.4 
Values were expressed as mean values ± SE (n=3), Calculation was based on total amount of 
hesperidin or narituitn from 250 ml of orange juice, OJ: smooth orange juice, OJ bits: orange juice 
‘with bits’, Gastric digestion for 1 h, small intestinal digestion for 6 h from 1 h to 7 h, 
* 
significantly 
different from OJ, p < 0.05 (paired t-test). 
3.3.3 Metabolism of orange juice flavanone in the large intestine 
3.3.3.1 Degradation of hesperidin and narirutin in the large intestine 
Hesperidin and narirutin were analysed by HPLC-PDA to monitor degradation of flavanones 
by gut bacteria (Table 3-7). There was a significant decrease in total flavanone by 56.6 %in 
orange juice with bits after 24 h fermentation by gut bacteria (p < 0.02). The gut bacteria 
transformed 65.7 % of narirutin into naringenin or phenolic acids from 3.5 ± 0.6 µM to1.2 ± 
0.3 µM (p < 0.001) during fermentation with orange juice ‘with bits’ . Hesperidin was 
significantly higher at 2 h of fermentation with orange juice ‘with bits’ than smooth orange 
juice (89.6 ± 9.5 µM vs. 77.1 ± 8.9 µM, p < 0.05).  
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Table 3-7 Concentration of hesperidin and narirutin (µM) during in vitro fermentation of smooth orange juice and orange juice ‘with bits’ by human 
gut bacteria 
 Time 0 h 2 h 4 h 6 h 24 h 
 Flavanone Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin 
OJ 
µM 2.7 ± 0.6 70.0 ± 13.3 2.7 ± 0.6 77.1 ± 8.9 2.5 ± 0.7 72.8 ± 8.4 2.0 ± 0.7 63.0 ± 13.8 1.4 ± 0.3 44.4 ± 12.6 
Recovery (%) -- -- 100 112 80.6 105.7 64.5 91.4 45.2 64.4 
OJ 
bits 
µM 3.5 ± 0.6 97.9 ± 10.1 2.8 ± 0.6 89.6 ± 9.5 
*
 2.4 ± 0.6 79.5 ± 14.8 1.8 ± 0.5 68.6 ± 18.7 1.2 ± 0.3 42.5 ± 15.9 
Recovery (%) -- -- 80.0 91.5 68.6 81.2 51.4 70.1 34.3 43.4 
Data expressed as mean values ± SE (n=6). OJ: smooth orange juice, OJ bits: orange juice ‘with bits’, ANOVA tests with post hoc Tukey-HSD were 
performed to determine significant difference from OJ, 
*
 significantly different from OJ, P < 0.05. 
Table 3-8 Concentrations of hesperetin and naringenin (µM) during 24 h fermentation with smooth orange juice and orange juice ‘with bits’ by 
human gut bacteria 
Sources  
0h 2h 4h 6h 24h 
Naringenin Hesperetin Naringenin Hesperetin Naringenin Hesperetin Naringenin Hesperetin Naringenin Hesperetin 
OJ Concentration 0.7 ± 0.4 0.4 ± 0.3 2.0 ± 0.7 1.4 ± 0.6 2.7 ± 0.9 2.7 ± 1.2 3.0 ± 1.2 2.9 ± 1.2 2.7 ± 1.0 4.6 ± 1.9 
OJ bits Concentration  0.7 ± 0.4 0.4 ± 0.3 1.8 ± 0.8 1.6 ± 0.8 2.2 ± 0.8 2.4 ± 1.1 2.2 ± 0.7 2.7 ± 0.9 2.4 ± 0.7 3.4 ± 1.4 
Data expressed as mean values ± SE (n=6). OJ: smooth orange juice, OJ bits: orange juice ‘with bits’, ANOVA tests with post hoc Tukey-HSD were 
performed to determine significant difference from OJ, P < 0.05.
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The aglycones, hesperetin and naringenin were produced by fermentation with gut bacteria. 
There were 4.6 ± 1.9 µM of hesperetin and 2.7 ± 1.0 µM of naringenin after 24 h 
fermentation with smooth orange juice, while 3.4 ± 1.4 µM of hesperetin and 2.4 ± 0.7 µM of 
naringenin were produced by fermentation with orange juice ‘with bits’ (Table 3-8). 
Total flavanone (hesperidin, narirutin, hesperetin and naringenin) was decreasing over 24 h of 
fermentation with human gut bacteria (Figure 3-2). Flavanones were more degraded into 
smaller molecular compounds in orange juice ‘with bits’ by gut bacteria than smooth orange 
juice (P < 0.001). At the end of fermentation by gut bacteria, 52 % of flavanone was degraded 
into smaller molecular compounds from orange juice ‘with bits’, in comparison with 28 % of 
flavanone from smooth orange juice (0 h compared with 24 h). 
 
Figure 3-2 Degradation of total flavanone (hesperidin, narirutin, hesperetin and naringenin) in 
smooth orange juice and orange juice ‘with bits’ by human gut bacteria  
Values are expressed as mean values ± SE (n=6). OJ: smooth orange juice, OJ bits: orange juice 
‘with bits’, ANOVA tests with Tukey-HSD post hoc were performed to determine significant difference 
from OJ, P < 0.05. 
 
 3.3.3.2 Production of phenolic acids in the large intestine  
There were 7 phenolic acids found during the fermentation of orange juices by human colonic 
bacteria. They were 3-(phenyl)propionic acid, 3-(phenyl)lactic acid, 4-hydroxybenzoic acid, 
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4-hydroxyphenylacetic acid, 3-(4'-hydrophenyl)propionic acid, dihydroferulic acid, and 3,4-
dihydroxyphenylpropionic acid were during the fermentation of orange juices by gut bacteria 
(Figure 3-4). The five phenolic acids (4-hydroxybenzoic acid, 4-hydroxyphenylacetic acid, 3-
(4'-hydrophenyl) propionic acid, dihydroferulic acid, and 3, 4-dihydroxyphenylpropionic 
acid) that assumed derived from orange juice flavanone were summed to give total phenolic 
content. Production of phenolic acids were similar between smooth orange juice and orange 
juice ‘with bits’ after 24 h of colonic fermentation (39.0 ± 12.5 µM and 42.3 ± 12.7 µM) 
(Figure 3-3).  
 
Figure 3-3 Change in concentration of phenolic acids (µM) during 24 h fermentation of orange 
juices by gut bacteria 
Data expressed as mean values ± SE (n=6).  Calculation was based on 7 phenolic acids, Blue line: 
smooth orange juice, Red line: orange juice ‘with bits’. ANOVA tests with post hoc Tukey-HSD were 
performed to determine significant difference from OJ, P < 0.05. 
3-(phenyl)propionic acid, 3-(phenyl)lactic acid, 4-hydroxybenzoic acid, 4-
hydroxyphenylacetic acid, 3-(4'-hydrophenyl)propionic acid, dihydroferulic acid, and 3,4-
dihydroxyphenylpropionic acid were produced during the fermentation of orange juices by 
gut bacteria (Figure 3-4). 4-dihydroferulic acid and 3-(3, 4-dihydroxyphenyl) propionic acid 
were significantly higher during fermentation of smooth orange juice than orange juice ‘with 
bits’ (P < 0.05). In addition, 3, 4-dihydroxyphenylpropionic acid was significantly highly 
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produced from orange juice ‘with bits’ by gut bacteria than smooth orange juice (8.6 ± 2.8 
µM vs.3.4 ± 1.6 µM, p ≤ 0.05).  
 
Figure 3-4 Production of phenolic acids (µM) at 0 h (A), 2 h (B), 4 h(C), 6 h(D) and 24 h(E) of the 
fermentation by human gut bacteria 
Expressed as mean value in µM ± SE (n=6), OJ: smooth orange juice, OJ bits: orange juice ‘with bits’, 
3-PPA: 3-(phenyl)propionic acid, 3-PAA: 3-(phenyl)acetic acid, 4-HBA: 4-hydroxybenzoic acid,4-
HPAA: 4-hydroxyphenylacetic acid, 4-HPPA: 4-hydroxyphenylpropionic acid, 4 - HPPA: 3-(4'-
hydrophenyl)propionic acid, DFA: dihydroferulic acid, 3,4-DHPPA: 3,4-dihydroxyphenylpropionic acid.   
ANOVA tests with post hoc Tukey-HSD were performed to determine significant difference from OJ, P 
< 0.05.   
At the beginning of fermentation, 3-(phenyl) propionic acid was the main phenolic acid (6.3 
± 2.3 µM and 6.0 ± 3.0 µM). The total phenolic acid were 12.9 ± 3.1µM and 11.7 ± 3.5 µM 
in the incubation of  smooth orange juice and orange juice ‘with bits’ respectively. 
During the period of 0 h to 2 h fermentation, 3-(3,4-dihydroxyphenyl)propionic acid 
increased by 3 times and 4 times respectively from smooth orange juice and orange juice 
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‘with bits’ (from 1.0 µM to 3.0 µM and from 1.4 µM to 5.5 µM). 3-(phenyl) propionic acid 
did not change (6.8 ± 3.2 µM and 6.5 ± 2.8 µM). The sum of 7 main phenolic acids was 18.6 
± 4.1 µM vs. 22.3 ± 5.4 µM) by fermentation of orange juice ‘with bits’ than smooth orange 
juice. From 2 h to 4 h, 3-pheylacetic acid increased to 13.3 ± 8.7 µM and 7.9 ± 3.2 µM, 
accounting for 29 % and 21 % of total seven phenolic acids respectively. Dihydroferulic acid 
and 3-(4'-hydrophenyl) propionic acid increased by 6 ~ 7 times through the fermentation of 
smooth orange juice and by 3.5 ~ 3.7 times through the fermentation of orange juice ‘with 
bits’. There was 45.8 ± 20.7 µM of total phenolic acids produced from smooth orange juice, 
while 38.4 ± 12.1 µM were produced from orange juice ‘with bits’. 
After 6 h fermentation, higher phenolic acids were found in the incubation of orange juice 
‘with bits’ compared  with smooth orange juice (53.7 ± 14.0 µM vs. 38.8 ± 11.1 µM, p < 
0.05). In addition, 3-(3, 4-dihydrophenyl)propionic acid was significantly higher during 
fermentation with orange juice ‘with bits’ than smooth orange juice (8.6 ± 2.8 µM vs. 3.4 ± 
1.6 µM, p < 0.05).       
At the end of 24 h fermentation, total phenolic acids increased to 100.9 ± 25.2 µM and 110.7 
± 20.5 µM in the incubation of smooth orange juice and orange juice ‘with bits’ respectively. 
3-phenylacetic acid (45.3 ± 11.2 µM, p < 0.05) was the highest phenolic acid compared with 
4-hydroxybenzoic acid (1.9 ± 0.3 µM), 4-hydroxyphenylacetic acid (4.4 ± 0.9 µM), 3-(4’-
hydrophenyl)propionic acid (10.3 ± 2.8 µM),  dihydroferulic acid (18.2 ± 5.4 µM), 3-(3,4-
dihydroxyphenyl)propionic acid (10.0 ± 4.0 µM) in the incubation of smooth orange juice. In 
terms of orange juice ‘with bits’, 3-phenylacetic acid (39.0 ± 6.9 µM, p < 0.05) was the 
highest phenolic acid compared with 4-hydroxybenzoic acid (3.1 ± 1.3 µM), 4-
hydroxyphenylacetic acid (3.7 ± 0.4 µM), 3-(3,4-dihydroxyphenyl)propionic acid (13.8 ± 2.3 
µM). 
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3.3.4 Total phenolic contents and antioxidant capacity of orange 
juice in GI tract 
3.3.4.1 Upper GI digestion 
Total phenolic contents (Table 3-9) and antioxidant capacity (Figure 3-5) were analyzed by 
Folin-Ciocalteau method and FRAP assay. Total phenols and antioxidant capacity of smooth 
orange juice and orange juice ‘with bits’ were similar during the upper GI digestion. The 
increase of total phenolic content was by 10.8 % and by 4.8 % respectively in smooth orange 
juice and orange juice ‘with bits’ than after the gastric digestion, while decreased to 104.1 ± 
13.5 mg GAE/250 ml and 112.3 ± 0.6 mg GAE/250 ml after the GI digestion (Table 3-9). 
Table 3-9 Total phenols of orange juices (mg GAE/ 250 ml) during the upper gastrointestinal 
digestion 
 
Gastric phase Small intestinal phase 
 
0 h 1 h 3 h 5 h 7 h 
OJ 150 ± 6.5 166.3 ± 3.3 108.8 ± 0.1 118.6 ± 0.6 104.1 ± 13.5 
Recovery (%) -- 110.8 72.5 79.1 69.4 
OJ bits 175.8 ± 0.6 184.3 ± 2.7
 *
 144.7 ± 5.4
 *
 143.1 ± 3.1 
*
 112.3 ± 0.6 
Recovery (%) -- 104.8 82.3 81.4 63.8 
Values are expressed as mean ± SE (n=3). OJ: smooth orange juice, OJ bits: orange juice ‘with bits’. 
Calculation based on 250 ml of orange juice Gastric digestion for 1 h, small intestinal digestion for 6 h 
from 1 h to 7 h, ANOVA tests with post hoc Tukey-HSD were performed to determine time was 
significantly different from 0 h, * , p < 0.05. 
However, antioxidant capacity of smooth orange juice and orange juice ‘with bits’ decreased 
by 56.1 % and 41.6 % respectively after the upper GI digestion (Figure 3-5). The antioxidant 
capacity of smooth orange juice and orange juice ‘with bits’ was significantly different 
during the upper GI digestion at 0 h (1.1 ± 0.0 mM Fe
2+ 
vs. 0.7 ± 0.0 mM Fe
2+
, p = 0.004), 1 
h (1.0 ±0.0 mM Fe
2+ 
vs. 0.7 ± 0.0 mM Fe
2+
, p = 0.004), 3 h (0.2 ± 0.0 mM Fe
2+ 
vs. 0.2 ± 0.0 
mM Fe
2+
, p = 0.001), 5 h (0.2 ± 0.0 mM Fe
2+ 
vs. 0.2 ± 0.0 mM Fe
2+
,  p = 0.04).  
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Figure 3-5 Antioxidant capacity of orange juices during the GI digestion  
Values are expressed as mean ± SE (n=3). OJ: smooth orange juice, OJ bits: orange juice ‘with bits’, 
Gastric digestion for 1 h, small intestinal digestion for 6 h from 1 h to 7 h, ANOVA tests with post hoc 
Tukey-HSD were performed to determine significant difference from OJ, *  p < 0.05, ** P < 0.001. 
3.3.4.2 Colonic fermentation 
Total phenolic content (Table 3-10) and antioxidant capacity (Figure 3-6) were similar 
between orange juices ‘with bits’ and smooth orange juice during fermentation. Total phenols 
decreased to 4.5 mM GAE/ ml after 24 h fermentation with smooth orange juice, while it 
increased to 4.9 mM GAE/ ml with orange juice ‘with bits’. The antioxidant capacity 
decreased from 0.8 mM Fe
2+
 to 0.7 mM Fe
2+ 
in the incubation with smooth orange juice, and 
from 0.8 mM Fe
2+
 to 0.7 mM Fe
2+
 in the incubation with with orange juice ‘with bits’.  
Table 3-10 Total phenols (mM GAE/ml) in incubation with orange juice digesta during 24 h 
fermentation with gut bacteria 
 
 0h 2h 4h 6h 24h 
OJ 
 5.3 ± 0.2 5.1 ± 0.4 4.9 ± 0.7 5.2 ± 0.4 4.5 ± 0.8 
Recovery 
(%) 
100 96.7 92.2 98.9 84.4 
OJ bits 
 4.6 ± 0.7 5.6 ± 0.2 5.0 ± 0.8 5.5 ± 0.4 4.9 ± 1.0 
Recovery 
(%) 
100 121.5 107.6 119 105.1 
Data expressed as mean values ± SE (n=6). OJ: smooth orange juice, OJ bits: orange juice ‘with bits’, 
ANOVA tests with post hoc Tukey-HSD were performed to determine significant difference from OJ, * 
p < 0.05. 
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Figure 3-6 Antioxidant capacity during 24 h fermentation with gut bacteria 
Data expressed as mean values ± SE (n=6).  OJ: smooth orange juice, OJ bits: orange juice ‘with 
bits’, ANOVA tests with post hoc Tukey-HSD were performed to determine significant difference from 
OJ, * p < 0.05. 
3.3.5 Change of faecal pH during in vitro fermentation 
pH did not change during fermentation with hesperidin or no substrates, while smooth orange 
juice and orange juice ‘with bits’ significantly decreased pH to 4.5 after 24 h fermentation (p 
< 0.05) (Figure 3-7). In addition, glucose significantly decreased pH from 7.2 to 5.1.  
 
Figure 3-7 pH in faecal samples during fermentation with human gut bacteria 
OJ: smooth orange juice, OJ bits: orange juice ‘with bits’, one way ANOVA with post hoc 
Tukey-HSD to determine significant differences, 
*
 significantly different from control, P < 
0.05, 
$
 significantly different from Hes, P < 0.05. 
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3.3.6 NEPP in orange juice with bits 
Higher polyphenols could be recovered in orange juice by using hydrolysis of extracted 
pellets with a mixture of pectinase and cellulase. There was 81.6 % of total phenol content 
extractable in orange juice. 
3.4 Discussion 
In this chapter, the variation in the content of a range of orange juices were determined and 
the impact of inclusion of ‘bits’ was tested in in vitro the upper GI tract and colon models.  
Total phenols were significantly higher in orange juice with bits compared with smooth 
orange juice (225.9 ± 16.7 µg GAE/ ml vs. 208.4 ± 10.7 µg GAE/ ml, p < 0.05), but 
hesperidin, narirutin, antioxidant capacity, total flavonoids were not different between 
smooth orange juice and orange juice with bits. In addition, the dietary fibre content ranged 
from 0.1 g / 100 ml to 0.3 g / 100 ml in the orange juices, but there was no difference 
between smooth orange juice and orange juice ‘with bits’ (Table 3-2). Thus, dietary fibre 
content was not a factor which affected the content of hesperidin and narirutin and 
degradation of phenolic acids during incubation in models simulating GI digestion and 
fermentation between smooth orange juice and orange juice with bits. 
This may differ from other orange juices with different processing and formulation but as 
other studies have not characterised the content of their juices in terms of dietary fibre and 
moreover sometimes have not given sufficient details of the juice to identify its origin it is not 
possible to explore the potential differences further. In addition, NEPP was detected about 3 
mg GAE/ml in extracted orange juice residues by using a mixture of pectinase and cellulase, 
or driselase. 
However, hesperidin was higher in orange juice ‘with bits’ compared with smooth orange 
juice when they were subjected to incubation with pepsin/HCl (33.1 ± 1.0 mg / 250 ml vs. 
25.8 ± 4.5 mg/ 250 ml hesperidin). This release of hesperidin may be due to non-extractable 
polyphenols.  Non-extractable polyphenols that are those linked to cell wall constituents 
(polysaccharides and protein) (Arranz et al., 2010, Hasni et al., 2011, Yuksel et al., 2010) 
which prevents extraction and detection by the usual analytical procedures (Perez-Jimenez et 
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al., 2013). Thus the acidic gastric conditions in the in vitro model released extra hesperidin 
from orange juice ‘with bits’. However, hesperidin was higher in smooth orange juice 
compared with orange juice ‘with bits’ after simulating gastric digestion (28.6 ± 2.2 mg / 250 
ml vs. 22.0 ± 1.0 mg/ 250 ml). Narirutin had similar amount between both of orange juices 
during the gastric digestion. Thus, the release / stability of hesperidin were determined by 
orange juice sources, but not narirutin in stomach. 
After the upper GI digestion, hesperidin and narirutin was reduced by 32.1 % and 42.9 % in 
orange juice ‘with bits’, which was similar to one study showing 70 % of hesperidin passed 
to the colon after a polyphenol-rich drink by ileostomists (Borges et al., 2013). However, 9.9 
% and 42.3 % were respectively not recovered in smooth orange juice, but no difference 
between juices. There was similar amounts of hesperidin and narirutin in the smooth orange 
juice and orange juice ‘with bits’ after the upper GI digestion at 22 mg and 1.0 mg /250 ml 
respectively even though there was a higher hesperidin in orange juice with bits. Thus, the 
different orange juice source might not affect the amount of hesperidin and nairutin passing 
to the colon. 
On the other hand, total phenolic contents reduced by 47 % in fruit beverages in models  
mimicking gastrointestinal digestion (Cilla et al., 2009).  In this study, total phenols also 
decreased in both of orange juice by 30.6 % and 36.2 % respectively in smooth orange juice 
and orange juice ‘with bits’ during in vitro digestion, However, total phenols was higher in 
orange juice ‘with bits’ than smooth orange juice during the gastrointestinal digestion, except 
at the end of the digestion. The antioxidant capacity decreased by 43.9 % and 47.6 % 
between smooth orange juice and orange juice ‘with bits’ after 2 h of small intestinal 
digestion under the mild alkaline conditions of the small intestine. In terms of antioxidant 
capacity (FRAP), smooth orange juice and orange juice ‘with bits’ decreased respectively by 
56.1 % and 41.6 % after the upper GI digestion. However, total phenols and antioxidant 
capacity did not change during fermentation with gut bacteria. Therefore, orange juice 
sources might mainly influence total phenolic content and antioxidant capacity of orange 
juice during the upper GI digestion. 
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Figure 3-8 the proposed catabolic pathways of orange juice flavanone degradation by human 
colonic microbiota 
Based on previous studies (Duda-Chodak et al., 2015, Rechner et al., 2004, Wang et al., 2015, 
Jaganath et al., 2009). 
In our study, acidic gastric conditions reduced hesperidin to a lower level in orange juice 
‘with bits’ and released higher amounts of hesperidin in incubation with orange juice ‘with 
bits’ during fermentation by gut bacteria. Other studies focusing on the stability of flavonoids 
by using in vitro upper GI digestion, orange juice flavanones were transformed into chalcones 
by 70 % during gastrointestinal digestion (Gil-Izquierdo et al., 2003) and hand squeezed, 
pasteurized and industrial proceed orange juice had varied flavanone during simulating 
gastrointestinal digestion (Gil-Izquierdo et al., 2003). In human studies, Tomas-Navarro and 
colleagues reported various levels of bioavailability of flavanones after consumption of fresh 
hand-squeezed orange juice, high pressure homogenised orange juice and pasteurised orange 
juice ranging from 6.7 % - 11 % (Tomas-Navarro et al., 2014). On the other hand, insoluble 
and soluble dietary fibre were changed by 39.06 % and 80 % respectively by processing in 
orange pulp (Larrea et al., 2005). Furthermore, dietary fibre was low and similar between 
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smooth orange juice and orange juice with bits in this study. Thus, this suggests that this 
difference in stability of polyphenols during digestion may not require high fibre contents. 
In addition, the narirutin content significantly decreased when passing from the acidic 
condition of the stomach model to the alkaline condition of the small intestinal tract, but 
hesperidin was not affected. This was similar with a study reporting the effects of 
gastrointestinal digestion on flavonoids. The decreased polyphenols, flavonoids and 
especially anthocyanins were caused by the transition from the acidic gastric to the mild 
alkaline intestinal environment (Tagliazucchi et al., 2010). In addition, Rodríguez and 
colleagues found no change of hesperidin and quercetin, but reduction of naringenin, caffeic 
acid, ferulic acid, p-coumaric acid, and 4-hydroxybenzoic acid, as well as an increase in 
chlorogenic acid, sinapic acid, rutin and (+)-catechin in a blended fruit juice containing 
orange, kiwi, pineapple and mango by the gastric digestion process (Rodríguez-Roque et al., 
2014). Low stability of narirutin during the gastrointestinal digestion could be attributed to 
the higher solubility of narirutin (Gil-Izquierdo et al., 2001). However, hesperidin is more 
abundant in ‘bits’ particles by its hydrophobic characteristics (Vallejo et al., 2010c). Thus, 
the chemical structures of flavanones potentially determine their stability /release in the 
gastrointestinal tract, so that food sources might influence flavanone in the gastrointestinal 
tract. 
Hesperidin was higher in the faecal incubations with orange juice ‘with bits’ compared with 
smooth orange juice at 2 h fermentation (89.6 ± 9.5 mg vs. 77.1 ± 8.9 mg, p ≤ 0.05). In 
addition, production of phenolic acids was higher at 6 h fermentation with orange juice ‘with 
bits’ compared with smooth orange juice (53.7 ± 14.0 µM vs. 38.8 ± 11.1 µM, p ≤ 0.04). 
However, hesperidin and narirutin, hesperetin and naringenin were similar between incubated 
smooth orange juice and orange juice ‘with bits’ after 24 h fermentation. Furthermore, pH 
was decreased to 4.5 in faecal samples after 24 h fermentation with both of orange juices. 
Thus, the presence of ‘bits’ affected the initial rate of  changes in hesperidin content and 
production of phenolic acids, but not metabolism of flavanone over 24 h of fermentation. 
Hesperidin and narirutin are metabolised depending on their concentration and structure, and 
the composition of the human gut microflora (Rechner et al., 2004). β-rhamnosidases and β-
glucosidases of colonic bacteria are responsible for cleavage of the rutinoside moiety (Aura et 
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al., 2002a). In this study, narirutin was degraded by 43 % from smooth orange juice and 
orange juice ‘with bits’, while hesperidin was transformed by 19 % and 32 % respectively, 
which was in accordance with higher urinary excretion of narirutin intake after consumption 
of orange juice by humans (Mullen et al., 2008a). Hesperidin and narirutin require hydrolysed 
into hesperetin and naringenin with relevant enzymes, such as with activity of α-
rhamnosidase and β-glucosidase, or catabolised to phenolic acids by gut bacteria prior to 
absorption through intestinal epithelium cells (Nielsen et al., 2006b, Brand et al., 2008, 
Manach et al., 2005). Hesperidin and narirutin in smooth orange juice were reduced to 42.5 ± 
15.9 µM and 1.2 ± 0.3 µM from 97.9 ± 10.1 µM and 3.5 ± 0.6 µM after 24 h fermentation 
with human gut bacteria. However, their aglycones, hesperetin and naringenin were not 
significantly different between smooth orange juice and orange juice ‘with bits’ during the 
fermentation (p = 0.75 and 0.52 respectively). After 6 h fermentation with gut bacteria, 
phenolic acids were higher in the incubation with orange juice ‘with bits’ than smooth orange 
juice. Phenolic acids were derived from aglycones by gut bacteria. The varied production of 
phenolic acids might reflect previous human studies that revealed various urinary excretion of 
flavanone dose after consumption of orange juice (Tomas-Navarro et al., 2014, Silveira et al., 
2014, Vallejo et al., 2010c). Thus, orange juice sources might influence the metabolism of 
orange juice flavanones.  
Gut bacteria, such as Bifidobacterium spp. and Lactobacillus spp. (Selma et al., 2009, 
Hidalgo et al., 2012) were affected by polyphenols. Tea polyphenols, (+)-catechin, and 
anthocyanins improved growth of Bifidobacterium spp. and Lactobacillus spp.(Lee et al., 
2006, Tzounis et al., 2008, Hidalgo et al., 2012). The different degree of flavanone 
degradation depending on sources provided various concentration of metabolites that might 
influence composition of gut bacteria during the fermentation. Thus, orange juice sources 
might affect the metabolism of flavanones relevant to absorption and elimination. 
In conclusion, this chapter illustrated the metabolism of flavanones in smooth orange juice 
and orange juice ‘with bits’ using simulating gastrointestinal digestion and colonic 
fermentation models. The GI stability / release of orange juice flavanones, especially 
hesperidin were affected by the types of orange juice. Production of phenolic acids was 
significantly different between orange juice sources. The derived aglycones were similar in 
incubation with both of orange juices during fermentation by gut bacteria. These results 
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might be a reason for the variability of bioavailability ranging from 0.8 to 16 % after 
consumption of orange juice in humans through gut metabolism. Thus, it is necessary to 
consider in detail the properties of the tested food in future clinical studies and when 
measuring consumption habits in epidemiological studies. In addition it is essential that full 
details of the juices are provided in papers which evaluate health outcomes of flavonoids 
intake from our diet. 
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Chapter 4 Effect of yoghurt on the metabolism of 
orange juice flavanones in an in vitro model of the 
GI tract 
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4.1 Introduction 
Polyphenol-rich food is often ingested with food containing polysaccharides, lipids and 
proteins, which may influence the bioavailability of polyphenols by interacting with them 
directly or by influencing the processes of digestion and absorption. Polyphenols have 
hydrophilic and hydrophobic qualities that interact with food ingredients (Roura et al., 2007a, 
Mullen et al., 2009b, Ortega et al., 2009a).  
Polyphenols have been reported to interact with milk proteins, particularly proline-rich 
proteins with hydrophobic characteristics (α- and β-caseins) (Hasni et al., 2011, Yuksel et al., 
2010). (+) Catechin in green tea was able to interact with β-casein to form complexes 
visualised by using fluorescent probe binding method and isothermal titration calorimetry 
analysis (Yuksel et al., 2010). Dairy matrices (milk, yoghurt and cheese) increased the 
amount of total phenols from green tea and antioxidant activity at the end of intestinal 
digestion in an in vitro digestion model (Lamothe et al., 2014).   
Yoghurt is a key source of milk proteins that is often mixed with fruits. There may be direct 
binding of flavonoids to these proteins. Caseins, 80 % of milk proteins, are aggregated to 
form a network during the fermentation of milk, which have a strong affinity for hydroxyl 
groups (Tamime and Robinson, 1999, Yuksel et al., 2010). The majority of anthocyanins 
(84.73%) were bound to proteins when pomegranate juice was added in 15 % reconstituted 
skimmed milk made from milk powder to a final concentration of 40 % (v/v) within one day 
and 90.06 % bound anthocyanins after 28 days, revealing the high affinity of anthocyanins 
for milk proteins (Trigueros et al., 2014). 
In addition, yoghurt also contains lactic acid bacteria. These bacteria include the starter 
cultures, for example Streptococcus thermophilus and Lactobacillus delbrueckii spp. 
bulgaricus. which ferment the milk to produce yoghurt (Ng et al., 2011). In a human study, 
Streptococcus thermophilus and Lactobacillus Delbrueckii survived in the gastrointestinal 
tract of subjects after 12 days consumption of fresh yoghurt (Mater et al., 2005).  Some 
yoghurt contains live probiotic bacteria, such as Bifidobacterium and Lactobacilli  (Hotel and 
Córdoba, 2001, Fuller, 2012, Rybka and Kailasapathy, 1995), which can survive in the 
human gut after consumption of yoghurt containing probiotics (Gorbach, 2000). 
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Bifidobacteria and lactobacilli have the highest activity of the β-glucosidases and sulfatases 
responsible for glycoside hydrolysis and subsequent aglycone cleavage (Steer et al., 2003, 
Turner, 2008). Thus, probiotics in yoghurt might affect polyphenols as they pass through the 
gastrointestinal tract and are degraded by gut bacteria in the colon.  
Physiological pH, nutrients from food, pepsin, pancreatin and bile salts, can influence 
probiotics in the gastrointestinal tract (Huang and Adams, 2004, Krasaekoopt et al., 2003, 
Gregurek, 1999). In an in vitro study, passion fruit or mixed berry improved survival of L. 
acidophilus (LAFTI L10) by, but not Lactobacillus acidophilus and Bifidobacterium animalis 
spp. Lactis during storage (Kailasapathy et al., 2008). In addition, green tea improved the 
survival of B. infantis by 5.05% and B. breve by 7.38% after simulated gastrointestinal 
digestion (Vodnar and Socaciu, 2012). Therefore, yoghurt bacteria might be affected by these 
flavonoid-rich products, and in turn, affect metabolism of flavonoids in GI tract. 
In a previous study in Glasgow, Mullen et al reported that full fat natural yoghurt reduced the 
urinary excretion of flavanone metabolites from 3.3 µM to1.5 µM at 0-5 h after ingestion of 
orange juice, but did not affect the 0-24 h urinary excretion, maximal plasma concentration 
and Tmax of two hesperetin-O-glucuronides (Mullen et al., 2008a). In addition, Roowi et al 
reported that full fat natural yoghurt also greatly reduced from 62 ± 18 μmol to 6.7 ± 1.8 
μmol  in the urinary excretion of five phenolic acids (3-hydroxyphenylacetic acid, 3-
hydroxyphenylhydracrylic acid, dihydroferulic acid, 3-methoxy-4-hydroxyphenylhydracrylic 
acid and 3-hydroxyhippuric acid) (Roowi et al., 2009a). This study suggested that full fat 
natural yoghurt might supress the degradative activity of gut bacteria to break down 
flavanones into phenolic acids. However the mechanism is not clear. It is possible that 
delivery of polyphenols to the colon may have been affected or absorption from the gut in the 
colon. There was no effect of full fat natural yoghurt on gastric emptying or small bowel 
transit time. 
Flavanone metabolites and phenolic metabolites are absorbed into the circulatory system after 
deglycosylation and degradation by intestinal enzymes or colonic bacteria (Manach et al., 
2005, Crozier et al., 2010, Pereira-Caro et al., 2014a, Roowi et al., 2009b). However, the 
mechanism by which yoghurt affects the production of flavanone metabolites and phenolic 
acids in the GI tract has not been explored. In addition, orange juice source (smooth orange 
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juice and orange juice ‘with bits’) affected metabolism of flavanone in GI tract, where there 
was lower hesperidin after gastric digestion and higher 3,4 –dihydroxyphenylpropionic acid 
at 6 h of fermentation from orange juice ‘with bits’ (Chapter 3). Thus, variable interactions of 
full fat natural yoghurt with smooth orange juice / orange juice ‘with bits’ might affect 
metabolism of flavanone in the GI tract. Moreover, various yoghurts containing probiotics or 
fruits might influence metabolism of orange juice flavanone in GI tract based on their 
ingredients (probiotics or extra polyphenols). The studies in this chapter were designed to 
elucidate the action of yoghurt/flavanone interactions using the GI model described in chapter 
3 by exploring the effects of natural full fat yoghurt which contained only starter culture 
organisms in in vitro models of the upper and lower gut. The starter culture organisms should 
not survive in the model. The effects were compared with yoghurt containing probiotic 
bacteria which should survive in the model.  In addition fruit containing yoghurt (live 
bacteria but extra polyphenols) were studied see any additional effects of the fruit. Thus the 
impact of yoghurt alone was tested in case this inhibited the phenolic acid production, 
probiotic bacteria may affect what phenolics enter the colon as they may metabolise the 
flavanones in the upper gut models as well as affect phenolic acid production in the colonic 
model. The fruit yoghurts may behave the same as the normal full fat yoghurt but the extra 
polyphenols from the fruit may interact with the gut bacteria and change total output. 
 
4.1.1 Hypothesis 
These studies aimed to test the hypothesis that yoghurt as part of the food matrix influences 
the metabolism of flavanones in an in vitro model of the upper and lower gut and to explore 
the mechanisms for any interactions. 
The following research questions were investigated: 
1)         Does full fat natural yoghurt affect the stability / release of orange juice flavanones in 
the upper gut model which may decrease delivery to the colon?  
2)          Was the reduced urinary excretion of phenolic acids seen in the in vivo study (Roowi 
et al., 2009b) with full fat yoghurt due to decreased production in the colon? 
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3)          Does full fat natural yoghurt have different actions between orange juice ‘with bits’ 
and orange juice ‘no bits’? 
4)          Do probiotics containing behave differently, can the probiotic bacteria degrade the 
flavanones in the upper gut models and or phenolic acid release in the colonic model 
resulting in reduced delivery of polyphenols to the colon? 
5)        Does probiotic fruit yogurt behave the same as non probiotic full fat yoghurt, or does 
the extra fruit affect phenolic acids production? 
 
4.2 Subjects and methods 
4.2.1 Chemicals and materials 
HPLC-grade methanol was obtained from Rathburn Chemicals (Walkerburn, UK). Formic 
acid was purchased from Riedel-deHaen (Seelze, Germany). Hydrochloric acid, sodium 
bicarbonate, pepsin (from porcine stomach mucosa), pancreatin (from porcine pancrease), 
bile acids (from porcine); tryptone, 2,4,5 – trimethoxycinnamic, anhydrous ethyl acetate, 
dichloromethane (DCM), N-methyl-N- (trimethylsily) trifluoracetateamide, prydine. 
CaCl2.2H2O, MnCl2.4H2O, NH4HCO3, NaHCO3, Na2HPO4, KH2PO4, MgSO4.7H2O, cysteine 
hydrochloride, NaOH, Na2S 
. 
9 H2O and resazurin solution were purchased from Sigma-
Aldrich Co Ltd (Poole, Dorset, UK). Hesperetin-7-O-rutinoside, narigenin-7-O-rutinoside, 3-
hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid , 4-hydroxyphenylpropionic acid,   3, 
4-dihydroxyphenylacetic acid, 3-(3, 4-dihydroxyphenyl) propionic acid, 4-hydroxy-3-
methoxy-phenylpropionic acid  (dihydrofeulic acid), 3-hydroxybenzoic acid, vanillic acid, 3-
hydroxy-4-methoxyphenyl propionic acid, 3-methoxy-4-hydroxyphenyl propionic acid, p-
coumaric acid and ferulic acid were purchased from Extrasynthese, Sigma-Aldrich Co Ltd 
(Poole, Dorset, UK) or Alfa Aesar (Karlsruhe, Germany). 
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4.2.2 Orange juices and yoghurt 
Two types of 100 % squeezed orange juice (Tropicana, not from concentrate, smooth orange 
juice (OJ) and orange juice ‘with bits’ (OJ bits)) were purchased from local supermarkets.  
Full fat natural yoghurt was made by the researcher from whole milk (Yeo Valley whole 
milk) and fermented by yoghurt cultures (Streptococcus thermophiles and Lactococcus 
bulgaricus) (Cheesemakingshop, Prospect Lane, Solihull, UK) in the lab with the following 
recipe: 1L of milk was heated and then quickly cooled down to 45 °C. A sachet of yoghurt 
starter (1 g) was dissolved with a cup of the heated milk, and then added to the rest of the 
milk.  The flask was sealed and allowed milk to ferment for 7 hours. And then, full fat natural 
yoghurt was kept in fridge for next day use. 
Probiotic containing natural full fat yoghurt was purchased from local supermarkets; Yeo 
Valley Natural Yoghurt containing Bifidobacterium (no species given), Lactobacillus 
acidophilus, and Streptococcus thermophilus. 
Strawberry yoghurt was purchased from local supermarket; Yeo Valley Strawberry yoghurt 
containing organic whole milk (86%), organic Strawberry Purée (5%), and live cultures: 
Bifidobacterium, Lactobacillus acidophilus, and Streptococcus thermophilus. 
4.2.3 Simulating GI digestion and fermentation of orange juice and 
full fat yoghurt with only starter culture 
The experiments conducted in this chapter are illustrated in Figure 4-1.Orange juice (40 ml) 
and 25 ml of full fat natural yoghurt (25 ml) was chosen based on the consumption of orange 
juice (250 ml) and full fat natural yoghurt (150 ml) in previous study (Mullen et al., 2008a).   
4.2.3.1 In vitro gastrointestinal digestion 
The model to simulate gastric and small intestinal digestion was adapted from Gil-Izquierdo 
(Gil-Izquierdo et al., 2003).  In vitro gastrointestinal digestion was conducted as described in 
section 2.3.1. 
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Figure 4-1 Details of the different stages of the simulating gastrointestinal model 
Y: full fat natural yoghurt, PY: probiotic containing yoghurt, FY, probiotic containing yoghurt with 
strawberry Purée (5 %) 
4.2.3.2 Faecal sample collection 
Six healthy Caucasian volunteers (same in Chapter 3) participated in this study and had a 
normal diet, were non-smokers, had no digestive diseases, no food allergies, and had not 
received antibiotics for at least 6 months before the study. Before providing faeces, 
participants agreed to take part in this study, and signed consent form. The volunteers 
followed a low-polyphenol diet avoiding fruits, vegetables, tea, coffee, wine and wholemeal 
foods for 2 days (details in Appendix 3) before providing a faecal sample according to 
information sheet (Appendix 2). Each faecal sample was collected by subjects in a special 
plastic box containing an AnaeroGen sacket (Oxioid, Hampshire, UK) to generate anaerobic 
conditions. Faecal samples were processed when brought to the lab. The food was recorded in 
a dietary record (Appendix 4). 
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4.2.3.3 In vitro fermentation with human colonic bacteria 
After in vitro gastrointestinal digestion, digesta was freeze-dried by using Edwards Micro 
Modulyo Freeze Dryer. The residues were stored at - 80 °C until colonic fermentation.  The 
fermentation was conducted as described in section 2.3.3.   
4.2.4 Analysis of flavanone and phenolic acids in digested and 
faecal samples 
Samples (1 ml) were extracted as described in section 2.9.1. The extracts were analysed by 
using HPLC-PDA as described in section 2.10. Phenolic acids were extracted as described in 
section 2.6. The extracts were analysed by using GC-MS as described in chapter 2.8. 
4.2.5 Analysis of total phenol and antioxidant capacity in digested 
and faecal samples 
Total phenols in digested and faecal samples were measured by using the Folin–Ciocalteau 
method. See section 2.4.1 for more details. Antioxidant capacity was determined by using 
FRAP assay in a redox-linked colorimetric reaction. See chapter 2.4.3 for more details. 
4.2.6 Survival test of yoghurt starter culture bacteria 
After gastric digestion of full fat natural yoghurt, digesta (1 ml) was diluted with sodium 
citrate (0.1 M) ranging from 1:10 to 1:1000 and poured in MRS agar plate. The plates were 
incubated 2 days at 37°C.  
4.2.7 Statistical analysis 
All data were presented as mean values with standard error. The unit used for the upper GI 
digestion was based on total amount of flavanone or total phenols in the digestive fluids 
expressed as mg/250ml, and used for the fermentation was based on concentration of 
flavanone or  total phenols in faecal sample expressed as µM. All data were assumed to be 
normally distributed, t-tests or ANOVA tests with Tukey-HSD was used to determine 
significant differences between orange juice with yogurt and orange juice without yogurt (P < 
0.05). The analysis was conducted with SPSS software version 22.  
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4.3 Results 
4.3.1 The effect of full fat natural yoghurt (Y) on GI metabolism of 
orange juice flavanone 
4.3.1.1 Hesperidin and narirutin in orange juices mixed with full fat natural 
yoghurt  
Hesperidin was higher in OJ + Y compared with OJ (40.5 ± 4.5
  
mg vs. 25.8 ± 4.5 mg, p < 
0.001) and OJ bits + Y compared with OJ bits (41.3 ± 2.1 mg vs. 33.1 ± 1.0 mg, p < 0.05) at 
the beginning of the GI digestion (Table 4-1). Narirutin was higher in OJ + Y compared with 
OJ at beginning of GI digestion (1.8 ± 0.3 mg vs. 1.7 ± 0.3 mg, p < 0.001). However, there 
was no difference of hesperidin and narirutin between OJ +Y and OJ bits + Y, even though 
hesperidin was higher in OJ bits than OJ (33.1 ± 1.0 mg vs. 25.8 ± 4.5 mg, p < 0.05). 
Table 4-1 Content of hesperidin and narirutin (mg/250ml) in orange juices mixed with and 
without full fat natural yoghurt at initial gastric digestion 
 
 Hesperidin Narirutin 
OJ 25.8 ± 2.6 1.7 ± 0.2 
OJ + Y 40.5 ± 2.6
 **
 1.8 ± 0.2
 
 
OJ bits 33.1 ± 0.6 
£
 1.7 ± 0.1 
OJ bits + Y 41.3 ± 1.2
 *
 1.8 ± 0.1 
Data expressed as mean values ± SE (n=3). Samples were collected when pepsin/HCl was added to 
individual inbubation. OJ: smooth orange juice, OJ+Y: smooth orange juice with full fat natural 
yoghurt, OJ bits: orange juice ‘with bits’, OJ bits +Y: orange juice ‘with bits’ with full fat natural yoghurt, 
* 
significantly different from OJ or OJ bits, P < 0.05 (pair t-test),
 ** 
significantly different from OJ or OJ 
bits, P < 0.001 (pair t-test), 
£ 
significantly different from OJ, p < 0.05 (independent t-test). 
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4.3.1.2 Hesperidin and narirutin in orange juices mixed with full fat natural 
yoghurt during in vitro GI digestion   
After gastric digestion, hesperidin was higher in OJ + Y (41.6 ± 2.0 mg/250 ml vs. 28.6 ± 1.6 
mg/250 ml, p = 0.002) and OJ bits + Y (38.5 ± 1.9 mg/250 ml vs. 22.0 ± 0.7 mg/250 ml, p = 
0.012) compared with OJ and OJ bits after the gastric digestion (Table 4-2). After the small 
intestinal digestion, hesperidin was higher in OJ bits + Y (47.9 ± 7.2 mg/250 ml vs. 22.5 ± 
1.7 mg/250 ml, p = 0.002) compared with OJ bits (p < 0.004), while hesperidin was higher in 
OJ + Y compared with OJ (34.9 ± 1.1 mg/250 ml vs. 22.9 ± 1.4 mg/250 ml, p = 0.031). 
Furthermore, narirutin was about 1.0 ± 0.1 mg / 250 ml in orange juices after the upper GI 
digestion.  
Table 4-2 Content of hesperidin and narirutin (mg/250ml) in digestive fluids during the upper 
GI digestion in vitro  
 
Narirutin Hesperidin Total Flavanone 
After gastric 
digestion 
After intestinal 
digestion 
After gastric 
digestion 
After intestinal 
digestion 
After gastric 
digestion 
After intestinal 
digestion 
OJ 1.8 ± 0.0 1.0 ± 0.1 28.6 ± 1.6 22.9 ± 1.0 30.3 ± 1.6 23.9 ± 1.1 
OJ +Y 1.8 ± 0.1 1.5 ± 0.1 
*
 41.6 ± 2.0 
*
 34.9 ± 1.1
*
 43.4 ± 2.1 
*
 36.4 ± 1.2* 
OJ bits 1.6 ± 0.1 1.0 ± 0.1 22.0 ± 0.7 22.5 ± 1.7 23.7 ± 0.7 23.5 ± 1.7 
OJ bits +Y 1.6 ± 0.1 1.6 ± 0.1 38.5 ± 1.9 
*
 47.9 ± 7.2 
*
 40.2 ± 1.9 
*
 49.6 ± 7.3 
*
 
Data expressed as mean values ± SE (n=3), samples were collected when pepsin/HCl was added to 
each inbubation. Calculation was based on total amount of hesperidin or narirutin from 250 ml of 
orange juice, OJ: smooth orange juice, OJ+Y: smooth orange juice with full fat natural yoghurt, OJ 
bits: orange juice ‘with bits’, OJ bits +Y: orange juice ‘with bits’ with full fat natural yoghurt, ANOVA 
tests with Tukey-HSD test was used to determine significant differences 
* 
significantly different from 
OJ or OJ bits, P < 0.05.. 
4.3.1.3 Hesperidin and narirutin in orange juices mixed with full fat natural 
yoghurt during in vitro fermentation by human gut bacteria 
Compared with OJ, hesperidin was higher in OJ + Y after 6 h fermentation with gut bacteria 
(63.0 ± 13.8 µM vs. 54.2 ± 11.9 µM, p ≤ 0.03) (Table 4-3). However, hesperidin and narirutin 
were higher in OJ bits than OJ bits + Y (97.9 ± 10.1 µM vs. 73.2 ± 11.8 µM, p ≤ 0.01; 3.5 ± 
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0.6 µM vs. 2.6 ± 0.5 µM, p < 0.05) at 0 h fermentation (Table 4-4). However, narirutin, 
hesperidin, hesperetin and naringenin were not significantly different between OJ and OJ +Y, 
or OJ bits and OJ bits + Y after 24 h colonic fermentation with gut bacteria. Total flavanone 
was 53.1 ± 13.1 µM and 55.1 ± 11.8 µM in the incubation with OJ and OJ +Y, 49.6 ± 16.6 
µM and 59.2 ± 15.2 µM in the incubation of OJ bits and OJ bits + Y respectively.  
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Table 4-3 Concentration of hesperidin, narirutin, hesperetin and naringenin (µM) from smooth orange juice during fermentation by human colonic 
bacteria in the presence of full fat natural yoghurt 
 
0 h 2 h 4 h 6 h 24 h 
OJ OJ +Y OJ OJ +Y OJ OJ +Y OJ OJ +Y OJ OJ +Y 
Narirutin 2.7 ± 0.6 3.6 ± 0.5 2.7 ± 0.6 3.1 ± 0.5 2.5 ± 0.7 2.0 ± 0.4 2.0 ± 0.7 2.5 ± 0.6 1.4 ± 0.3 1.2 ± 0.3 
Hesperidin 70.0 ± 13.3 79.2 ± 11.1 77.1 ± 8.9 87.4 ± 5.9 72.8 ± 8.4 64.1 ± 6.9 63.0 ± 13.8 54.2 ± 11.9 
*
 44.4 ± 12.6 47.4 ± 12.0 
Naringenin 0.7 ± 0.4 0.4 ± 0.2 2.0 ± 0.7 1.7 ± 0.6 2.7 ± 0.9 2.3 ± 0.9 3.0 ± 1.2 1.5 ± 0.4 2.7 ± 1.0 2.7 ± 0.6 
Hesperetin 0.4 ± 0.3 0.2 ± 0.1 1.4 ± 0.6 1.1 ± 0.4 2.7 ± 1.2 2.3 ± 1.1 2.9 ± 1.2 1.1 ± 0.3 4.6 ± 1.9 3.8 ± 1.4 
Total 73.8 ± 14.1 83.4 ±11.4 83.3 ± 9.2 93.3 ± 6.6 80.8 ± 7.6 70.7 ± 7.8 70.9 ± 15.1 59.3 ± 11.7 
*
 53.1 ± 13.1 55.1 ± 11.8 
Data expressed as mean values ± SE (n=6), OJ: smooth orange juice, OJ +Y: smooth orange juice with full fat natural yoghurt, ANOVA tests with Tukey-HSD 
test was used to determine significant differences 
* 
significantly different from OJ, P < 0.05. 
Table 4-4 Concentration of hesperidin, narirutin, hesperetin and naringenin (µM) from orange juice ‘with bits’ during fermentation by human 
colonic bacteria in the presence of full fat natural yoghurt 
 
0 h 2 h 4 h 6 h 24 h 
OJ bits OJ bits+ Y OJ bits OJ bits+ Y OJ bits OJ bits+ Y OJ bits OJ bits+ Y OJ bits OJ bits+ Y 
Narirutin 3.5 ± 0.6 2.6 ± 0.5 
*
 2.8 ± 0.6 2.8 ± 0.5 2.4 ± 0.6 2.2 ± 0.3 1.8 ± 0.5 1.9 ± 0.5 1.2 ± 0.3 1.4 ± 0.5 
Hesperidin 97.9 ± 10.1 73.2 ± 11.8 
*
 89.6 ± 9.5 72.8 ± 15.3 79.5 ± 14.8 78.2 ± 11.2 68.6 ± 18.7 70.1 ± 16.0 42.5 ± 15.9 52.9 ± 14.5 
Naringenin 0.7 ± 0.4 0.4 ± 0.3 1.8 ± 0.8 1.0 ± 0.3 2.2 ± 0.8 2.3 ± 0.8 2.2 ± 0.7 1.6 ± 0.6 2.4 ± 0.7 1.7 ± 0.7 
Hesperetin 0.4 ± 0.3 0.2 ± 0.2 1.6 ± 0.8 0.6 ± 0.3 2.4 ± 1.1 2.1 ± 0.8 2.7 ± 0.9 1.9 ± 0.5 3.4 ± 1.4 3.1 ± 1.0 
Total 102.5 ± 10.3 76.4 ± 12.3 
*
 95.8 ± 10.2 77.2 ± 15.9 86.5 ± 14.9 84.8 ± 11.9 75.3 ± 19.4 75.6 ± 16.9 49.6 ± 16.6 59.2 ± 15.2 
Data expressed as mean values ± SE (n=6), OJ bits: orange juice ‘with bits’, OJ bits +Y: orange juice ‘with bits’ with full fat natural yoghurt, ANOVA tests with 
Tukey-HSD test was used to determine significant differences, 
* 
significantly different from OJ bits, P < 0.05. 
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4.3.1.4 Phenolic acids derived from orange juices mixed with full fat natural 
yoghurt after in vitro fermentation 
The five phenolic acids (4-hydroxybenzoic acid, 4-hydroxyphenylacetic acid, 3-4'-
hydrophenylpropionic acid, dihydroferulic acid, and 3, 4-dihydroxyphenylpropionic acid) 
that are assumed to be derived from orange juice flavanones were summed to give total 
phenolic content. There was no significantly different production of phenolic acids in the 
incubations of orange juices with or without yoghurt after 24 h fermentation (Table 4-5). In 
addition, the yoghurt did not affect the amount of each phenolic acid during the fermentation 
of smooth orange juice and orange juice ‘with bits’.  
Table 4-5 Concentration of five phenolic acids (µM) derived from orange juice during 
fermentation by human colonic bacteria in the presence of full fat natural yoghurt 
 
0 h 2 h 4 h 6 h 24 h 
OJ 4.1 ± 1.4 6.9 ± 2.5 19.2 ± 9.3 19.7 ± 5.3 39.0 ± 12.5 
OJ +Y 3.1 ± 1.0 8.1 ± 3.3 15.5 ± 7.6 22.7 ± 8.3 42.3 ± 12.7 
OJ bits 4.7 ± 1.6 10.7 ± 3.6 20.1 ± 10.4 26.1 ± 8.5 37.4 ± 10.3 
OJ bits + Y 4.9 ± 1.8 15.8 ± 8.6 17.3 ± 9.8 21.3 ± 9.1 42.2 ± 12.0 
Data expressed as mean values ± SE (n=6), OJ: smooth orange juice, OJ+Y: smooth orange juice 
with full fat natural yoghurt, OJ bits: orange juice ‘with bits’, OJ bits +Y: orange juice ‘with bits’ with full 
fat natural yoghurt, ANOVA tests with Tukey-HSD test was used to determine significant differences, 
* 
significantly different from OJ or OJ bits, P < 0.05.  
4.3.2 The GI metabolism of hesperidin and narirutin from different 
orange juice in the presence of full fat natural yoghurt 
4.3.2.1 The stability / release of hesperidin and narirutin during the upper GI 
digestion 
There was no significant difference in hesperidin and narirutin between OJ + Y and OJ bits + 
Y during the upper GI digestion. Hesperidin decreased from 40.5 ± 2.6 to 34.9 ± 0.9 mg/ 
250ml in OJ +Y, and ranged from 41.3 ± 2.1 to 47.9 ± 10.0 mg/ 250ml in OJ bits +Y. 
Narirutin decreased from 1.8 ± 0.3 to 1.5 ± 0.1 mg/ 250ml  (p < 0.02)  in OJ + Y. Total 
flavanone decreased to 36.4 ± 0.9 mg/ 250ml (13.9 % of loss) in OJ + Y, but increased to 
49.6 ± 5.9 mg/ 250 ml  (115.1 % of recovery) in OJ bits +Y.  
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Table 4-6 Contents of hesperidin and narirutin (mg/250ml) in orange juices in the presence of full fat natural yoghurt during the upper GI digestion 
  
0 h 1 h 3 h 5 h 7 h 
Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin 
OJ+Y 40.5 ± 2.6 1.8 ± 0.2 41.6 ± 1.6 1.8 ± 0.1 35.2 ± 1.7 1.6 ± 0.1 29.0 ± 2.3 1.4 ± 0.1 34.9 ± 0.9 1.5 ± 0.1 
Recovery (%) -- -- 103.5 ± 5.9 100.4 ± 10.9 87.3 ± 4.6 90.6 ± 9.0 73.1 ± 11.2 76.3 ± 11.3 87.4 ± 8.3 81.7 ± 12.1 
OJ bits +Y 41.3 ± 1.2 1.8 ± 0.1  38.5 ± 1.5 1.6 ± 0.1  30.4 ± 2.4 1.4 ± 0.1 32.0 ± 0.5 1.4 ± 0.1 47.9  ± 5.8 1.6 ± 0.1 
Recovery (%) -- -- 94.1 ± 6.4 91.5 ± 4.2 74.2 ± 7.3 79.2 ± 8.1 78.0 ± 3.0 79.7 ± 5.3 117.2 ± 16.1 91.0 ± 10.5 
Data expressed as mean values ± SE (n=3).  Calculation was based on total amount of hesperidin or narirutin from 250 ml of orange juice, OJ+Y: smooth 
orange juice with full fat natural yoghurt, OJ bits + Y: orange juice ‘with bits’ with full fat natural yoghurt, gastric digestion for 1 h, small intestinal digestion for 6 
h from 1 h to 7 h, ANOVA tests with Tukey-HSD was used to determine significant differences, 
* 
significantly different from OJ + Y, P < 0.05.  
 
Table 4-7 Concentration of hesperidin and narirutin (µM) from orange juices during colonic fermentation by human gut bacteria in the presence of 
full fat natural yoghurt 
 
0 h 2 h 4 h 6 h 24 h 
 Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin Narirutin 
OJ+Y 79.2 ± 11.1 3.6 ± 0.5 87.4 ± 5.9 3.1 ± 0.5 64.1 ± 6.9 2.0 ± 0.4 54.2 ± 11.9 2.5 ± 0.6 47.4 ± 12.0 1.2 ± 0.3 
OJ bits +Y 73.2 ± 11.8 2.6 ± 0.5 72.8 ± 15.3 2.8 ± 0.5 78.2 ± 11.2 2.2 ± 0.3 70.1 ± 16.0 1.9 ± 0.5 52.9 ± 14.5 1.4 ± 0.5 
Data expressed as mean values ± SE (n=6), OJ+Y: smooth orange juice with full fat natural yoghurt, OJ bits + Y: orange juice ‘with bits’ with full fat natural 
yoghurt. ANOVA tests with Tukey-HSD test was used to determine significant differences, 
* 
significantly different from OJ + Y, P < 0.05.  
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4.3.2.2 Degradation of hesperidin and narirutin during in vitro fermentation 
4.3.2.2.1 Hesperidin and narirutin, and their aglycones (hesperetin and 
naringenin) in the incubation with orange juices in the presence of full fat 
natural yoghurt 
Hesperidin and narirutin were similar between OJ and OJ bits in the presence of full fat 
natural yoghurt during fermentation by gut bacteria (Table 4-7). There was 44 ± 11 % of 
hesperidin degraded by colonic bacteria in OJ, while 39 ± 15% was transformed from OJ bits 
in the presence of full fat natural yoghurt, but there was no significantly different degradation 
of hesperidin between smooth orange juice and orange juice with bits in the presence of the 
yoghurt. Narirutin was degraded by 67.6 ± 4.9 % and 46.5 ± 15.4 % after 24 h fermentation 
of OJ +Y and OJ bits +Y.  
Hesperetin and naringenin, aglycones of hesperidin and narirutin, were produced in similar 
amounts between OJ and OJ bits in the presence of full fat natural yoghurt (Table 4-8). There 
was 22.5 % of flavanone including hesperidin, narirutin, hesperetin and naringenin reduced 
by 27.8 ± 13.6 % in OJ bits + Y, and 34.4 ± 9.6 % in OJ + Y after 24 h fermentation (Table 
4-9). 
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Table 4-8 Concentration of hesperetin and naringenin (µM) produced from orange juices during colonic fermentation by human gut bacteria in the 
presence of full fat natural yoghurt 
 
0h 
 
2h 
 
4h 
 
6h 
 
24h 
 
 
Hesperetin Naringenin Hesperetin Naringenin Hesperetin Naringenin Hesperetin Naringenin Hesperetin Naringenin 
OJ + Y 0.2 ± 0.2 0.4 ± 0.2 1.1 ± 0.4 1.7 ± 0.6 2.3 ± 1.1 2.3 ± 0.9 1.1 ± 0.4 1.5 ± 0.4 3.8 ± 1.4 2.7 ± 0.6 
OJ bits + Y 0.2 ± 0.2 0.4 ± 0.3 0.6 ± 0.3 1.0 ± 0.3 2.1 ± 0.8 2.3 ± 0.8 1.9 ± 0.5 1.6 ± 0.7 3.1 ± 1.0 1.8 ± 0.7 
Data expressed as mean values ± SE (n=6), OJ+Y: smooth orange juice with full fat natural yoghurt, OJ bits + Y: orange juice ‘with bits’ with full fat natural 
yoghurt, ANOVA tests with Tukey-HSD test was used to determine significant differences, 
* 
significantly different from OJ + Y, P < 0.05.  
Table 4-9 Concentration of total flavanone (µM) from orange juice during fermentation by human colonic bacteria in the presence of full fat natural 
yoghurt 
 
0 h 2 h 4 h 6 h 24 h 
OJ + Y 83.4 ± 12.0 93.3 ± 7.4 70.7 ± 9.3 59.3 ± 13.3 55.2 ± 14.4 
Recovery (%) -- 111.9 84.8 71.1 66.2 
OJ bits +Y 76.4 ± 12.8 77.1 ± 16.4 84.8 ± 13.1 75.6 ± 17.5 59.2 ± 16.6 
Recovery (%) -- 100.9 111 99 77.5 
Data expressed as mean values ± SE (n=6), Total flavanone includes hesperidin, narirutin, hesperetin and naringenin, OJ+Y: smooth orange juice with full fat 
natural yoghurt, OJ bits + Y: orange juice ‘with bits’ with full fat natural yoghurt. , ANOVA tests with Tukey-HSD test was used to determine significant 
differences, 
* 
significantly different from OJ + Y, P < 0.05
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4.3.2.2.2 Production of phenolic acids in the incubation with orange juices in 
the presence of full fat natural yoghurt 
Phenolic acids were produced through the activity of gut bacteria over 24 h of fermentation 
(Figure 4-2). After 24 h fermentation, five phenolic acids increased to 107.4 ± 37.1 µM and 
110.8 ± 36.6 µM respectively in the incubation with OJ + Y and OJ bits + Y.  
  
Figure 4-2 Production of five phenolic acids (µM) by human gut bacteria in incubation of 
smooth orange juice and orange juice ‘with bits’ in the presence of full fat natural yoghurt 
Values expressed as mean values ± SE (n=6), OJ+Y: smooth orange juice with full fat natural 
yoghurt, OJ bits + Y: orange juice ‘with bits’ with full fat natural yoghurt. ANOVA tests with Tukey-HSD 
test was used to determine significant differences  
As shown in Figure 4-3, 3-phenylpropionic acid was main phenolic acid at the beginning of 
the fermentation of OJ and OJ bits (6.1 ± 2.9 µM and 7.7 ± 3.0 µM), followed by 3-(3, 4-
dihydroxyphenyl) propionic acid (2.4 ± 1.9 µM and 3.4 ± 2.9 µM) and 3-phenylacetic acid 
(2.5 ± 0.5 µM and 3.1 ± 0.6 µM) at 0 h of fermentation. At first 2 h, 3-phenylpropionic acid 
increased to 12.3 ± 4.7 µM in fermentation of OJ bits +Y (p < 0.05). 3-phenylacetic acid 
increased to 9.1 ± 2.3 µM in OJ + Y (p < 0.03). From 2 h to 4 h of fermentation, 3-(phenyl) 
acetic acid was produced to 21.9 ± 11.8 µM and 21.5 ± 10.2 µM respectively in the 
incubation of OJ + Y and OJ bits + Y.  4-hydrophenylpropionic acid significantly increased 
to 8.9 ± 2.1 µM (p < 0.02) and 5.9 ± 2.9 µM (p < 0.02) in incubation with OJ+Y and OJ bits 
+ Y at 6 h of fermentation. 3, 4-dihydroxyphenyl) propionic acid was higher in incubation of 
OJ + Y compared with OJ bits +Y (7.4 ± 1.9 µM vs. 4.6 ± 1.2 µM, P < 0.02). Dihydroferulic 
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acid was significantly increased from 3.8 ± 2.8 µM to 6.5 ± 2.9 µM during the period of 4 h 
to 6 h. Among the phenolic acids, 3-phenylpropionic acid and 3-phenylacetic acid had higher 
amount (11.1 ± 4.0 µM & 12.3 ± 4.1 µM; 21.9 ± 9.9 µM & 19.1 ± 7.9 µM) separately in the 
fermentation with OJ+Y and OJ bits + Y.  
 
Figure 4-3 Production of phenolic acids by gut bacteria at 0 h (A), 2 h (B), 4 h(C), 6 h(D) and 24 
h(E) of fermentation of smooth orange juice and orange juice ‘with bits’ in the presence of full 
fat natural yoghurt 
Expressed as mean value in µM ± SE (n=6), quantified using the available standard. 3-PPA: 3-
(phenyl)propionic acid, 3-PAA: 3-(phenyl)acetic acid, 4-HBA: 4-hydroxybenzoic acid,4-HPAA: 4-
hydroxyphenylacetic acid, 4-HPPA: 4-hydroxyphenylpropionic acid, 3-HPPA: 3-3'-
hydroxyphenylpropionic acid, 4 - HPPA: 3-(4'-hydrophenyl)propionic acid, DFA: Dihydroferulic acid, 
3,4-DHPPA: 3,4-dihydroxyphenylpropionic acid,  OJ+Y: smooth orange juice with full fat natural 
yoghurt, OJ bits + Y: orange juice ‘with bits’ with full fat natural yoghurt. ANOVA tests with Tukey-HSD 
test was used to determine significant differences, * 3, 4-DHPPA Significantly different from 6 h, P < 
0.05.  
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4.3.2.3 Total phenolic contents and antioxidant capacity in orange juices in the 
presence of full fat natural yoghurt during in vitro GI digestion and 
fermentation 
Total phenolic contents was analysed by Folin-Ciocalteau method (Figure 4-4). Total 
phenolic content of OJ + Y kept stable during pepsin/HCl digestion about 484.7 ± 16.0 mg 
GAE / 250ml, and then decreased to 339.4 ± 1.5 mg GAE / 250 ml after pancreatin/ bile acids 
digestion. The total phenols for the OJ bits + Y was stable during the gastrointestinal 
digestion from 367.9  ± 83.4 mg GAE / 250ml  to 352.4 ± 12.0 mg GAE /250 ml. Total 
phenol was higher in OJ + Y  digesta than OJ bits + Y digesta after the pepsin / HCl 
digestion. 
 
Figure 4-4 Total phenols of orange juice (mg/250ml GAE) during in vitro gastrointestinal 
digestion in the presence of full fat natural yoghurt 
Data expressed as mean values ± SE (n=3), total phenol was based on 40 ml of orange juice, OJ+Y: 
smooth orange juice with full fat natural yoghurt, OJ bits + Y: orange juice ‘with bits’ with full fat natural 
yoghurt, gastric digestion for 1 h, small intestinal digestion for 6 h from 1 h to 7 h, ANOVA tests with 
Tukey-HSD test was used to determine significant differences, * Significantly different from OJ + Y, P 
< 0.05.  
 
Antioxidant capacity were respectively analyzed by FRAP assay (Figure 4-5). There was no 
significant difference in terms of antioxidant capacity, which was 0.6 mM Fe
2+
 during the 
upper GI digestion with OJ + Y or OJ bits + Y.  
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Figure 4-5 Antioxidant capacity of orange juice (mM Fe
2+
) during in vitro gastrointestinal 
digestion in the presence of full fat natural yoghurt 
Data expressed as mean values ± SE (n=3).  OJ+Y: smooth orange juice with full fat natural yoghurt, 
OJ bits + Y: orange juice ‘with bits’ with full fat natural yoghurt, Gastric digestion for 1 h, small 
intestinal digestion for 6 h from 1 h to 7 h. ANOVA tests with Tukey-HSD test was used to determine 
significant differences, * Significantly different from OJ + Y, P < 0.05.
 
Figure 4-6 Total phenols in the incubation with orange juices by gut bacteria in the presence of 
full fat natural yoghurt 
Data expressed as mean values ± SE (n=6).  OJ+Y: smooth orange juice with full fat natural yoghurt, 
OJ bits + Y: orange juice ‘with bits’ with full fat natural yoghurt, ANOVA tests with Tukey-HSD test was 
used to determine significant differences, * significantly different from OJ + Y, P < 0.05. 
Total phenolic content of faecal water is shown in Figure 4-6. Total phenolic content 
remained stable during fermentation with OJ + Y and OJ bits +Y from 1.1 ± 0.1 mg/ml GAE 
to 1.2 ± 0.1 GAE mg/ml and 1.0 ± 0.2 to 1.2 ± 0.2 GAE mg/ml. Compared with fermentation 
of OJ and OJ bits, total phenolic contents were similar between in the incubation of OJ +Y 
and OJ bits + Y (1.2 ± 0.2 vs. 1.2 ± 0.2 GAE mg/ml). 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0h 1h 3h 5h  7h
F
ra
p
 (
m
M
 F
e
2
+
) 
Time (h) 
OJ+Y
OJbits+Y
0
0.4
0.8
1.2
1.6
0h 2h 4h 6h 24h
T
o
ta
l 
p
h
en
o
l 
(m
g
/m
l 
G
A
) 
Time (h) 
OJ+Y
OJbits+Y
117 
 
 
 
In terms of antioxidant capacity, faecal samples were 0.8 m MFe
2+
 during fermentation of OJ 
+ Y and OJ bits + Y with gut bacteria over 24 h (Figure 4-7). 
  
Figure 4-7 Antioxidant capacity in the incubation with orange juices by gut bacteria in the 
presence of full fat natural yoghurt 
Data expressed as mean values ± SE (n=6).  OJ+Y: smooth orange juice with full fat natural yoghurt, 
OJ bits + Y: orange juice ‘with bits’ with full fat natural yoghurt, ANOVA tests with Tukey-HSD test was 
used to determine significant differences, * significantly different from OJ + Y, P < 0.05. 
4.3.2.4 pH in incubation with orange juices in the presence of full fat natural 
yoghurt during in vitro fermentation 
pH was significantly lower in the incubation of orange juices in the presence of full fat 
natural yogurt (4.2 ~ 4.5) compared with control (7.3) after 24 h colonic fermentation (p < 
0.05), but there was no difference between OJ / OJ +Y, OJ bits / OJ bits + Y, OJ + Y / OJ bits 
+ Y Compared with fermentation with OJ or OJ bits, full fat natural yoghurt did not affect the 
pH (Figure 4-8). 
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Figure 4-8 pH during fermentation with colonic bacteria 
OJ: smooth orange juice, OJ bits: orange juice ‘with bits’, OJ+Y: smooth orange juice adding yoghurt, 
OJ bits + Y: orange juice ‘with bits’ adding yoghurt, ANOVA tests with Tukey-HSD test was used to 
determine significant differences,* significantly different from control, p < 0.05. 
 
4.3.3 Probiotics containing yoghurt and strawberry purée (5 %) and 
probiotics containing yoghurt on flavanone and phenolic acids in 
orange juices during the upper GI digestion 
4.3.3.1 The effect of yoghurt containing probiotics (PY) on hesperidin and 
narirutin during the upper GI digestion 
As shown in Table 4-11, hesperidin was significantly different in OJ + PY than OJ during the 
upper GI digestion (p < 0.05). Hesperidin and narirutin were similar between OJ + PY and OJ 
before the upper GI digestion (4.9 ± 0.1 mM vs. 4.5 ± 0.2 mM, 10.0 ± 0.6 mM vs. 10.4 ± 0.1 
mM) (Table 4-10). After gastric digestion, hesperidin was lower in OJ + PY than OJ (8.2 ± 
0.3 mM vs. 10.2 ± 0.2 mM, p < 0.05) after the gastric digestion, and  was lower in OJ + FY 
(9.3 ± 1.7 mM vs. 11.1 ± 0.4 mM, p < 0.05) after the upper GI digestion.  
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Table 4-10 Effect of probiotic yoghurt (PY), yoghurt containing fruits (FY) on flavanones in 
smooth orange juice during simulating upper GI digestion 
 
0 h After gastric digestion After small intestinal digestion 
Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin 
OJ + PY 
&
 4.9 ± 0.1 10.0 ± 0.6 3.6 ± 0.1 8.2 ± 0.3 
*
 3.5 ± 0.3 14.7 ± 0.8 
OJ + FY 
*&€
 3.2 ± 0.3 
*$
 9.2 ± 1.0 2.6 ± 0.5 8.4 ± 1.4 2.7 ± 0.3 9.3 ± 1.7 
*
 
OJ 4.5 ± 0.2 10.4 ± 0.1 3.6 ± 0.2 10.2 ± 0.2  2.8 ± 0.3 11.1 ± 0.4 
OJ + Y 
*&
 4.4 ± 0.2 9.3 ± 0.2 3.0 ± 0.2 8.1 ± 0.3 3.4 ± 0.4 12.4 ± 1.7 
Values are means ± SE (mM) (n = 3). OJ+Y: smooth orange juice with full fat natural yoghurt, OJ + Y: 
smooth orange juice with full fat natural yoghurt, OJ + PY: smooth orange juice with probiotic yoghurt, 
OJ + FY: smooth orange juice with strawberry yoghurt, OJ: smooth orange juice. ANOVA tests with 
Tukey-HSD test was used to determine significant differences,* significantly different amount of 
narirutin from OJ, p < 0.05, 
&
 significantly different amount of hesperidin from OJ, p < 0.05, 
€
 
significantly different amount of narirutin from OJ + Y, 
ƒ
 significantly different amount of hesperidin 
from OJ+Y, 
£
 significantly different from OJ + Y, p < 0.05, 
$
 significantly different from OJ + PY, p < 
0.05. 
Narirutin was higher in OJ bits + PY than OJ bits (3.5 ± 0.1 mM vs. 2.3 ± 0.1 mM, p < 0.05), 
after the upper GI digestion (Table 4-11).  
Table 4-11 Effect of full fat natural yoghurt (Y), probiotic containing yoghurt (PY), yoghurt 
containing fruits (FY) on flavanone in orange juice ‘with bits’ during gastrointestinal digestion 
 0 h After gastric digestion After small intestinal digestion 
Narirutin Hesperidin Narirutin Hesperidin Narirutin Hesperidin 
OJ bits + PY 
*
 3.9 ± 0.2 10.1 ± 0.8 3.5 ± 0.3 10.7 ± 0.4 
£
 2.4 ± 0.1 13.7 ± 1.6 
OJ bits + FY 
*
 3.5 ± 0.2 10.2 ± 0.1 3.3 ± 0.1 
*
 10.2 ± 0.1 
£
 3.5 ± 0.1 
*£
 14.7 ± 0.5 
OJ bits  4.3 ± 0.2 9.6 ± 0.4 2.0 ± 0.1 7.7 ± 0.5 2.3 ± 0.1 11.1 ± 0.2 
OJ bits + Y 
*
 3.7 ± 0.3 9.4 ± 0.5 2.9 ± 0.2 8.8 ± 0.3 2.9 ± 0.2 14.3 ± 0.8 
Values are means ± SE (mM) (n = 3).OJ bits + Y: orange juice ‘with bits’ with full fat natural yoghurt; 
OJ bits + Y: orange juice ‘with bits’ with probiotic yoghurt; OJ bits: orange juice ‘with bits’, OJ bits + 
FY: orange juice ‘with bits’ with strawberry, OJ bits + Y: orange juice ‘with bits’ with full fat natural 
yoghurt; ANOVA tests with Tukey-HSD test was used to determine significant differences, ,* 
significantly different amount of narirutin  from OJ bits, p < 0.05, 
£
 Significantly different from OJ bits + 
Y, p < 0.05, 
$
 significantly different from OJ bits + PY, p < 0.05. 
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4.3.3.2 The effect of strawberry purée (5 %) and probiotic containing yoghurt 
(FY) on hesperidin and narirutin during the upper GI digestion 
Narirutin was lower in OJ + FY than OJ (3.2 ± 0.3 mM vs. 4.5 ± 0.2 mM, p < 0.05), while 
hesperidin was similar between OJ + FY and OJ before the upper GI digestion (Table 4- 11). 
Hesperidin and narirutin was similar between OJ bits + FY and OJ bits (Table 4-12). 
Narirutin was higher in OJ bits + FY than OJ bits after the gastric digestion (3.3 ± 0.1 mM vs. 
2.0 ± 0.1, p < 0.05) (Table 4-12). There were similar amount of narirutin and hesperidin at 
2.6 ± 0.5 mM and 8.4 ± 1.4 mM in OJ + FY, and 3.6 ± 0.2 mM and 10.2 ± 0.2 mM after the 
gastric digestion. Hesperidin was significantly lower in OJ + FY compared with OJ after 
small intestinal digestion (9.3 ± 1.7 mM vs. 11.1 ± 0.4 mM, P < 0.05), while narirutin was 
similar. However, narirutin was higher in OJ bits + FY than OJ bits (3.5 ± 0.1 mM vs. 2.3 ± 
0.1 mM, p < 0.05), while hesperidin was similar between OJ bits + FY and OJ bits. 
Furthermore, PY and FY did not affect hesperidin and narirutin during the upper GI digestion 
compared with smooth orange juice with full fat natural yogurt (Table 4-10). Hesperidin was 
higher in OJ bits + PY (10.7 ± 0.4 mM) and OJ bits + FY (10.2 ± 0.1 mM) compared with OJ 
bits + Y (8.2 ± 0.3 mM) (P < 0.05) after the gastric digestion, even though it was similar in 
OJ bits + PY, OJ bits + FY and OJ bits + Y after the small intestinal digestion (Table 4-12). 
After the small intestinal digestion, narirutin was higher in OJ bits + FY compared with OJ 
bits + Y (3.5 ± 0.1 mM vs. 2.9 ± 0.2 mM, P < 0.05), but was similar between OJ bits + PY 
(2.4 ± 0.1mM) and OJ bits + Y (2.9 ± 0.2 mM) (Table 4 -12). 
4.3.3.3 Phenolic acids 
There were eight phenolic acids were detected in digesta during the upper GI digestion. They 
were 3-hydroxybenzoic acid, vanillic acid, 3,4-dihydroxyphenylacetic acid, 3-hydroxy-4-
methoxyphenyl propionic acid, 3-methoxy-4-hydroxyphenyl propionic acid, 3,4-
dihydroxyphenylpropionic acid, p-coumaric acid and ferulic acid. 3, 4-dihydroxyphenylacetic 
acid, 3-hydroxy-4-methoxyphenyl propionic acid, 3-methoxy-4-hydroxyphenyl propionic 
acid, 3, 4-dihydroxyphenylpropionic acid were assumed to be derived from orange juice 
flavanone. The others were already present in the OJ. Four phenolic acids was higher at 6.3 ± 
0.7 mM in OJ + FY compared with OJ + PY, at 6.2 ± 3.2 mM in OJ bits + Y, compared with 
OJ bits + PY and OJ bits + FY after the upper GI digestion (p < 0.05) (Table 4-12).  
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Table 4-12 Effect of Y, PY and FY on sum of phenolic acids (mM) in smooth orange juice and 
orange juice ‘with bits’ during the upper GI digestion 
 OJ OJ bits 
Before After Before After 
 Y 0.0 ± 0.0  3.4 ± 0.7  ↑  0.3 ± 0.2 6.2 ± 3.2 ↑ 
PY 0.0 ± 0.0 2.2 ± 1.2
*
 ↑ 0.2 ± 0.2 2.3 ± 0.8& ↑ 
FY 0.5 ± 0.0 6.3 ± 0.7↑ 0.2 ± 0.1  1.8 ± 1.4& $ ↑ 
Values are means ± SE (n = 3).The sum of phenolic acids was based on 8 phenolic acids, Y:full fat 
natural yoghurt, PY: probiotic containing yoghurt, FY: strawberry purée (5 %) and probiotic containing 
yoghurt, OJ: smooth orange juice, OJ bits: orange juice ‘with bits’, nd, not detected, ANOVA tests with 
LSD test was used to determine significant differences, *  significantly different from OJ + FY, p < 
0.05; 
&
 significantly different from OJ bits + Y, p < 0.05, ↑ increase after the upper GI digestion. 
4.3.3.3.1 The effect of full fat natural yoghurt on phenolic acids 
Phenolic acids were significantly higher in OJ bits + Y compared with OJ bits during the 
upper GI digestion (0.0 ± 0.0 mM vs. 0.5 ± 0.0 mM at 1 h, 1.0 ± 0.2 mM vs. 6.8 ± 1.3 mM at 
2 h and 2.8 ± 0.5  mM vs. 6.1 ± 2.0 mM, P < 0.05)   (Table 4-13). There were similar amount 
of phenolic acids between OJ and OJ + Y. Phenolic acids were significantly higher during 
small intestinal digestion compared with gastric digestion. Moreover, there were more 
phenolic acids from the digestion of OJ bits with full fat natural yoghurt. 
Table 4-13 Effect of full fat natural yoghurt (Y) on phenolic acids (mM) in smooth orange juice 
and orange juice ‘with bits’ during the upper GI digestion 
 
0 h 1 h 2 h 4 h 
OJ nd nd 4.2 ± 2.7 
#£
 1.8 ± 0.4 
#£
 
OJ + Y nd nd 2.9 ± 0.8 
#£
 2.8 ± 0.5 
#£
 
OJ bits nd nd 1.0 ± 0.2
 #£
 0.6 ± 0.0
 #£
 
OJ bits + Y 
*
 0.2 ± 0.2  0.5 ± 0.0  6.8 ± 1.3
 #£
 6.1 ± 2.0
* #£
 
Values are means ± SE (n = 3). sum of phenolic acids was based on 8 phenolic acids, OJ+Y: smooth 
orange juice adding full fat natural yoghurt, OJ bits + Y: orange juice ‘with bits’ adding full fat natural 
yoghurt; OJ + Y: smooth orange juice adding full fat natural yoghurt, OJ bits + Y: orange juice ‘with 
bits’ adding full fat natural yoghurt; OJ : smooth orange juice, OJ bits + W: orange juice ‘with bits’, nd, 
not detected, univariate Analysis of Variance test with post  hoc LSD was used to determine 
significant differences, 
#
 different from at 0h, P < 0.05; 
£
 different from sum of phenolic acids at 1 h, P 
< 0.05; 
^
 different from sum of phenolic acids at 2 h, P < 0.05, 
&
 significantly different from at sum of 
phenolic acids 2 h, P < 0.05, * significantly different from OJbits, p < 0.05. 
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 4.3.3.3.2 The effect of probiotic containing yoghurt on phenolic acid 
production  
There were similar amount of phenolic acids during the digestion with orange juices with 
yoghurt containing probiotics (Table 4-14). Phenolic acids were increased after small 
intestinal digestion. 
Table 4-14 Effect of probiotics containing yoghurt (PY) on phenolic acids (mM) in smooth 
orange juice and orange juice ‘with bits’ during the upper GI digestion 
 0 h 1 h 2 h 4 h 
OJ  nd nd 4.2 ± 2.7 
#£
 1.8 ± 0.4 
#£
  
OJ + PY nd nd 4.2 ± 1.6 
#£
 1.8 ± 0.9 
#£
 
OJ bits  nd nd 1.0 ± 0.2
 #£
 0.6 ± 0.0
 #£
 
OJ bits + PY 0.2 ± 0.1 0.4 ± 0.1 5.0 ± 1.0 
#£
 2.2 ± 0.6 
#£^
 
Values are means ± SE (mM) (n = 3). OJ + PY: smooth orange juice with probiotic yoghurt, OJ bits + 
PY: orange juice ‘with bits’ with probiotic yoghurt; OJ: smooth orange juice, OJ bits: orange juice ‘with 
bits’, , univariate Analysis of variance test with LSD was used to determine significant differences, 
#
 
significantly different from sum of phenolic acids at 0 h, P < 0.05; 
£
 significantly different from at sum 
of phenolic acids 1 h, P < 0.05; 
^
 significantly different from at sum of phenolic acids 2 h, P < 0.05. * 
Significantly different from OJbits, p < 0.05. 
Table 4-15 Effect of strawberry purée (5 %) and probiotic containing yoghurt (FY) on sum of 
phenolic acids (mM) in smooth orange juice and orange juice ‘with bits’ during the upper GI 
digestion 
 0 h 1 h 2 h 4 h 
OJ  0.0 ± 0.0 0.0 ± 0.0 4.2 ± 2.7 
#£
 1.8 ± 0.4 
#£
  
OJ + FY  0.4 ± 0.0 
ηβ
 1.1 ± 0.6 
ηβ
 5.2 ± 1.3 
#£β
 7.0 ± 0.6 
α #£β
 
OJ bits  0.0 ± 0.0 0.0 ± 0.0 1.0 ± 0.2
 #£
 0.6 ± 0.0
 #£
 
OJ bits + FY 0.2 ± 0.1 0.3 ± 0.1 4.3 ± 1.4
 #£
 1.9 ± 0.3
 #£
 
FY 0.1 ± 0.1  0.2 ± 0.1 5.1 ± 3.1 
#£
 1.6 ± 0.7 
#£
 
Values are means ± SE (mM) (n = 3), OJ + FY: smooth orange juice with strawberry yoghurt, OJ bits 
+ FY: orange juice ‘with bits’ with strawberry yoghurt; OJ: smooth orange juice, OJ bits: orange juice 
‘with bits’, nd, not detected, univariate Analysis of Variance test with post host hoc LSD was used to 
determine significant differences, * significantly different from OJ + FY, P < 0.05; 
# 
significantly 
different from sum of phenolic acids at 0 h, P < 0.05; 
£
 different from sum of phenolic acids at 1 h, P < 
0.05; ^ different from sum of phenolic acids at 2 h, P < 0.05. 
η
  significantly different from OJ, p < 0.05, 
β
 significantly different from FY, p < 0.05, 
α
 significantly different from OJ bits + FY, p < 0.05. 
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4.3.3.3.3 The effect of strawberry purée (5 %) and probiotic containing yoghurt 
on phenolic acids 
Phenolic acids were significantly higher in OJ + FY than OJ or FY after the upper GI 
digestion (Table 4-15).  
4.4 Discussion 
It had previously been shown that yoghurt fed to humans with orange juice had limited 
effects on their metabolism and bioavailability in the upper GI tract but decreased phenolic 
acid excretion in urine substantially.  In this chapter the mechanisms for this effect were 
explored in vitro by investigating the effect of full fat yogurt on the metabolism of the 
flavanones from orange juice (and orange juice with bits) on their own and in the presence of 
full fat yoghurt, probiotic containing yoghurt and fruit and probiotic contained yoghurt in 
models of the upper and lower GI tract, Full fat natural yoghurt was made by using yoghurt 
starter culture bacteria (Streptococcus thermophilus and Lactococcus bulgaricus). In this 
study, there no bacteria survived after simulating upper GI digestion. Hesperidin was 
increased by 1.5 fold in OJ and 1.8 fold in OJ bits after the gastric digestion and by 1.4 fold 
in OJ bits after the small intestinal digestion in the presence of full fat natural yoghurt. In 
addition, full fat natural yoghurt increased four phenolic acids from 0.6 ± 0.0 mM to 6.1 ± 2.0 
Mm during the upper GI digestion with OJ bits. However, the yoghurt did not affect 
individual phenolic acid during the fermentation of smooth orange juice and orange juice 
with bits. During 24 h fermentation, full fat natural yoghurt did not affect hesperetin and 
naringenin in the incubation batches, as well as production of phenolic acids from OJ and OJ 
bits. Furthermore, full fat natural yoghurt increased total phenolic contents from 104.1 ± 13.5 
mg GAE/250 ml to 339.4 ± 1.5 mg GAE/250 ml in OJ and from 112.3 ± 0.6 mg GAE to 
352.4 ± 12.0 mg GAE in OJ bits after the upper GI digestion (p < 0.05). Full fat natural 
yoghurt did not affect the antioxidant capacity in smooth orange juice and orange juice ‘with 
bits’ during the gastrointestinal digestion and did not change antioxidant capacity in faecal 
samples during in vitro fermentation. Thus this does not explain the results of the human 
study, where phenolic acids in urine were substantially decreased (Roowi et al., 2009b).    
On the other hand, stability / release of hesperidin and narirutin and production of hesperetin 
and naringenin were similar in smooth orange juice and orange juice ‘with bits’ during the GI 
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digestion and fermentation. There was 44 ± 11 % and 39 ± 15 % of hesperidin degradation by 
colonic bacteria respectively in OJ and OJ bits in the presence of full fat natural yogurt after 
24 h fermentation. Five phenolic acids were 107.4 ± 37.1 µM and 110.8 ± 36.6 µM 
respectively in the incubation with OJ + Y and OJ bits + Y.  
Hesperidin was higher in OJ + Y and OJ bits + Y compared with OJ bits after the small 
intestinal digestion. The results was consistent with a previous study  (Rodríguez-Roque et 
al., 2014) that investigated increased release of  many phenolic substances around  5 % and 
93 % during in vitro gastrointestinal digestion after adding milk to a blended fruit juice 
(orange, kiwi, pineapple and mango). As we know, polyphenols have hydrophobic activity 
that are able to bind to carbohydrates and protein (Siebert et al., 1996, Seshadri and Dhanaraj, 
1988). In addition, interactions between milk protein and polyphenols are responsible for 
polyphenol release during small intestinal digestion (Moser et al., 2014, Neilson et al., 2007). 
On the other hand, stability of orange juice flavanones partially depends on precipitation of 
transformed chalcones into the cloud under physiological conditions of the intestine(Gil-
Izquierdo et al., 2003). The reaction between flavanone and yoghurt might inhibit formation 
of chalcone to increase flavanone recovery in the upper GI tract.  Thus, yoghurt may have 
interactions with orange juice to promote hesperidin release during upper GI digestion. 
Hesperidin was lower in OJ + Y and OJ bits + Y compared with OJ and OJ bits respectively 
at 6 h and 0 h during the fermentation with gut bacteria. Polysaccharide was reported to 
promote formation of complexes with whey proteins and caseins (Tromp et al., 2004). 
Dietary fibre was low and similar amounts between smooth orange juice and orange juice 
‘with bits’. However, insoluble fibre and soluble fibre in orange pulp varied  depending on 
extrusion processing (Larrea et al., 2005). The “bits” in the orange juice are likely to be 
responsible for actions of full fat natural yoghurt on flavanone stability /release in the GI 
tract. The results confirmed different interaction of yoghurt with orange juices during the 
colonic fermentation.  
Yoghurt did not affect the amount of each phenolic acid during the fermentation of smooth 
orange juice and orange juice with bits. However, Roowi et al reported that full fat natural 
yogurt reduced urinary excretion of five phenolic acids including 3-hydroxyphenylacetic 
acid, 3-hydroxyphenylhydracrylic acid, dihydroferulic acid, 3-methoxy-4-
hydroxyphenylhydracrylic acid and 3-hydroxyhippuric acid from 62 ± 18 μmol to 6.7 ± 1.8 
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μmol (Roowi et al., 2009a), which was inconsistent with our study(Roowi et al., 2009b). Our 
results did not confirm those of the in vivo study, which might be due to physiological 
functions in humans after consumption of orange juice and yoghurt, or types of yoghurt. Even 
though probiotic yoghurt and strawberry purée (5 %) and probiotics yoghurt had similar 
effects with full fat natural yoghurt on hesperidin and narirutin during the upper GI digestion 
in terms of hesperidin and narirutin, full fat yoghurt significantly increased four phenolic 
acids from 0.6 ± 0.0 mM to 6.1 ± 2.0 mM. This is not due to bacteria in the yoghurt, but may 
be a property of other yoghurt components which survive digestion in the upper gut.  This 
needs to be explored further. The lack of extra effects of probiotic yoghurts apart from some 
release of phenolic acids in the upper gut model means that it is unlikely that the reduction in 
phenolic acids seen in vivo was due to any probiotics in the yoghurt used. 
Phenolic acids were significantly produced during small intestinal digestion in smooth orange 
juice and orange juice ‘with bits’ with or without the presence of yogurts, which revealed that 
the alkaline condition of small intestine could stimulate production of phenolic acids. In this 
study, strawberry purėe (5 %) containing yoghurt significantly increased four phenolic acids 
(3, 4-dihydroxyphenylacetic acid, 3-hydroxy-4-methoxyphenyl propionic acid, 3-methoxy-4-
hydroxyphenyl propionic acid, 3, 4-dihydroxyphenylpropionic acid) in OJ during the upper 
GI digestion compared with full fat natural yoghurt and probiotic containing yoghurt, while it 
did not affect the increase of these phenolic acids in OJ bits compared with probiotic 
containing yoghurt. It indicated that different types of yoghurt have different effects on 
phenolic acids, even yoghurt with Bifidobacterium spp and Lactobacillus acidophilus that 
might enhance production of phenolic acids derived from flavanones during the upper GI 
digestion.  
In conclusion, hesperidin was higher in smooth orange juice and orange juice ‘with bits’ in 
the presence of full fat natural yoghurt after the upper GI digestion. During in vitro 
fermentation with gut bacteria, lower hesperidin was found at 6 h incubation with smooth 
orange juice, and at 0 h fermentation with orange juice with bits. However, full fat natural 
yoghurt did not affect degradation of flavanone and production of phenolic acids after 24 h 
fermentation. In Mullen’s human study, 24 h urinary excretion of flavanone was also not 
affected, but the 0-5 h excretion of flavanone metabolites in urine was reduced by the 
consumption of full fat natural yoghurt and orange juice. The temporary reduction might 
relate to formation of the polysaccharide-protein-flavanone complexes, which needs to be 
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verified in future, and could be broken down by gut bacteria to release flavanone in the colon. 
In terms of phenolic acids, the reduction of urinary excretion was not found in this in vitro 
study. During the upper digestion phase, strawberry containing yoghurt increased four 
phenolic acids, while full fat natural yoghurt increased phenolic acids in orange juice with 
bits, which also could not explain the reduced phenolic acids in urine. Even though starter 
culture did not survive in the upper GI model, the probiotic bacteria may have survived but 
still had no effect in the phenolic acids and metabolism of flavanones in the colon. In general, 
the food matrix (yoghurt) influenced flavanone and phenolic acids in the GI tract so that 
potentially affect absorption of aglycone and /or phenolic acids, but this needs to be 
confirmed in vitro and in vivo in future.  
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CHAPTER 5 Effect of raftiline (non-digestible 
carbohydrate) and glucose on metabolism of hesperidin 
by gut bacteria in vitro 
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5.1 Introduction 
As the main site of flavanone metabolism is in the human colon and by the colonic 
microbiota, any component of food which influences the gut bacteria has the potential to 
modify the bacterial metabolism of the flavanones and the production of phenolic acids. 
Dietary fibre consists of non-starch polysaccharides, resistant oligosaccharides, resistant 
starch and lignin associated with the dietary fibre polysaccharides which include cellulose, 
hemicellulose, pectin, β-glucans, gums, and lignin, classified as soluble dietary fibre and 
insoluble dietary fibre (Gallaher and Schneeman, 2001, Gorinstein et al., 2001, Dhingra et al., 
2012). 
In this chapter the impact of the non-digestible carbohydrate raftiline (fructo-
oligosaccharides) and also glucose were used as models for fermentable fibres to test the 
effect of increased carbohydrate fermentation on flavanone metabolism in in vitro models of 
the large intestine. Raftiline is a low molecular weight component of inulin that is rapidly 
fermented by the colonic bacteria producing short chain fatty acids, such as propionate, 
acetate and butyrate and reducing colonic pH (Ramnani et al., 2012, Pascoal et al., 2013) it 
also selectively stimulates the growth of lactic acid bacteria (Ramchandran and Shah, 2010). 
Many fibres contain glucose (eg cellulose and beta glucan) and while raftiline is a selective 
substrate most bacteria can ferment glucose so comparing the two gives more information 
about the mechanism by which fermentation may affect bacterial flavanone degradation. 
There are several mechanisms by which different dietary fibres may affect the bioavailability 
of flavanones. Various cellular components in fruits and vegetables and other products can 
act as a physical barrier to the release of nutrients (bioaccessibility) during digestion in the GI 
tract (Jeffery et al., 2012, Saura-Calixto, 2010). Therefore, the physical state of bioactive 
compounds in the plant cell determines their release and subsequent absorption. For example, 
β-carotene was approximately 3 times higher in plasma 9.5 h after consumption of papayas 
(13.0 mg lycopene and 1.3 mg β-carotene) than carrots (13.0 mg lycopene & 1·6 mg β-
carotene and tomatoes (13.0 mg lycopene & 2.3 mg β-carotene), and 2.6 fold plasma 
lycopene than after the tomatoes in healthy humans (Schweiggert et al., 2014). The maximal 
concentrations of quercetin in plasma were higher at 0.7 μM at 0.7 h after consumption of 
fried onions containing 225 ± 43 μmol quercetin than apple (apple sauce and apple peel) 
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providing 325 ± 7 μmol quercetin (0.3 μM at 2.5 h), and urinary excretion of quercetin was 
also higher (1.4 % vs. 0.4 %) of intake dose and in humans (Hollman et al., 1997).  
On the other hand, non-extractable polyphenols (NEPP) are linked to cell wall constituents 
(polysaccharides and protein) or can bind with food matrix components by hydrophobic 
interactions (Arranz et al., 2010, Hasni et al., 2011, Yuksel et al., 2010). These polyphenols 
are not released by the usual extraction process during analysis for food polyphenols (Perez-
Jimenez et al., 2013), but may be released in the gut and have physiological effects. The 
NEPP content ranged from 210 mg to 880 mg per 100 g in dried fruits and cereals (Arranz et 
al., 2010) and the true ingestion of polyphenols can be underestimated if they are not 
considered. NEPP which are attached by ester bonds to polysaccharides in foods can be 
released by the action of esterase in both the small and large intestine (Saura-Calixto, 2010). 
In chapters 3 and 4, we found that the amount of hesperidin increased during the small 
intestinal digestion phase of the model with orange juice suggesting there are some NEPP in 
the juice. Thus, dietary fibre probably influences flavonoids available for metabolism and 
absorption, however there was very little fibre in these juices so it may be small amounts of 
cell wall and other structural tissues that are important rather than a high fibre content. 
The bulking and hydrophobic binding properties of dietary fibre may impact on the 
metabolism and bioavailability of flavonoids. A wheat fibre supplement reduced 24 h plasma 
genistein by 55 %, and total urinary genistein by 20 %, but not daidzein after intake of soy in 
7 healthy women (Tew et al., 1996). In a study in rats, plasma daidzein was significantly 
lower after feeding cellulose-daidzein diet with added rice bran hemicellulose for 30 days 
compared with the same diet without dietary fibre in rats (Tamura et al., 2009). A 
carbohydrate-rich food containing starch (hydrolysed wheat, wheat, barley, maize and oats) 
and malt extract (2 g/kg of body weight) reduced Cmax of procyanidin trimer in plasma after 
feeding grape seed procyanidin extracts (1 g / kg of body weight) to rats (Serra et al., 2010). 
Oatmeal consumption delayed maximum urinary excretion of anthocyanins after blackcurrant 
ingestion in rats (Walton et al., 2009).  
Some dietary fibres are able to increase viscosity of intestinal contents to slow gastric 
emptying and small intestinal absorption (Dikeman et al., 2006). Many soluble dietary fibres 
are viscous (Dikeman and Fahey Jr, 2006). Rice brans, soy hulls, and wood cellulose have the 
lowest viscosities, whereas guar gum, psyllium, and xanthan gum had the highest viscosities, 
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regardless of concentration under gastric and small intestinal conditions (Dikeman et al., 
2006) Psyllium (3.6 g) significantly delayed gastric emptying by 10 % and 20 % at 3 h and 6 
h after a meal (40 g carbohydrates, 23 g lipids, 21 g proteins) in healthy humans (Bergmann, 
Chassany et al. 1992). High-methoxy pectin was more viscous than low methoxy pectin 
(Yoo, Fishman et al. 2006). Nishijima and colleagues found that apple highly methyoxyl 
esterified pectin increased 2.3 times urinary excretion of quercetin and its metabolites 
compared with non-methoxy pectin, while there was no difference between non-methoxy 
pectin and low-methoxy pectin after consumption of quercetin drink in humans (Nishijima et 
al., 2015) . 
On the other hand, the major mechanism by which dietary fibre impacts on the metabolism 
and absorption of flavonoids is likely to be in the colon by influencing the metabolism or 
composition of the gut microbiota with resultant changes in pH, bacterial metabolic 
capability, gut mucosal mass (Cummings et al., 1987),  and colonic motility (Squires et al., 
1992). Fermentation of carbohydrates in the colon produces short chain fatty acids, these 
reduce pH which can be as low as 5.5 in the proximal colon when highly fermentable non 
digestible carbohydrates are ingested (Cummings et al., 1987, Cummings and Bingham, 
1986, Hijova and Chmelarova, 2007).   
The gut microflora plays an essential role in the metabolism and bioavailability of flavonoids. 
They deconjugated the parent compound and release the aglycone and then produce 
metabolites such as phenolic acids which may be responsible for the health effects of high 
flavonoid ingestion (Selma et al., 2009). Bacteroides, bifidobacteria, and lactobacilli have the 
highest activity of the β-glucosidases and sulfatases responsible for glycoside hydrolysis and 
subsequent aglycone cleavage (Steer et al., 2003, Turner, 2008). Dietary fibre may affect the 
bioavailability of flavonoids through changing colonic microbiota composition. Plasma 
quercetin and isorhamnetin concentrations were significantly higher in rats after 14 d feeding 
pectin-rutin diet (2.5 ± 1.3 and 6.7 ± 4.4 vs. 0.9 ± 0.3 and 0.6 ± 0.3) with an increased number 
of faecal bacteria (9.7 ± 0.4 vs. 10.8 ± 0.2 expressed as log10 of the number of viable total 
bacteria per gram wet weight of faeces) including Bacteroidaceae, Eubacteria, Clostridia, 
Lactobacilli, Enterobacteria, and Streptococci compared with a cellulose-rutin diet (Tamura 
et al., 2007b).  
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It is well established that some non-digestible carbohydrates such as inulin (which includes 
raftiline) increase the proportion of Bifidobacteria and Lactobacilli in the colon and when 
present in the diet alongside flavonoids there may be some effects on phenolic acid 
production due to changes in the bacterial populations and also the chemical environment in 
terms of pH. Bifidobacterium longum, Bifidobacterium pseudocatenulatum and 
Bifidobacterium adolescentis were increased after intake of inulin-type fructans prebiotics for 
3 months by obese women (Salazar et al., 2015). Moreover, inulin-type fructans stimulate the 
growth of Bifidobacteria, Lactobacilli and other lactic acid bacteria (Campbell et al., 1997, 
Ito et al., 2011). Raftiline (inulin) as a fructo-oligosaccharide (soluble fibre) which is not 
viscous, is well established as a prebiotic that increases the growth of Bifidobacteria (Clark et 
al., 2012, Gibson et al., 1995). 
Citrus fruits contain dietary fibre (pectin, cellulose,etc.) (Figuerola et al., 2005), with 
properties of water and oil holding capacity and colonic fermentability (Grigelmo-Miguel and 
Martı́n-Belloso, 1998), and the amount varies  depending on the processing of the orange 
juice (Figuerola et al., 2005). Even dietary fibre was low in orange juices, the physiological 
characteristics of dietary fibre might influence metabolism of orange juice by modifing if 
sufficient fibre is present. In this chapter, raftiline and glucose were used to test the effects of 
fermentation on the metabolism of hesperidin by human gut bacteria in the in vitro model. 
5.1.1 Hypothesis 
To test the hypothesis that the presence of raftiline or glucose changes degradation of 
hesperidin in the large intestinal tract 
Do Fermentable carbohydrates affect degradation of hesperidin into aglycone and production 
of phenolic acids using in vitro fermentation model with human gut bacteria? 
5.2 Materials and methods 
5.2.1 Chemicals 
Hesperidin, formic acid, hydrochloric acid, 2, 4, 5–trimethoxycinnamic acid, anhydrous ethyl 
acetate, dichloromethane (DCM), N-methyl-N- (trimethylsily) trifluoracetateamide, prydine. 
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CaCl2.2H2O, MnCl2.4H2O, NH4HCO3, NaHCO3, Na2HPO4, KH2PO4, MgSO4.7H2O, 
cysteine hydrochloride, NaOH, Na2S
.
9H2O and resazurin solution were purchased from 
Sigma-Aldrich Co Ltd (Poole, UK). Raftiline was purchased from Siber Hegner Ltd 
(Beckenham, UK). 
3-phenylpropionic acid, 3-hydroxyphenylacetic acid, 4-hydroxybenzoic acid, 4-HPAA: 4-
hydroxyphenylacetic acid, 3-hydroxyphenylpropionic acid, 3, 4-dihydroxyphenyl propionic 
acid were purchased from Sigma-Aldrich Co Ltd (Poole, Dorset, UK) or Alfa Aesar 
(Karlsruhe, Germany). N, o-bis (Trimethylsilyl) trifluoroacetamide (BSTFA) + 10 % 
trimethylchlorosilane (TMCS), 2, 4, 5– trimethoxycinnamic acid and HPLC grade methanol 
were obtained from Fisher Scientific (Loughborough, UK). 
5.2.2 In vitro fermentation 
The fermentation was conducted as described in section 2.3.3. The amount of hesperidin (10 
µg) with or without glucose (0.5 g) (Jaganath et al., 2009) for incubation was based on the 
levels of orange juice consumption by subjects in previous study (250 mL) for investigation 
of effect of glucose on metabolism of hesperidin (n=6).    
Raftiline (1 g) was added to fermentation medium (50 ml) based on fibre consumption (6 g) 
in 300 ml of colonic content (Khossousi et al., 2008) for investigation of dietary fibre on 
metabolism of hesperidin.  
5.2.2.1 Faecal sample collection from participants 
For investigation in metabolism of hesperidin in the presence of dietary fibre (Raftiline), ten 
healthy Caucasian volunteers 19 - 33 y with BMI 22.5 ± 3.0 (Table 5-1) who participated in 
this study followed a 3 days low-polyphenol diet avoiding fruits, vegetables, tea, coffee, 
wine, food high in polyphenols (Appendix 3) before providing a faecal sample on the 4
th
 day. 
The faecal sample was collected in a special plastic box containing an AnaeroGen sacket 
(Oxioid, Hampshire, UK) to generate anaerobic conditions (done by Dr Bahareh and Areej). I 
analysed samples from 7 participants as the other samples were missing. 
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Table 5-1 Body characteristics of participants 
 
Gender Age(years) Height (cm)  Weight BMI 
1 M 22 175.5 84 19.7 
2 F 19 161 47.9 27.4 
3 F 21 158 63.9 18.4 
4 F 21 156 54 25.6 
5 F 26 174 57.2 22.2 
6 F 22 160 50.5 18.9 
7 F 25 161 54.3 20.9 
8 M 23 183 77.8 23.2 
9 M 33 175 76 24.8 
10 M 23 176 72.2 23.3 
Mean ± SD 
 
23 ± 3.8 152 ± 53.7 63.8 ± 12.8 22± 2.9 
Values are mean ± SD, M: male, F: female, BMI: body mass index 
For investigation of metabolism of hesperidin in the presence of glucose, six different healthy 
Caucasian volunteers (Chapter 3) who participated in this study had a normal diet, were non-
smokers, had no digestive diseases, no food allergies, and had not received antibiotics for at 
least 6 months before the study. The volunteers followed a low-polyphenol diet avoiding 
fruits, vegetables, tea, coffee, wine and wholemeal foods for 2 days (details in Appendix 3) 
before providing a faecal sample according to information sheet (Appendix 2). Each faecal 
sample was collected by subjects in a special plastic box containing an AnaeroGen sacket 
(Oxioid, Hampshire, UK) to generate anaerobic conditions. Faecal samples were processed 
when brought to the lab. The food was recorded in a dietary record (Appendix 4). 
5.2.3 Extraction of hesperidin, narirutin, hesperetin, and naringenin 
after in vitro digestion and fermentation  
Samples were thawed and homogenized with a Disruptor Genie (Scientific Industries, UK). 
Extraction was the same as orange juice described in 2.9.1.  
5.2.4 Analysis of faecal samples by using HPLC-PDA 
Hesperidin, narirutin, hesperetin and naringenin were analysed by using HPLC-PDA as 
described in section 2.10.  
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5.2.5 Extraction and derivatization of phenolic acids in faecal 
slurries 
Extraction of phenolic acids was done by the methods published by Fry et al (Fry et al., 
2001), as described in section 2.9.2. 
5.2.6 Analysis of phenolic acids in faecal samples by using GC-MS  
GC-MS analysis was illustrated in chapter 2.12. Phenolic acids including 3-
hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, 4-hydroxyphenylpropionic acid, 3, 4-
dihydroxyphenylacetic acid, 3- (3, 4-dihydroxyphenyl) propionic acid, 4-hydroxy-3-
methoxyphenylpropionic acid (dihydrofeulic acid), 3-(3’-hydroxyphenyl) propionic acid, 3-
4’-hydroxyphenyl propionic acid were identified according to mass spectra and retention 
times obtained from authentic standards analysed under identical conditions. When standards 
were not commercially available, identification was achieved through the integrated NIST 
mass spectral library 2008 (Scientific Instruments Services Inc., Ringoes, NJ, USA), with a 
confidence of 70 % or above. Calibration curves of the ratio between the target ions of the 
internal standard (2, 4, 5–trimethoxycinnamic acid, m/z 279) were computed, with 
concentrations ranging from 3- 40 mg ml
-1
 (R
2 
> 0.95). Values for phenolic acids in the faecal 
slurries were expressed in µM as mean values ± S.E (n = 6 or 7).  
5.2.7 Statistical analysis 
 Analysis was conducted in duplicate and data are presented as mean values ± SE (n=6 or 7). 
Where appropriate, data was subjected to statistical analysis using paired t-test or one way 
ANOVA of the results to determine significant differences (P < 0.05) with SPSS software 
version 22. 
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5.3 Results 
5.3.1 Effect of raftiline on metabolism of hesperidin 
5.3.1.1 Degradation of hesperidin and production of hesperetin by human 
colonic bacteria in the presence of raftiline  
Hesperidin was hydrolysed into hesperetin by gut bacteria during fermentation (Table 5-2). 
The amount of hesperidin decreased from 50.9 µM to 30.2 µM by activity of gut bacteria –
after 6 h of fermentation in the absence of raftiline. There was 35.5 µM of hesperidin present 
in the incubation with raftiline higher than that without raftiline at 6 h, even though they were 
not   significantly different. From 6 h to 24 h fermentation, hesperidin still kept higher 
concentration in the fermentation with raftiline (35.2 µM) than that without raftiline (27.6 
µM). What is more, hesperetin was also higher in the fermentation with raftline during 24 h 
of fermentation of hesperidin hanging from 0.3 µM to 0.7 µM. There was about 0.2 µM of 
hesperetin in the absence of hesperidin during 24 h of fermentation of hesperidin by gut 
bacteria. In total, 46 % of hesperidin was degraded over 24 h of fermentation by gut bacteria.  
 
Table 5-2 Concentrations of hesperidin and hesperetin (µM) during 24 h fermentation by gut 
bacteria 
 
Treatment 0 h 2 h 4 h 6 h 24 h 
Hesperetin 
No Raf 0.2 ± 0.1 0.3 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 
Raf 0.3 ± 0.2 0.7 ± 0.2 0.6 ± 0.2 0.3 ± 0.1 0.4 ± 0.2 
Hesperidin 
No Raf 50.9 ± 5.1 44.3 ± 5.2 39.3 ± 3.6 30.2 ± 3.6 27.6 ± 6.1 
Raf 54.2 ± 3.3 40.3 ± 6.4 40.5 ± 6.9 35.5 ± 5.6 35.2 ± 4.1 
Values are means ± SEMs (n = 7). No Raf: no adding raftiline, Raf: adding raftiline,
 *
 Different from 
fermentation without raftiline, P <0.05 (paried t-test).  
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Figure 5-1 Effect of raftiline on total flavanone (hesperetin + hesperidin) (µM) during 24 h 
fermentation of hesperidin by gut bacteria 
Values are means ± SEM (n=7), No Raf: no adding raftiline, Raf: adding raftiline,
 *
 Different from 
fermentation without raftiline, P <0.05 (paried t-test). 
5.3.1.2 Production of phenolic acids by human colonic bacteria in the presence 
of raftiline 
There were six phenolic acids present in the batches of fermentation through cleavage of 
hesperetin by gut bacteria. They are 3-phenylpropionic acid, 3-hydroxyphenylacetic acid, 4-
hydroxybenzoic acid, 4-hydroxyphenylacetic acid, 3-hydroxyphenylpropionic acid, and 3, 4-
dihydroxyphenyl propionic acid (Table 5-3). The sum of 6 phenolic acids was increasing 
during 24 h of fermentation of hesperidin by gut bacteria (Figure 5-2). The sum of 6 phenolic 
acids was significantly increased with or without raftiline by gut bacteria at the end of 
fermentation (220.3 µM, p< 0.05; 126.6 µM, p < 0.05). Raftiline significantly decreased 
production of phenolic acids from 220.3 µM to 126.6 µM over 24 h of fermenting hesperidin 
by gut bacteria (p < 0.05).  
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Figure 5-2 Concentration of phenolic acids over 24 h of fermentation with hesperidin or 
hesperidin and raftiline by gut bacteria 
Values are means ± SE (µM) (n = 7), No Raf: no added raftiline; Raf: added raftiline,
 *
 Different from 
fermentation without raftiline, P <0.05 
 
Among the phenolic acids, 3-phenylacetic acid, 4-hydroxyphenylacetic acid and 3-
hydroxyphenylpropionic acid were main products from hesperidin degradation over 24 h in 
the absence of raftiline by gut bacteria (22.5 µM, 43.2 µM and 102.1 µM, p < 0.05). In 
addition, 4-hydroxybenzoic acid was significantly increased by adding raftiline (0 µM vs. 0.6 
µM at 0 h, 0.2 µM vs. 1.0 µM at 2 h, 0.2 µM vs. 0.9 µM at 4 h, 0.4 µM vs. 1.3 µM at 6 h, p 
<0.05). The appearance of 4-hydroxyphenylacetic acid was also inhibited by raftiline to 20.5 
µM from 43.2 µM (without raftiline) at the end of fermentation by gut bacteria (p < 0.05).  3-
phenylpropionic acid accounted for about 37 % and 47 % of phenolic acids at 0 h of 
fermentation with hesperidin with or without raftiline respectively. 
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Table 5-3 Production of phenolic acids during 24 h fermentation of hesperidin with or without raftiline by human gut bacteria 
Time Treatment 3-PPA 3-HPAA 4-HBA 4-HPAA 3-HPPA 3,4-DHPPA Total 
0h 
No Raf 21.0 ± 0.9 0.1 ± 0.1
£
 0.6 ± 0.2 
£
 15.6 ± 3.7 16.4 ± 2.8 2.8 ± 1.8 
£
 56.6 ± 5.4 
Raf 24.2 ± 1.5 0.2 ± 0.2
£
 nd
*£
 10.2 ± 3.7 
£
 13.4 ± 3.5 
£
 3.1 ± 2.0 
£
 51.1 ± 4.0 
2h 
No Raf 23.0 ± 2.0 0.4 ± 0.2
£
 1.0 ± 0.3 
£
 18.3 ± 5.3 19.7 ± 0.7 5.7 ± 2.0 
£
 68.1 ± 4.5 
Raf 24.9 ± 1.6 4.2 ± 2.6 
£
 0.2 ± 0.1 
*£
 12.3 ± 3.5 
£
 19.0 ± 0.6 4.1 ± 2.0 
£
 64.8 ± 6.6 
4h 
No Raf 20.6 ± 3.7 0.7 ± 0.4 
£
 0.9 ± 0.3 
£
 19.0 ± 6.4 16.9 ± 2.9 10.1 ± 4.5 
£
 68.2 ± 13.2 
Raf 19.6 ± 5.6 3.5 ± 2.5 
£
 0.2 ± 0.1
*
 11.9 ± 3.3 13.5 ± 3.5 7.5 ± 4.6 56.1 ± 15.8 
6h 
No Raf 26.7 ± 3.2 0.6 ± 0.2 1.3 ± 0.3 20.2 ± 3.2 22.1 ± 1.0 41.4 ± 32.2 112.4 ± 33.3 
Raf 27.1 ± 1.9 7.7 ± 3.8 
£
 0.4 ± 0.1
*£
 19.1 ± 3.7 19.5 ± 0.9 8.3 ± 5.3 
£
 81.0 ± 10.0 
24h 
No Raf 22.5 ± 4.4 
&
 8.1 ± 7.6 1.7 ± 0.6 43.2 ± 9.8 
&
 102.1 ± 41.9 
&
 39.5 ± 33.3 220.3 ± 46.8 
&
 
Raf 27.2 ± 2.5 2.3 ± 0.9 0.7 ± 0.3 20.5 ± 6.5 
*
 34.7 ± 17.7 41.5 ± 10.0 126.6 ± 44.1 
*&
 
Values are means ± SE (µM) (n = 7). 3-PPA: 3-phenylpropionic acid; 3-HPAA: 3-hydroxyphenylacetic acid; 4-HBA: 4-hydroxybenzoic acid; 4-HPAA: 4-
hydroxyphenylacetic acid; 3-HPPA: 3-hydroxyphenylpropionic acid; 3, 4-DHPPA: 3, 4-dihydroxyphenyl propionic acid; No Raf: no added raftiline; Raf: added 
raftiline, ANOVA tests with LSD test was used to determine significant differences, * Different from fermentation without raftiline, P <0.05; 
&
 Different from 
fermentation at 0 h, P <0.05; 
£
 Different from 3-PPA, P <0.05;
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The first metabolite broken down from hesperetin by gut bacteria was 3, 4-dihydroxyphenyl 
propionic acid (Figure 5-4). The gut bacteria were significantly active in pathway 1 (p < 
0.05), regardless of addition of raftiline. However, raftiline significantly impacted amount of 
phenolic acids in pathway 2 at the end of fermentation (21.3 µM vs. 43.9 µM, p < 0.05). 
 
Figure 5-3 Proposed pathway of degradation of hesperidin to phenolic acids 
 
Table 5-4 Phenolic acids produced in pathway1 and pathway 2 over 24h of fermentation of 
hesperidin and hesperidin with raftiline by human gut bacteria 
 
No Raf Raf 
Time Pathway 1 Pathway 2 Pathway 1 Pathway 2 
0 h 37.5 ± 2.8 
&
 16.3 ± 3.8 37.8 ± 3.5 
&
 10.2 ± 3.8 
*
 
2 h 43.1 ± 1.8 
&
 19.3 ± 5.2 48.1 ± 3.5 
&
 12.6 ± 3.5 
4 h 38.2 ± 6.6
&
 19.9 ± 5.6 36.5 ± 9.8 
&
 12.1 ± 3.3 
6 h 49.4 ± 3.2
&
 21.5 ± 3.1 53.2 ± 4.4 
&
 19.5 ± 3.6 
24 h 136.9 ± 31.3
&
 43.9 ± 10.3 63.9 ± 19.9 
&
 21.2 ± 6.3 
*
 
Values are means ± SE (µM) (n = 7). No Raf: no added raftiline; Raf: added raftiline. * Different from 
fermentation without raftiline, P <0.05; 
&
: Different from pathway 2 (paired t-test).  
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5.3.2 Effect of glucose on metabolism of hesperidin 
5.3.2.1 Degradation of hesperidin and production of hesperetin by human 
colonic bacteria in the presence of glucose  
Hesperidin was rapidly degraded by colonic bacteria in the presence of glucose (Table 5-6 
and Figure 5-5). There was 78.1 µM and 64.8 µM of detected hesperidin and 0.7 µM and 0.2 
µM of hesperetin production at initial fermentation. There was 87.6 % and 84.1 % of 
hesperidin degraded by gut bacteria after 24 h fermentation of hesperidin and hesperidin with 
glucose respectively. Glucose induced rapid decrease of hesperidin over 2 to 4 h of 
fermentation (22.0 ± 2.5 µM vs. 9.2 ± 6.2 µM, p = 0.073). At the end of fermentation, there 
was about 10 µM of flavanone (hesperidin + hesperetin) that was not degraded. 
 
 
Figure 5-4 Effect of glucose on hesperetin and hesperidin) (µM) during 24 h of fermentation  
Values are means ± SE (n = 6); No Glu: no adding glucose, Glu: adding glucose, ANOVA tests with 
LSD test was used to determine significant differences, * significantly different from No Glu. 
 
 
 
 
 
 
 
0
20
40
60
80
100
0 2 4 6 8 10 12 14 16 18 20 22 24
C
o
n
c
e
n
tr
a
ti
o
n
 (
µ
M
) 
Fermentation time (h) 
No Glu
Glu
141 
 
 
 
Table 5-5 Effect of glucose on production of hesperetin (µM) and degradation of hesperidin 
(µM) by gut bacteria 
   Treatment 0 h 2 h 4 h 6 h 24 h 
Hesperidin 
  
No Glu 78.1 ± 4.8 60.9 ± 2.6 39.0 ± 4.1 20.6 ± 5.3 5.7±1.3 
Glu 65.9 ±3.3 40.3 ±10.0 31.0 ± 9.7 22.8 ± 9.6 10.3 ± 4.4 
Hesperetin 
  
No Glu 0.7 ± 0.4 2.7 ± 0.8 8.0 ± 1.6 5.4 ± 2.0 4.5 ± 3.4 
Glu 0.2 ± 0.1 2.9 ± 0.8 9.8 ± 2.1 10.1 ± 3.9 0.6 ± 0.5 
Data expressed as mean values ± SE (n=6).  No Glu: no adding glucose, Glu: adding glucose 
ANOVA tests with LSD post hoc was used to determine significant differences, * significantly different 
from No Glu. 
6.3.2.2 Production of phenolic acids by human colonic bacteria in the presence 
of glucose 
The sum of total phenolic acids were 280.3 ± 90.8 µM and 226.1 ± 41.4 µM respectively by 
24 h fermentation of hesperidin and hesperidin with glucose respectively (p = 0.4) (Figure 5-
5). 3-(phenyl) propionic acid, 3-phenyllactic acid, 4-hydroxybenzoic acid, 4-
hydroxyphenylacetic acid, 3-hydroxyphenyl) propionic acid, 4-hydrophenyl propionic acid, 
dihydroferulic acid, and 3, 4-dihydroxyphenyl) propionic acid were found (Figure 5-6).  
 
Figure 5-5 Concentration of phenolic acids (µM) after 24 h fermentation with hesperidin or 
hesperidin and glucose by gut bacteria 
 Values are means ± SE (n = 6), No Glu: no adding glucose, Glu: adding glucose, 
* 
significantly 
different from No Glu, P < 0.05 (paired t-test) 
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Figure 5-6 Impact of glucose on phenolic acids at 0 h (A), 2 h (B), 4h (C), 6 h (D) and 24 h (E)  of 
hesperidin fermentation with human gut bacteria 
Expressed as mean value in µM ± SE (n=6), blue bar: not adding glucose, red bar: adding glucose, 3-
PPA: 3-(phenyl)propionic acid, 3-PAA: 3-(phenyl)acetic acid, 4-HBA: 4-hydroxybenzoic acid, 4-HPAA: 
4-hydroxyphenylacetic acid, 3-HPPA: 3-(3'-hydroxyphenyl)propionic acid, 4-HPPA): 3-(4'-
hydrophenyl)propionic acid, DFA: Dihydroferulic acid, 3,4-DHPPA: 3,4-dihydroxyphenylpropionic acid, 
3-(3,4-DHPPA): 3-(3,4-dihydroxyphenyl)propionic acid, HES: hesperidin, HES+G: hesperidin plus 
glucose, ANOVA tests with LSD test was used to determine significant differences, * significantly 
different from No Glu.* Significantly different from HES fermentation, P < 0.05. 
At the beginning, 3-phenylacetic acid, 3-hydroxyphenylpropionic acid, and 4-hydrophenyl 
propionic acid were rapidly produced respectively at 7.5 µM, 8.7 µM and 4.0 µM. In 
addition, 3, 4-dihydroxyphenylpropionic acid was present in the incubation of hesperidin plus 
glucose (4.1 µM). From 0 h to 2 h, the addition of glucose significantly increased 4-
hydroxyphenyl)propionic acid and dihydroferulic acid (3.0 ± 1.4 µM vs. 3.7 ± 1.6 µM, p < 
0.03; 0.5 ± 0.2 µM vs. 1.1 ± 0.4 µM, p ≤ 0.05). From 2 h to 4 h, glucose significantly 
increased production of phenolic acids from 38.0 ± 6.8 µM compared with 62.1 ± 11.0 µM (p 
< 0.02). Addition of glucose significantly increased 3-phenyl acetic acid from 15.3 ± 4.1 µM 
to 23.1 ± 5.4 µM (p < 0.01). The phenolic acids was increased to 85.3 ± 22.4 µM and 105.7 ± 
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30.0 µM by 6 h fermentation of hesperidin and hesperidin plus glucose. Addition of glucose 
significantly increased 3-phenylacetic acid from 30.6 ± 13.6 µM to 39.5 ± 12.8 µM (p ≤ 
0.04). However, addition of glucose decreased production of 3'-dihydroxyphenylpropionic 
acid from 88.0 ± 29.1 µM to 31.3 ± 18.5 µM after 24 h of fermentation (p ≤ 0.04).  
5.4 Discussion 
The human gut microbiota has the ability to degrade hesperidin into its aglycone and smaller 
molecular weight compounds (phenolic acids). Two different fermentable carbohydrates were 
tested for their effects on these processes. Raftiline is selectively used by lactic acid bacteria 
and glucose is used by a wider range of colonic bacteria, so by comparing their effects the 
mechanism for the effects of increased fermentation can be considered. Glucose changed the 
rate of hesperidin degradation over 2-4 h in the faecal incubations, while raftiline did not 
affect the metabolism of hesperidin during 24 h fermentation. However, raftiline significantly 
decreased production of phenolic acids from 220.3 µM to 126.6 µM after 24 h fermentation 
of hesperidin by gut bacteria (p < 0.05). However, glucose did not affect the production of 
phenolic acids after 24 h of fermentation, but increased production of phenolic acids from 
38.0 ± 6.8 µM to 62.1 ± 11.0 µM at 4 h fermentation (p < 0.02) suggesting a change in the 
rate of metabolism rather than an increase in total phenolic acid production.   
There were 46 % and 87.6 % of hesperidin degraded after 24 h fermentation with gut 
bacteria, but there was no significant difference after adding raftiline or glucose. Fructo-
oligosaccharides stimulated the growth of Bifidobacterium in vivo and in vitro (Bouhnik et 
al., 1997, Steer et al., 2003(Yang, 2013 #618). In addition, raftline stimulates the growth of 
lactic acid bacteria (Ramchandran and Shah, 2010). However, degradation of hesperidin was 
not increased during the fermentation with raftiline through stimulation of gut bacteria in 
vitro.  
Hesperetin was similar deglycosided from hesperidin by gut bacteria during the fermentation 
with or without glucose. Jaganath et al detected phenolic acids ranging from 33 μmol to 39 
μmol at 24 h during fermentation of rutin without / with glucose by gut bacteria from 3 
participants (Jaganath et al., 2009), showing limited effect of glucose in production of 
phenolic acids, which was similar with our results. It is well known that glycosylated 
polyphenols can be hydrolysed to aglycones by β –glucosidases (Dabek et al., 2008, Laparra 
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and Sanz, 2010). There are several studies describing the ability of β-glucosidase and β-
rhamnosidase of gut bacteria to hydrolyse polyphenols in vitro and in vivo (Aura et al., 
2002b, Bokkenheuser et al., 1987, Schneider et al., 1999). The gut microbiota can degrade 
flavonoids, and transform aglycones and conjugated metabolites into phenolic acids (Hooper 
et al., 2002, Wilson and Nicholson, 2009, Dueñas et al., 2015). The phenolic acids were 
higher at 4 h in the presence of glucose. This might indicate that gut bacteria can rapidly use 
glucose as energy source and increase degradation of hesperidin and the flux to phenolic 
acids rather than decreasing production of hesperidin.  
However, the inhibitory property of raftiline on the production of phenolic acids was found 
during the fermentation. There was 72 %, 59 %, 53 %, and 76 % reduction of 3-
hydroxyphenylacetic acid, 4-hydroxybenzoic acid, 4-hydroxyphenylacetic acid and 3-
hydroxyphenylpropionic acid in the presence of raftiline, which was similar with in vitro 
incubation of rutin with dietary fibre, raftiline reduced total phenolic acids, 3-
hydroxyphenylacetic acid and 4-hydroxyphenylacetic acid at the end of 24 h fermentation 
with rutin (Mansoorian et al., 2015). The major fermentation products in our study were 3,4-
dihydroxyphenyl propionic acid, 3-hydroxyphenylpropionic acid, 4-hydroxyphenylacetic 
acid, which were similar to metabolites reported from the fermentation of  rutin, naringin, 
quercetin, naringenin, and procyanidins (Rechner et al., 2002, Serra et al., 2012, Serra et al., 
2011). Thus, raftiline may have inhibited these gut bacteria and reduced transformation of 
hesperidin into phenolic acids. 
The production of phenolic acids were 3 fold higher in pathway 1 compared with pathway 2 
during the fermentation with or without raftiline. However, raftiline significantly decreased 
production of phenolic acids in proposed pathway 2. Flavonoids are dehydrolysed, 
demethylated, decarboxylated  to metabolites through the action of dehydroxylase, 
demethylase or decarboxylase by Ruminococcus, Eggertheilla, Bifidobacterium, Clostridium, 
Bacterioides, Eubacterium, Streptococcus and Lactobacillus bacteria (Clavel et al., 2005, 
Keppler and Humpf, 2005, Schneider et al., 1999, Blaut and Clavel, 2007, Kim et al., 1998). 
This implies that raftiline influenced pathway 2 related bacteria. 
As we know, the level of flavonoid metabolites produced in the colon has been linked to their 
potential health effects. Hesperidin and /or hesperetin were reported to reduce cardiovascular 
disease related adiponectin expression (Liu et al., 2008), inflammation biomarker (IL-6) 
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(Choi and Lee, 2010), and carcinoid tumors cell proliferation. In addition, 3,4-
dihydroxyphenylacetic acid was observed to have anti-proliferative activity in prostate and 
colon cancer cells in vitro, and protected against pancreatic β-cells dysfunction 
that  represents a transition from pre-diabetes to diabetes (Gao et al., 2006a, Carrasco-Pozo et 
al., 2015). The phenolic acids, 4-hydroxybenzoic and 4-hydroxyphenylacetic protected 
against pathogenic bacteria in the gut (Si et al., 2006, Lee et al., 2006, Cueva et al., 2010). It 
indicated that inhibitory effect of raftiline on production of phenolic acids may affect 
properties of polyphenols. 
In conclusion, in this study, the rate and extent of hesperidin degradation was affected by 
fermentable carbohydrates that might be due to modification of gut bacteria or their relevent 
enzymes. Raftiline had an inhibitory effect on degradation of hesperidin probably through 
selective modification of gut bacteria. Production of phenolic acids was more sensitive to 
fermentable carbohydrate than hesperidin or hesperetin. Thus, dietary fibre or other aspects of 
the food matrix should be considered when investigating bioavailability or bioactivity of 
flavonoids through modification of metabolites, especially phenolic acids.  Although not 
studied in this thesis the flavonoids or their derived products (aglycones and phenolic acids) 
may influence the composition of gut bacteria that should be explored in future.  In addition, 
the effect of dietary fibre on colonic metabolism of hesperidin or other flavonoids should be 
considered when the benefits of flavonoids or dietary fibre in humans are investigated in vitro 
or in vivo.  
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CHAPTER 6 Impact of a four week exercise 
intervention on bioavailability of flavanone from 
orange juice in previously sedentary women 
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6.1 Introduction 
As we discussed before, flavanone bioavailability is very low in humans (section 1.4.2). 
Factors affecting bioavailability have been increasingly explored by researchers in order to 
improve health effects of dietary flavonoids in humans. The bioavailability was enhanced 
from 7 % to 47 % by using α-rhamnosidase to hydrolyse flavanone in orange juice 
(Bredsdorff et al., 2010). The fortified juice with orange flavonoid extract had the highest 
urinary excretion of flavanone metabolites in comparison with commercial orange juice and 
flavonoid contained drinks (Vallejo et al., 2010a). Moreover, full fat natural yoghurt reduced 
maximal concentration (Cmax) of  flavanone metabolites in plasma and production of five 
phenolic acids in urine, and increased the time to achieve maximal concentration (Tmax) of 
metabolites in plasma, but did not modify 24 h urinary excretion of flavanone metabolites 
after orange juice intake (Roowi et al., 2009b, Mullen et al., 2008a).   
There is limited evidence which suggest that the bioavailability of flavonoids can be 
favourably modified by participation in exercise. As described in chapter 1,  24 h urinary 
excretion of naringenin, eriodictyol, and hesperetin metabolites were 92 %, 88 %, and 53 % 
higher  in very well trained athletes than in sedentary individuals after ingestion of aronia-
citrus juice (Medina et al., 2012). However, this study has several limitations. Firstly, it 
focused on cross sectional populations with different lifestyles (active and sedentary).  
Secondly, both of the groups consumed different doses of aronia-citrus juice (200 ml for 
atheletes /400 ml for non-trained subjects) with different one week diet (a diet without 
polyphenol for non-trained group, another one diet for triathletes included the plant-foods 
containing flavanones with a balanced carbohydrates, proteins, fats, vitamins and 
microelements), even though flavanone dose was similar. Thirdly, the athlete group kept their 
active lifestyle during this one week juice consumption. Additionally, urine samples were 
hydrolysed with β-glucuronidase for analysis. The one week diet before urine collection was 
not same between two groups. Therefore the study does not allow a conclusion that exercise 
can directly enhance bioavailability of flavanone in those who are not professionally trained 
as athletes.   
Flavanone metabolites and phenolic metabolites can be absorbed into the circulatory system 
or excreted into urine after deglycosylation, degradation and conjugation of flavanone by 
intestinal enzymes or colonic bacteria. The deglycosylation of dietary flavonoids depends on 
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β-glucosidase  activity from human small intestine mucosa (Németh et al., 2003). Absorption 
of flavonoids involves epithelial brush border membrane transporters, such as Na-dependent 
GLUT-1, and UDP-glucuronosyl transferase (Gee et al., 1998, Henry-Vitrac et al., 2006). In 
addition, physiological functions of gastrointestinal intestine tract have been linked to 
absorption or/and rate of drug and flavonoids, such as gastric emptying and gut transit time 
(Clements et al., 1978, Mullen et al., 2008a, Mullen et al., 2008b, Mullen et al., 2009a). It is 
well known that flavonoid metabolites can be distributed into tissues through the blood 
stream in the host. Gastrointestinal hormones might impact on intestinal functions. Peptide 
YY delayed gut transit time from 67 ± 4 mins to 94 ± 7 mins and 192 ± 9 mins, and 
prolonged gastric emptying from 37 ± 8 mins to 63 ±10 mins and 130 ±12 mins when 
subjects received low dose of infusion at 0.4 pmol/kg/min dose (50 ml), and high dose 
infusion at 1.1 pmol/kg/min (50 ml) (Savage et al., 1987). Naslund and his colleagues 
supposed that peptide YY was responsible for intestinal motility and glucagon-like peptide -1 
dominated early gastric emptying (Naslund et al., 1998).  
Colonic microbiota have enormous catalytic and hydrolytic ability to degrade flavonoids and 
involving demethylation, dehydroxylation and decarboxylation activities and thus play an 
important role in metabolism of flavonoids (Aura, 2008). The activities of β-glycosidases and 
β-glucuronidases are the main enzymes to degrade polysaccharides and xenobiotics by gut 
bacteria (Laparra and Sanz, 2010). Clostridium, Butyrivibrio and Bacteroides species have 
enzyme activities to hydrolyse glycosides and ring diffusion of flavonoids in the colon in 
relation to their α-rhamnosidase, β-glycosidase and β-glucuronidase (Winter et al., 1989, Kim 
et al., 1998, Selma et al., 2009, Minamida et al., 2006, Tzounis et al., 2008, Laparra and Sanz, 
2010, Rechner et al., 2002). 
Clark et al reported more diversity of gut bacteria in athletes compared with sedentary 
humans (Clarke et al., 2014). However, higher quantities of calories, protein, fat, 
carbohydrates, sugar and saturated fat per day were consumed by athletes than the sedentary 
population, among which protein intake in athletes was positively associated with microbial 
diversity (Clarke et al., 2014). However, it is not clear if it is the effect of physical activity or 
diet that changes the composition of the gut bacteria, even though an animal study revealed  
different TGGE profiles of gut bacteria 16S rRNA from 5 of 7 male rats subjected to wheel-
running exercise for 5 weeks (Matsumoto et al., 2008). If the bacteria change with exercise 
then the flavanone metabolism in the gut may also change.   
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Exercise modifies physiological functions as described in chapter 1. Chronic exercise can be 
expected to modify flavanone metabolism by several other mechanisms, including 
physiological functions of gastrointestinal tract and circulatory system (Ebeling et al., 1993, 
Pollock et al., 1995, Watkins et al., 1994, Carrio et al., 1989, Koffler et al., 1992, Piatkowski 
et al., 1993). 
Due to lack of studies on effects of physical activity on dietary flavonoids in a normal 
population, a crossover controlled study was carried out to investigate whether a 4 weeks 
moderate intensity exercise programme physical activity affects the bioavailability of 
flavanones and the colonic catabolism of flavanone after orange juice in humans. Based on 
present evidence, it has been hypothesised that metabolism of flavonoids can be impacted by 
physical activity in sedentary humans.  
6.1.1 Hypothesis 
To test the hypothesis that 4 weeks moderate intensity exercise increases bioavailability and 
metabolism of orange juice flavanone in previously sedentary females 
Does a 4 weeks moderate physical intensity physical exercise affect bioavailability of 
flavanone and production f phenolic acids after the consumption of orange juice ‘with bits’? 
6.2 Subjects and study design 
6.2.1 Study design 
Twenty sedentary females were recruited by advertisement in a Glasgow community website, 
by Student voice (a student community social website) (Appendix 6), posters and leaflets in 
the area of Glasgow city. Inclusion criteria for this study were Caucasian females, sedentary 
for at least 6 weeks, 18-45 years old, non-smoker, not taking any medication, non-
gastrointestinal disease, non-vegetarian, non-pregnant, BMI < 30. The study was explained to 
all of potential participants. Potential participants went through a screening process. They 
were asked to fill physical activity readiness questionnaire and health screening questionnaire 
(Appendix 10). If they were willing to take part in this study, the consent form was signed 
before the intervention study. MVLS Ethics Committee at University of Glasgow reviewed 
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and approved this study (No. 200140020), and participants provided implied consent by 
returning their questionnaires. 
In this study, healthy Caucasian women, aged 18-45 years, had sedentary lifestyle (less than 
1h physical activity per week and a sedentary job) for at least 6 weeks, had no digestive 
problems, diabetes, thyroid problems, blood disorders, kidney and liver problems, convulsion 
and epilepsy, non-smokers, not pregnant, had a regular menstrual cycle, non any medications 
or nutritional supplements before 6 months, and those who said ‘no’ to all of PRQ were 
recruited (Appendix 11). 
Fifteen participants needed to undergo 4 weeks of moderate intensive exercise including 
running, cycling or combination of both, 4 sessions every week. Participants needed to 
complete experimental tests before and after 4 weeks of intervention. Prior to experimental 
tests, participants followed a well-designed list of polyphenol-free foods for 2 days (appendix 
8) and the food was same for all of participants during the experimental day. The low 
polyphenol diet was strict in order to obtain an ideal baseline that excluded fruit, vegetables, 
legumes, whole cereal, wine, tea, cocoa, coffee, and so on, which was recorded in food 
inventory and participants repeated the same diet for 2 days before the second experimental 
test. The two days low polyphenol food was recorded in food inventory (Appendix 7). In 
addition, for the 2 days, the participants were restricted from high fibre containing food to 
minimize non-orange juice fibre induced H2 exhalation from any remaining fermentable 
carbohydrates in the colon (Bertram et al., 2014, Brummer et al., 1985). 
Participants attended the metabolic investigation room between 0800 and 0900 h after a 12 h 
fast and brought an overnight urine sample. Body composition (weight, BMI, body fat), was 
measured using TBF-310GS body composition analyzer (Tanita), and height and waist 
circumference were also measured using standard protocols (Marfell-Jones et al., 2012). 
Blood pressure and heart pulse was measured by using a portable blood pressure monitor. 
After body composition measurement, a venous cannula was introduced into an antecubital 
vein. After an interval of 10 min, a baseline blood sample (9 ml) was obtained into an EDTA 
tube. The first breath hydrogen value was tested by a breath hydrogen monitor (Bedfont 
Scientific Ltd., Kent, UK). Immediately, subjects were provided a cup of orange juice ‘with 
bits’ (500 mL). Blood samples were obtained at 1, 2, 3, 4, 5, 6, 7, 8 h after the juice intake. 
Expiratory breath hydrogen levels were monitored every 30 minutes at following 8 hours 
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after the orange juice intake. For breath hydrogen test, they were asked to maximally inhale 
and hold the inhalation for 15 s and then expire into the monitor. The time of first sustained 
rise of breath hydrogen was taken as the mouth to caecum transit time. They were allowed to 
drink water. Lunch included a white roll, butter and ham, a package of ready salted crisps 
(carbohydrates, 39.88 g; fat, 18.15 g; protein, 17.44 g; energy, 388.5 kcal) after 4 h 
consumption of orange juice and at the end of the experimental test. The dinner was of 
polyphenol-free food and was recorded. The cannula was removed after 8 h blood sample 
collection and the participants left the laboratory to sleep at home, and then came back in the 
next morning for the fasting blood sampling. Urine samples were collected before orange 
juice intake and 0-2, 2-5, 5-8, 8-10, 10-20, 20-24 h after juice consumption.  
Exercise training consisted of 4 weeks’ sessions of moderate intensity exercise (cycling, 
running or combination of both). Each exercise session lasted for 40 minutes in week 1, 50 
minutes in week 2, 60 minutes in week 3 and 4. The exercise programme was set at an 
individually pre-determined work rate and achieved 70-80 % of their predicted maximal heart 
rate. Exercise sessions could be separated into smaller sessions if required by the participants, 
but finished in the same day. The training sessions took place at the Exercise and Energy 
Balance Laboratory (New Lister Building, the Glasgow Royal Infirmary), or Stevenson 
Building (Glasgow University).  
6.2.2 Orange juice and chemicals 
Orange juice was purchased in the local supermarket, freshly squeezed, not from 
concentration. Orange juice was homogenized in a large clean container, and separated to 500 
ml, and stored in freezer until consumption (flavanone kept stable during the whole study). 
Aliquots of orange juice were used to analyze flavanone content. 
HPLC grade methanol was purchased from Fisher Scientific (Loughborough, UK). 
Hesperetin-7-O-rutinoside, narigenin-7-O-rutinoside, 3-hydroxyphenylacetic acid , 4-
hydroxyphenylacetic acid , 4-hydroxyphenylpropionic acid,   3, 4-dihydroxyphenylacetic 
acid, 3-(3, 4-dihydroxyphenyl) propionic acid, 4-hydroxy-3-methoxy-phenylpropionic acid 
were purchased from Sigma-Aldrich Co Ltd (Poole, Dorset, UK) or Alfa Aesar (Karlsruhe, 
Germany). Formic acid, N-methyl-N-(trimethylsilyl) trifluoroacetamide, pyridine, 2, 4 ,5 -
trimethoxycinnamic acid, 4-hydroxybenzoic acid, ferulic acid, 4’-hydroxyphenylacetic acid, 
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3’-methoxy-4’-hydroxyphenylacetic acid, hippuric acid, 3-(3’-methoxy-4’-
hydroxyphenyl)propionic acid, and 3-(3’-hydroxy-4’-methoxyphenyl)propionic acid were 
purchased from Sigma-Aldrich Co Ltd (Poole, UK). 4’-hydroxyhippuric acid was obtained 
from Bachem (UK) Ltd. Hesperetin-7-O-rutinoside and narigenin-7-O-rutinoside were 
acquired from Extrasyntheses (Genay Cedex, France). 3-(3’-Hydroxyphenyl) hydracrylic 
acid, hesperetin-7-O-glucuronide, naringenin-4’-O-glucuronide, and naringenin-7-O-
glucuronide were purchased from Toronto Research Chemicals Inc.  Ethyl acetate and 
dichloromethane (DCM) were purchased from Rathburn Chemicals Ltd (Walkerburn, 
Peeblesshire, UK).   
6.2.3 Extraction of flavonoids in orange juice and phenolic acids in 
urine 
Orange juice (1 ml) was extracted as mentioned in section 2.9.1. Extraction of phenolic acids 
was done by the methods, as described in section 2.9.2. 
6.2.4 Identification and quantification of flavonoids in orange juice 
with HPLC- PDA-MS 
Orange juice was analyzed by HPLC-PDA-MS
2
 described in section 2.11. The extracted 
samples were injected in duplicate. 
6.2.5 Identification of flavanone metabolites in urine by HPLC- PDA-
MS 
Urine samples were centrifuged at 13,000 rpm at 4 °C for 10 min. Supernatants (100 μl) were 
analyzed by using HPLC–PDA-MS2 as described in section 2.11.  
Quantification of hesperetin and narigenin metabolites was respectively based on 
chromatographic peak areas acquired at 290 nm and expressed against standards of 
hesperetin-7-O-glucuronide and naringenin-7-O-glucuronide equivalents with limit of 
detection at 0.1ng. The standards were dissolved in methanol at concentrations ranging from 
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0.1 to 100 ng. A linear response was obtained for all the standard curves when a linear 
regression analysis was R
2
 > 0.999.  
6.2.6 Identification and quantification of phenolic acids by GC-MS 
GC-MS analysis was illustrated in section 2.12. Phenolic acids (3-hydroxybenzoic acid, 3’-
hydrophenylacetic acid, 4-hydroxybenzoic acid, 4’-hydrophenylacetic acid, vanillic acid, 3-
methoxy-4-hydroxyphenylacetic acid, 3, 4-dihydroxybenzoic acid, 3, 4-
dihydroxyphenylacetic acid, 3-hydoxy-4-methoxphenylhydracrylic acid, hippuric acid, 3-
hydoxyphenylhydracrylic acid, 3-(3-methoxy-4-hydroxyphenyl) propionic acid, 3-(3,4-
dihydroxyphenyl) propionic acid, 3’-hydroxyhippuric acid, 4’-hydroxyhippuric acid were 
identified according to mass spectra and retention times obtained from authentic standards 
analysed under identical conditions. When standards were not commercially available, 
identification was achieved through the integrated NIST mass spectral library 2008 
(Scientific Instruments Services Inc., Ringoes, NJ, USA), with a confidence of 70 % or 
above. Calibration curves of the ratio between the target ion of the internal standard (2, 4, 5-
trimethoxycinnamic acid, m/z 279) were achieved with concentrations ranging from 3- 60 
ng/µl (R
2 
> 0.95).  
6.2.7 Sample size and statistical analysis 
The sample size was based on pilot data (Malkova et al unpublished data) obtained in a 
previous study on the impact of detraining on urinary excretion of flavanone metabolites.  
Assuming that the intervention will induce an effect size of ~0.5 SD units (i.e. it is half as 
effective), 10 subjects were needed to complete the study to achieve a significant difference 
before and after the intervention with 85% power at p < 0.05. All data were presented as 
mean values with standard error. All data were assumed to be normally distributed and was 
subjected to statistical analysis using a paired t-test, independent t-test and ANOVA tests 
with LSD post-hoc test. Statistical significance was set at a p-value < 0.05 for two-tailed 
comparisons.  
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6.2.8 Hypothesis 
Four weeks moderate intensity physical exercise programme affects bioavailability of 
flavanone metabolites and phenolic acids 
6.3 Results 
6.3.1 Pre intervention characteristics of subjects by groups 
Age, height, weight, BMI, WC (waist circumference) and body fat were not different 
between exercise and control groups prior to the intervention study (Table 6-1).  
Table 6-1 Anthropometric characteristics and body composition of healthy females before 
exercise and habitual life intervention 
Age (years) 22.4 ± 1.3 
Height (cm) 167.9 ± 6.4 
Weight (kg)  64.5 ±8.6 
BMI (Kg/m
2
) 22.9 ± 2.2 
Waist circumference (cm) 79.9 ± 9.0 
Body fat (%) 28.0 ± 6.3 
SBP (mm Hg) 119.1 ± 8.6 
DBP (mm Hg) 77.0 ± 11.7 
Heart rate (bpm) 77.2 ± 8.1 
Values are expressed as means ± SE (n = 15). SBP: systolic blood pressure, DBP, diastolic blood 
pressure   
6.3.2 Identification and quantification of flavanones in orange juice 
The orange juice (500 ml) consumed by participants contained 1.1 mmol of hesperidin and 
0.1 mmol of narirutin respectively. There were no detectable aglycones in orange juice (Table 
6-2). 
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Table 6-2 Quantities of hesperidin and narirutin in 500 ml orange juice ‘with bits’ 
Flavanone Concentration (mmol ) 
Narirutin 0.1 ± 0.01 
Hesperidin 1.1 ± 0.1 
Values are means ± SD (mmol / 500 mL) (n=3). 
6.3.3 Effect of exercise intervention on body composition and 
anthropometric characteristics 
As shown in Table 6-3, height, weight, BMI, waist circumference, body fat, SBP, DBP, and 
pulse were similar before and after 4 weeks of moderate intensive exercise programme within 
exercise group. 
Table 6-3 Anthropometric characteristics in healthy females before and after 4 weeks intensive 
exercise 
 
Exercise 
Before After 
Age (years) 24.7 ± 6.6 24.7 ± 6.6 
Height (cm) 166.8 ± 6.0 165.9 ± 6.1 
Weight (Friesenecker et al.) 64.5 ± 7.7 63.6 ± 7.0 
BMI (Kg/m
2
) 23.2 ± 2.6 23.2 ± 2.7 
Waist circumference (cm) 80.8 ± 8.4 78.2 ± 6.9 
Body fat (%) 29.3 ± 6.3 28.6 ± 6.6 
SBP (mm Hg) 116.1 ± 8.1 114.6 ± 8.5 
DBP (mm Hg) 74.6 ± 9.3 69.6 ± 9.2 
Pulse 78.0 ± 7.9 70.0 ± 10.2 
Values are expressed as means ± SD (n= 15), ANOVA test was performed to determine intervention 
was significantly different from baseline. * Significantly different from baseline (before), p < 0.05. 
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6.3.4 Effect of 4 weeks intensive exercise intervention on mouth to 
caecum transit time (MCTT) in sedentary healthy females 
We measured MCTT by the breath hydrogen technique. We assumed that the orange juice 
contained sufficient fibre to be fermented in the colon. This was before we had the results on 
the actual fibre content. In reality this was too low to produce large changes in breath 
hydrogen. We could have used a small dose of lactulose to supplement the substrate available 
for hydrogen production (Mullen et al., 2008a, Bertram et al., 2014). Thus may however, 
change the transit time by the osmotic effect of the lactulose in the small intestine stimulating 
peristalsis. Even though the hydrogen value was lower than desired and disappeared quickly 
when reaching the first time rise (Figure 6-1), the result was still valuable. Data from two 
subjects were excluded because the monitor malfunctioned or the subject had not complied 
with the proper diet before the test. The breath hydrogen was measured for 8 h, so data from 
those transit times > 8 h was considered 8 h for calculation. In addition, mouth to caecum 
transit time was delayed through 4 weeks intensive physical activities in females (3.0 ± 0.2 h 
vs. 4.5 ± 0.7 h, p ≤ 0.056) (Table 6-4).  
Table 6-4 First time sustained rise of breath hydrogen in sedentary females before and after 4 
weeks exercise or habitual life intervention 
 
Gut transit time (h) 
Before 3.0 ± 0.2 
After 4.5 ± 0.7 * 
Values are means ± SE (n = 15). Paired t-test analysis was performed to determine intervention was 
significantly different from baseline. * Significantly different from baseline (before) at P ≤ 0.056. 
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Figure 6-1 Individual gut transit time after intake of 500 ml of orange juice ‘with bits’ in females 
before and after 4 weeks exercise intervention  
Values are the first time rise of breath hydrogen measured by breath hydrogen monitor (h) (n = 13). 
Paired t-test analysis was performed to determine. * Significantly different from baseline (before) at P 
≤ 0.056. 
6.3.5 Effect of 4 weeks intensive exercise intervention on urinary 
excretion of flavanone metabolites in sedentary humans 
The excretion of flavanones over 0-2, 2-5, 5-8, 8-10, 10-20, and 20-24 h urine after orange 
juice consumption are shown in Table 6-5. Quantities of metabolites (µM) were based on 
total amount in urine. The flavanone metabolites included hesperetin sulfoglucoside, 
naringenin glucuronide (2 isomers), hesperetin diglucuronide, naringenin diglucuronide, 
hesperetin sulfoglucuronide, hesperetin glucuronide (3 isomers), and hesperetin sulphate 
detected in urine after intake of orange juice ‘with bits’. The hesperetin and naringenin 
metabolites in total accounted for 67.3 % and 32.7 % of the total intake before 4 weeks 
intensive physical exercise in females after the consumption of orange juice ‘with bits’. After 
the 4 weeks exercise intervention, 65.7 % were hesperetin metabolites in urine. Naringenin -
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O- glucuronide (2 isomers), hesperetin -O- sulfoglucoside, hesperetin -O- glucuronide were 
the main metabolites in urine. Naringenin-diglucuronide was the lowest metabolite after 
orange juice intake (Table 6-5). 
The urinary excretion of ten flavanone metabolites was 96.4 ± 10.6 µmol in total after intake 
of 500 mL orange juice ‘with bits’ by sedentary females, which reduced to 87.0 ± 12.5 µmol 
after 4 weeks of exercise training, but the reduction was not significant. However, one isomer 
of hesperidin glucuronide was significantly decreased from 10.4 ± 2.9 µmol to 6.2 ± 1.7 µmol 
after 4 weeks of exercise training (p < 0.02). In addition, the urinary excretion of flavanone 
metabolites (hesperetin metabolites and naringenin metabolites) was significantly reduced 
after 4 weeks intensive physical activities in females over 10-20 h after orange juice intake 
(21.4 ± 5.5 µmol vs. 18.8 ± 4.8 µmol, p ≤ 0.008).  
 Naringenin metabolites expressed as a percentage of orange juice flavanone intake was 
higher than hesperidin metabolites in urine over 24 h after juice intake before and after 4 
weeks intensive physical activities (Before: 6.0 ± 1.0 % vs. 23.2 ± 4.0 %; After: 5.3 ± 1.0 % 
vs. 21.9 ± 3.0 %) (Table 6-6). However, there was no significantly different excretion of 
flavanone metabolites in urine after 4 weeks intensive physical activities (before: 7.8 ± 0.9 %, 
after: 7.1 ± 1.0 % exercise). During the period of 24 h urine collection, the largest amount of 
flavanone metabolites were excreted over 5-8 h after orange juice intake, accounting for 29.4 
% and 37.1 % of total urinary excretion in females respectively before and after 4 weeks 
physical activities. 
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Table 6-5 Quantities (µmol) of flavanone metabolites excreted in urine over 24 h after consumption of 500 ml orange juice by sedentary females 
before and after 4 weeks of moderate intensive exercise programme 
 
0-2 h 2-5 h 5-8 h 8-10 h 10-20 h 24 h Total excreted 
Before After Before After Before After Before After Before After Before After Before After 
Hesperetin 
sulfoglucoside 
1.0±0.4 1.0±0.4 3.5±1.3 2.0±0.5 3.7±1.2 2.6±1.2 1.8±0.7 1.5±0.6 2.5±1.1 1.3±0.4 0.1±0.0 0.1±0.0 12.5±3.9 8.5±1.9 
Naringenin 
glucuronide 
1.3±0.4 1.0±0.5 2.2±0.8 2.3±0.4 3.8±1.0 2.1±0.9 4.4±1.6 3.7±0.8 2.5±0.9 5.2±1.4 1.0±0.4 0.7±0.2 14.5±2.6 14.8±2.4 
Naringenin 
glucuronide 
1.8±0.6 2.2±0.9 2.6±0.9 2.4±0.6 5.2±2.3 4.5±2.0 3.1±1.5 1.0±0.3 1.9±0.5 3.5±1.0 0.9±0.4 0.1±0.0 14.7±4.5 14.4±2.9 
Hespereretin 
diglucuronide 
0.6±0.4 0.1±0.0 0.7±0.4 0.2±0.1 0.7±0.5 1.4±1.0 0.7±0.4 0.4±0.2 1.5±0.8 1.0±0.5 0.2±0.1 0.2±0.1 4.3±1.6 3.1±1.3 
Naringenin 
diglucuronide 
nd nd 0.3±0.2 0.2±0.1 0.4±0.2 0.8±0.4 0.5±0.3 0.2±0.1 1.0±0.6 0.3±0.2 nd 0.1±0.0 2.3±0.9 1.6±0.8 
Hesperetin 
sulfoglucuronide 
0.5±0.3 0.1±0.1 1.8±0.6 1.1±0.4 1.3±0.4 1.3±0.3 0.7±0.3 0.3±0.2 0.9±0.6 0.5±0.3 nd nd 5.1±1.0 3.3±0.9 
Hesperetin 
glucuronide 
0.6±0.3 0.3±0.1 3.6±0.8 2.0±0.8* 3.0±1.2 2.4±0.8 1.2±0.6 0.5±0.3 2.1±1.0 0.7±0.4 0.1±0.0 0.3±0.3 10.4±2.9 6.2±1.7* 
Hesperetin 
glucuronide 
0.3±0.2 0.1±0.0 3.9±0.8 3.7±1.2 4.3±1.4 4.4±1.4 3.1±1.9 1.7±0.8 4.7±1.6 2.5±1.3* 0.2±0.1 0.2±0.1 16.3±4.3 12.4±3.5 
Hesperetin 
glucuronide 
nd 0.2±0.1 2.7±1.3 2.6±1.3 2.7±1.8 8.4±4.0 0.5±0.3 2.4±1.5 3.2±3.1 2.3±2.2 nd 0.3±0.2 9.1±4.2 16.1±7.5 
Hesperetin sulfate nd nd 1.7±0.9 0.3±0.2 1.3±0.6 0.8±0.3 0.1±0.1 0.5±0.3 0.6±0.5 1.3±0.9 nd nd 3.7±1.5 3.0±1.3 
Hesperetin 
metabolites 
2.8±1.1 5.1±1.1 18.8±2.9 16.9±3.0 18.8±4.0 32.3±5.8 8.4±3.1 12.6±2.8 15.9±5.1 18.8±4.8* 0.5±0.1 1.60.7 64.9±10.5 57.2±11.5 
Naringenin 
metabolites 
3.1±0.7 1.8±0.5 5.1±1.2 12.2±3.0 9.4±2.5 25.0±5.0 7.4±2.4 7.6±2.4 5.5±1.3 9.8±4.0 1.4±0.5 0.9±0.6 31.5±5.4 29.8±4.1 
Flavanone 
metabolites 
5.9±1.5 5.1±1.1 23.9±3.0 16.9±3.0 28.3±4.2 32.3±5.8 15.8±3.9 12.6±2.8 21.4±5.5 18.8±4.8* 1.9±0.5 1.6±0.7 96.4±10.6 87.0±12.5 
Values are means ± SE (n=15). Univariate analysis of variance test with post hoc LSD was used to determine significant differences * significantly different from 
baseline at P ≤ 0.05. 
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Table 6-6 Urinary excretion of hesperetin, narigenin, and flavanone metabolites as a percentage of orange juice hesperidin, narirutin, and 
flavanone intakes over 24 h by sedentary females before and after 4 weeks of moderate intensity intensive exercise programme  
Urinary 
excreted 
metabolites 
0-2 h 2-5 h 5-8 h 8-10 h 10-20 h 24 h Total 
Before After Before After Before After Before After Before After Before After Before After 
Hesperetin 
metabolites 
0.2±0.1 0.1±0.0 1.8±0.3 1.0±0.3 1.8±0.4 2.4±0.4 0.8±0.3 0.7±0.2 1.5±0.5 1.0±0.4 0.0±0.0 0.1±0.1 6.0±1.0 5.3±1.0 
Naringenin 
metabolites 
2.3±0.5 2.4±0.7 3.7±0.9 3.5±0.5 6.9±1.8 5.4±1.6 5.4±1.7 3.6±0.7 4.0±0.9 6.6±1.6 1.1±0.4 0.5±0.2 23.2±4.0 21.9±3.0 
Flavanone 
metabolites 
0.5±0.1 0.4±0.1 1.9±0.2 1.4±0.2
*
 2.3±0.3 2.6±0.5 1.3±0.3 1.0±0.2 1.7±0.4 1.5±0.4 0.2±0.0 0.1±0.1 7.8±0.9 7.1±1.0 
Values are means ± SEMs (n=15). Univariate analysis of variance test with LSD was used to determine significant differences 
*
 significantly different from 
baseline (P ≤ 0.05). 
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Figure 6-2 Effect of 4 weeks moderate intensive exercise on 24 h cumulative urinary excretion 
of hesperetin metabolites (µmol) after 500ml of orange juice intake in sedentary females  
Values are means ± SE (n= 15). ANOVA with post host hoc HSD was used to determine significant 
differences * significantly different after 4 weeks intensive physical activities in exercise group, P ≤ 
0.05.  
 
Figure 6-3 Effect of 4 weeks moderate intensity exercise programme on cumulative urinary 
excretion of naringenin metabolites (µmol) over 24 h after 500ml of orange juice intake in 
sedentary females  
Values are means ± SE (n= 15). ANOVA with post hoc HSD was used to determine significant 
differences * significantly different after 4 weeks of exercise programme P ≤ 0.05.  
 
Hesperidin metabolites were significantly reduced from 21.6 ± 2.8 µmol to 14.0 ± 3.0 µmol 
in urine over 2-5 h after 500 mL of orange juice with bits after 4 weeks moderate physical 
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activities in females (p < 0.03) (Figure 6-2). In terms of flavanone metabolites as cumulative 
urinary excretion following orange juice intake, 4 weeks of moderate intensity exercise 
significantly decreased 0-5 h cumulative excretion in urine (29.7 ± 2.9 µmol vs. 22.0 ± 2.9  
µmol, p < 0.02) (Figure 6-4).  
 
 
Figure 6-4 Effect of 4 weeks moderate intensity exercise programme on cumulative urinary 
excretion of total flavanone metabolites (µmol) over 24 h after 500ml of orange juice intake in 
sedentary females  
Values are means ± SE (n= 15). ANOVA with post hoc HSD was used to determine significant 
difference, * significantly different after 4 weeks of exercise programme p ≤ 0.05.  
 
0.0
20.0
40.0
60.0
80.0
100.0
120.0
2 4 6 8 10 12 14 16 18 20 22 24C
u
m
u
la
ti
v
e 
u
ri
n
a
ry
 e
x
cr
et
io
n
 (
µ
m
o
l 
) 
Time (h) 
Before
After* 
  
163 
 
Table 6-7 Urinary excretions (µmol) of phenolic acids before and after 4 weeks of moderate intensity exercise programmme over 24 h after intake 
of 500 ml orange juice ‘with bits’  
 0-2 h 2-5 h 5-8 h 8-10 h 10-20 h 20-24 h Total 
 Before After Before After Before After Before After Before After Before After Before After 
3-HBA 
0.0 ± 
0.03 
0.1 ± 0.1 0.4 ± 0.4 0.5 ± 0.5 0.5 ± 0.5 0.3 ± 0.3 0.3 ± 0.2 0.1 ± 0.1 0.5 ± 0.4 0.3 ± 0.3 0.1 ± 0.1 0.1 ± 0.1 1.8 ± 1.5 1.4 ± 1.3 
3-HPAA 1.7 ± 0.6 1.2 ± 0.6 1.9 ± 1.1 1.2 ± 0.6 2.0 ± 0.8 1.0 ± 0.5 1.5 ± 0.6 0.6 ± 0.2 * 3.9 ± 1.1 1.4 ± 0.5 0.8 ± 0.3 0.7 ± 0.4 11.8 ± 3.4 6.0 ± 2.3 
4-HBA 
14.9 ± 
3.5 
13.2 ± 3.8 14.8 ± 3.7 14.9 ± 4.3 13.7 ± 3.2 11.8 ± 2.9 2.7 ± 1.1 3.0 ± 1.3 7.4 ± 1.9 7.0 ± 3.6 3.5 ± 2.4 0.6 ± 0.2 56.8 ± 11.5 50.5± 12.3 
4-HPAA 
13.1 ± 
1.8 
15.5 ± 2.1  12.1 ± 1.6 13.3 ± 2.2 15.3 ± 2.5 19.2 ± 2.2 9.4 ± 2.2 14.9 ± 4.6 27.6 ± 5.1 27.7 ± 3.6 6.4 ± 1.7 3.5 ± 0.6 83.5 ± 10.4 94.0 ± 7.7 
VA 4.1 ± 1.8 3.2 ± 2.2 3.7 ± 1.5 4.1 ± 1.7 4.7 ± 2.4 3.0 ± 1.6 1.5 ± 0.7 1.1 ± 0.8 3.9 ± 2.0 1.0 ± 0.4 1.0 ± 0.7 0.9 ± 0.5 18.9 ± 8.2 13.3 ± 4.6 
3-m-4-HPAA 8.9 ± 1.4 9.1 ± 1.6 9.4 ± 1.4 10.3 ± 1.9 9.2 ± 1.7 9.9 ± 1.9 & 4.0 ± 0.9 4.3 ± 0.9 8.5 ± 1.5 8.5 ± 1.1 2.2 ± 0.6 1.4 ± 0.2 & 42.0 ± 5.2 43.4 ± 6.0 
3.4-DHBA 2.1 ± 1.2 0.8 ± 0.6 2.7 ± 1.6 0.8 ± 0.6 2.0 ± 1.2 1.2 ± 0.8 1.2 ± 0.7 0.5 ± 0.4 3.9 ± 1.9 0.6 ± 0.5 0.4 ± 0.2 0.1 ± 0.0 12.3 ± 5.4 3.9 ± 2.3 
3,4-DHPAA 1.7 ± 0.7 1.9 ± 0.8 2.1 ± 0.9 3.6 ± 1.7 1.6 ± 0.6 5.6 ± 2.6 1.0 ± 0.5 1.3 ± 0.5 1.3 ± 0.5 2.8 ± 1.1 0.3 ± 0.2 0.9 ± 0.3 8.0 ± 2.8 16.0 ± 5.9 
3-h-4-MPHA 7.4 ± 1.4 13.6 ± 4.4 8.9 ± 1.8 11.1 ± 2.4 9.7 ± 1.4 17.3 ± 7.7 5.8 ± 1.6  7.1±1.9 15.0 ± 3.7 14.5 ± 2.8 4.6 ± 1.6 3.0 ± 0.8 51.2 ± 8.8 66.5± 14.6 
HA 
120.0 ± 
28.0 
186.2 ± 
86.2 
114.1 ± 
30.8 
106.4 ± 
35.4 
203.9 ± 
39.5 
199.0 ± 
45.6 
148.8 ± 
34.7  
153.3 ± 
41.1 
373.1 ± 
118.8 
384.4 ± 
59.1 
77.8 ± 
 13.3 
85.5 ±  
19.7 
1032.7 ± 
229.6 
1109.2 ± 
225.5 
3-HPHA 4.9 ± 1.6 3.2 ± 1.0 4.3 ± 1.5 4.8 ± 1.9 7.8 ± 3.0 10.3 ± 4.3 2.8 ± 1.1 2.8 ± 1.0 6.5 ± 1.7 5.0 ± 1.3 1.6 ± 0.4 1.1 ± 0.4 27.7 ± 6.3 27.1 ± 7.0 
3-m-4-HPPA 1.1 ± 0.5 4.0 ± 1.4 2.8 ± 1.0 3.8 ± 1.6 6.0 ± 1.4 6.3 ± 1.4 2.0 ± 0.7 1.9 ± 0.6 2.5 ± 1.1 3.3 ± 1.0  1.1 ± 0.7 0.8 ± 0.2 15.4 ± 3.8 20.1 ± 5.3 
3,4-DHPPA 0.6 ± 0.5 0.6 ± 0.5 0.6 ± 0.4 1.7 ± 0.8 0.7 ± 0.4 0.8 ± 0.4 0.4 ± 0.3 0.7 ± 0.4 0.7 ± 0.4 0.6 ± 0.4 0.3 ± 0.2 0.4 ± 0.3 3.4 ± 1.8 4.7 ± 2.3 
3-HHA 7.1 ± 1.8 6.8 ± 1.7 7.1 ± 1.5 6.8 ± 2.0 9.9 ± 1.9 9.9 ± 2.3 7.1 ± 2.0 7.1 ± 2.3 20.7 ± 5.6 25.3 ± 9.3 5.9 ± 2.2 3.5 ± 1.0 57.3 ± 11.8 59.1± 12.1 
4-HHA 
17.4 ± 
1.9 
13.0 ± 2.3 0.4 ± 0.4 0.5 ± 0.5 22.9 ± 2.9 23.4 ± 3.2 0.3 ± 0.2 0.1 ± 0.1 27.3 ± 5.5 28.2 ± 7.4 9.0 ± 2.6 4.3 ± 0.8 108.0±11.2 99.8± 14.1 
Values are expressed as means ± SE (n = 15). 3-HBA: 3’-hydroxybenzoic acid, 3-HPAA: 3’-hydrophenylacetic acid, 4-HBA: 4’-hydroxybenzoic acid, 4-HPAA: 
4’-hydrophenylacetic acid, VA: vanillic acid, 3-m-4-HPAA: 3-methoxy-4-hydroxyphenylacetic acid, 3.4-DHBA: 3, 4-dihydroxybenzoic acid, 3,4-DHPAA: 3, 4-
dihydroxyphenylacetic acid, 3-h-4-MPHA: 3-hydoxy-4-methoxphenylhydracrylic acid, HA: hippuric acid, 3-HPHA: 3’-hydoxyphenylhydracrylic acid, 3-m-4-
HPPA: 3-(3-methoxy-4-hydroxyphenyl) propionic acid, 3,4-DHPPA: 3-(3’, 4’-dihydroxyphenyl) propionic acid, 3-HHA: 3’-hydroxyhippuric acid, 4-HHA: 4’-
hydroxyhippuric acid, univariate analysis of variance test with post hoc LSD was used to determine significant differences * significantly different from baseline at p 
≤ 0.05. 
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6.3.6 Effect of 4 weeks moderate intensity exercise on urinary 
excretion of phenolic acids in sedentary humans 
There were 15 phenolic acids detected in urine samples, including 3’-hydroxybenzoic acid, 
3’-hydrophenylacetic acid, 4’-hydroxybenzoic acid, 4’-hydrophenylacetic acid, vanillic acid, 
3-methoxy-4-hydroxyphenylacetic acid, 3, 4-dihydroxybenzoic acid, 3, 4-
dihydroxyphenylacetic acid, 3-hydoxy-4-methoxphenylhydracrylic acid, hippuric acid, 3’-
hydoxyphenylhydracrylic acid, 3-(3-methoxy-4-hydroxyphenyl) propionic acid, 3-(3’, 4’-
dihydroxyphenyl) propionic acid, 3’-hydroxyhippuric acid, 4’-hydroxyhippuric acid (Table 6-
7). The baseline level of urinary phenolic acids in urine collected overnight prior to 
consumption of orange juice ‘with bits’, was similar before and after 4 weeks physical 
activities intervention in exercise group (82.9 ± 15.5 µmol vs. 81.8 ± 15.8 µmol, p = 0.87). 
Cumulative urinary excretion of phenolic acids without hippuric acid was not affected 
through 4 weeks moderate intensity exercise (498.0 ± 37.2 µmol vs. 505.8 ± 40.8 µmol) 
(Figure 6-5). During the period of 8-24 h after orange juice intake, cumulative urinary 
excretion of 3’- hydroxyl phenylacetic acid was significantly reduced after 4 weeks moderate 
intensity exercise (7.2 ± 2.5 µmol vs. 3.9 ± 1.8 µmol, p ≤ 0.01) (Figure 6-6).  
 
Figure 6-5 Urinary excretions (µmol) of phenolic acids without hippuric acid during 24 h after 
intake of orange juice before and after 4 weeks moderate intensity exercise. 
Values are means ± SE (n = 15), ANOVA with post host hoc HSD was used to determine significant 
differences, * significantly different after 4 weeks of exercise programme, P ≤ 0.05. 
0
100
200
300
400
500
600
2 4 6 8 10 12 14 16 18 20 22 24
C
u
m
u
la
ti
v
e
 u
ri
n
a
ry
 e
x
c
re
ti
o
n
 
(µ
m
o
l)
 
Time (h) 
Before
After
165 
 
 
 
For excreted phenolic acids over 0-2, 2-5, 5-8, 8-10, 10-20, and 20-24 h urine, there was no 
significant difference before and after 4 weeks moderate intensity physical exercise (Figure 
6-6). The production of 3’-hydrophenylacetic acid reduced after 4 weeks of exercise 
programme over 8-10 h after orange juice intake (1.5 ± 0.6 µmol vs. 0.6 ± 0.2 µmol, p < 
0.05) (Figure 6-7).  
 
 
Figure 6-6 Cumulative urinary excretions of 3’- hydroxylphenylacetic acid (µmol), over 24 h 
after 500 ml of orange juice ‘with bits’ before and after 4 weeks of exercise 
Values are means ± SE (n = 15). ANOVA with post host hoc HSD was used to determine significant 
differences * significantly different after 4 weeks of exercise programme, P < 0.05, ** significantly 
different after 4 weeks 
6.3.7 Effect of 4 week moderate intensity exercise intervention on 
urinary excretion of total metabolites in sedentary females 
The total metabolites (flavanone metabolites and phenolic acids) were 594.4 ± 40.3 µmol and 
592.8 ± 46.0 µmol before and after 4 weeks physical exercise in urine over 24 h after 
consumption of orange juice ‘with bits’ (Table 6-8). Exercise intervention had no effect on 
total flavanone and phenolic metabolite excretion and the metabolites were mainly excreted 
during the period of 5 - 8 h (Before, 134.3 ± 7.3µmol; after, 152.4 ± 15.9 µmol) and 10 - 20 h 
(Before, 151.1 ± 23.6 µmol; After, 145.1 ± 26.4 µmol) after orange juice consumption (Table 
6-8).  
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Table 6-8 Urinary excretion of total metabolites (µmol) over 24 h after intake of orange juice 
before and after 4 week moderate intensity exercise programme  in previously sedentary 
females 
 
0-2 h 2-5 h 5-8 h 8-10 h 10-20 h 20-24 h 
Before 92.5 ± 6.0 118.9 ± 13.9 136.4 ± 6.0 
ƒƔ
 53.7 ± 10.9 
*£
 164.2 ± 33.1 
ƒƔ
 46.9 ± 14.3 
*£
 
After 96.6 ± 11.0 109.6 ± 15.0 152.7 ± 22.0 
ƒƔ
 64.1 ± 16.8 *£ 160.4 ± 36.8 
ƒƔ
 22.3 ± 5.3
 *£
 
Values are means ± SE (n = 10).ANOVA tests with post hoc LSD analysis were performed to 
determine different, * significantly different from 5 - 8 h of urinary excretion, p < 0.05; ƒ significantly 
different from 8-10 h of urinary excretion, p < 0.05; £ significantly different from 10-20 h of urinary 
excretion, p < 0.05; Ɣ significantly different from 20 - 24 h of urinary excretion, p < 0.05. 
3-hydroxyphenylacetic acid, 3-hydroxyphenylhydracrylic acid, dihydroferulic acid, 3-
methoxy- 4-hydroxyphenylhydracrylic acid, 3-(3-hydroxy-4- methoxyphenyl)hydracrylic 
acid, 3-(3-hydroxy-4-methoxyphenyl)propionic acid, 3-(4-hydroxy-3-
methoxyphenyl)propionic acid, 3-methoxy-4-hydroxyphenylacetic acid, 3-hydroxyhippuric 
acid, and 4-hydroxyhippuric acid has been considered as main phenolic acids produced from 
flavanone in urine after consumption of orange juice (Roowi et al., 2009b, Pereira-Caro et al., 
2014a). Thus, 7 phenolic acids including 3-hydroxyphenylacetic acid, 3-methoxy-4-
hydroxyphenylacetic acid, 3-hydroxy-4- methoxyphenyl)hydracrylic acid, 3-
hydroxyphenylhydracrylic acid, dihydroferulic acid, 3-hydroxyhippuric acid, and 4-
hydroxyhippuric acid,  were contributed to metabolites with hesperetin and naringinin 
metabolites, which was around 33 % of consumed flavanones in urine over 24 h after orange 
juice intake (Table 6-9). 
6.4 Discussion 
The main finding of this study is that 4 week moderate intensity training programme did not 
affect urinary excretion of total metabolites (flavanone metabolites and phenolic acids) over 
24 h after intake of orange juice in sedentary females.  At the same time it demonstrated that 
following a 4 week exercise programme urinary excretion of flavanone metabolites from 
orange juice was diminished in some fractions. Hesperetin metabolites significantly 
decreased in urine collected over 0-5 h after juice consumption. In addition, the urinary 
excretion of 3-hydroxyphenylacetic acids was significantly reduced over 24 h after 
consumption of orange juice. The MCTT was prolonged from 3.0 ± 0.2 h to 4.5 ± 0.7 h in 
females by 4 weeks moderate intensity exercise programme. Physical exercise did not affect 
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anthropometric characteristics in healthy sedentary females: weight, BMI, body fat, waist 
circumference, and SBP, DBP, or heart rate (bpm).   
Table 6-9 Cumulative urinary excretion of metabolites as a percentage of intakes (%) over 24 h 
after intake of orange juice before and after 4 weeks moderate exercise in previously 
sedentary females 
Time (h) Before After 
0 -- -- 
0-2 4.4 ± 0.4 4.5 ± 0.5 
0-5 10.8± 0.9 10.3± 1.1 
0-8 18.6 ± 1.0 19.3 ± 2.0 
0-10 22.7± 1.4 23.4± 2.3 
0-20 31.3 ± 2.5 32.0± 3.2 
0-24 33.8± 2.8 33.2± 3.3 
Values are means ± SE (n = 15). ANOVA tests with post hoc LSD analysis were performed to 
determine different from before, p < 0.05. 
Previous studies showed variable bioavailability of flavanone metabolites (1 ~ 16 %) as a 
percentage of flavanone intake, 1.4 – 33 % of narirutin intake and 0.7 -14 % of hesperidin 
intake from orange juice, citrus juice or pure compounds (Vallejo et al., 2010c, Mullen et al., 
2008a, Manach et al., 2003, Bredsdorff et al., 2010, Perez-Jimenez et al., 2010, Ameer et al., 
1996). Brett et al revealed no significant different urinary production of hesperetin and 
naringenin between orange fruit and juice (Brett et al., 2009). Vallejo et al found lowest 
urinary excretion of flavanone metabolites after consuming pulp enriched juice (1.3 %) 
compared with other four beverages (two commercial orange juice, flavonoid rich orange 
juice, and  water containing orange flavanone extract) (Vallejo et al., 2010c).  Our study had 
a similar bioavailability of flavanone that was 7.8 % and 7.1 % over 24 h after consumption 
of orange juice in females before and after 4 weeks moderate intensity exercise programme. 
Several studies demonstrated that structure and solubility of flavonoids determine their 
bioavailability (Mullen et al., 2008a, Brett et al., 2009, Vallejo et al., 2010c). Narirutin is 
more soluble than hesperidin in orange juice (Vallejo et al., 2010c). It is consistent with our 
study that naringenin metabolites represented 23.2 % and 21.9 % of narirutin intake, 
significantly higher than that of hesperidin intake (Before: 6.0 %, after: 5.3 %) in females 
before and after 4 weeks physical exercise.  
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Previous studies showed phenolic acids to be the majority of metabolites in urine after orange 
juice intake (37 - 88 %) (Pereira-Caro et al., 2014a, Roowi et al., 2009b). Hippuric acid is the 
product of glycine conjugated with benzoic acid (Hutt and Caldwell, 1990), mainly from 
amino acids and plant phenolics derived from polyphenols by gut bacteria, and sodium 
benzoate (Sakai et al. 1995). In our study, urinary excretion of metabolites was ~ 33 % of 
flavanone intake before and after the 4 week exercise in females.    
It is well known that flavanone linked to a rhamnose moiety (hesperidin and narirutin) need 
to reach the colon for hydrolysis and cleavage into  aglycones and then be absorbed by 
passive diffusion through the epithelial cells into blood stream (Manach et al., 2004). In 
addition, absorption, metabolism and bioavailability depends on the solubility of flavonoids, 
the interaction with ingredients in diet, intestinal enzymes, transporters, and the metabolic 
activity of gut microbiota (Neilson and Ferruzzi, 2011, Rein et al., 2013). Thus, gut transit 
time might determine rate of flavanone metabolism by gut bacteria. In a previous study, 
mouth to cecum transit time increased in 9 subjects but decreased in 5 even though transit 
time was not significantly modified by physical activity or fitness (Bingham and Cummings, 
1989). In our study, 4 weeks of participation in moderate intensity exercise programme 
prolonged mouth to caecum transit time from 3.0 ± 0.2 h to 4.5 ± 0.7 h in healthy previously 
sedentary females. Prolonged transit time found in this study was matched with lower 
excretion of flavanones in urine over 0-5 h after orange juice intake following 4 weeks of 
moderate intensity exercise training (Before, 29.7 ± 2.9 µmol, After, 22.0 ± 2.9 µmol; p < 
0.05). Lower urinary excretion of hesperidin occurred over 0-5 h after the intake of orange 
juice ‘with bits’ in females. It could be that longer delivery of orange juice to the intestine 
tract after exercise training delayed degradation of flavanones by gut bacteria.  
In addition, longer residence of flavanone in the upper GI tract tended to reduce bio 
accessibility of hesperidin from orange juice reaching to the colon (data not shown), which 
probably also reduced urinary excretion of hesperidin metabolites over 5 h after orange juice 
intake in females after 4 weeks exercise programme.  
Data obtained in this study are different from Medina’s study shows fivefold urinary 
excretion of flavanone metabolites in athletes after consuming 200 ml of aronia – citrus juice, 
compared with sedentary volunteers who drunk 400 ml of the juice (Medina et al., 2012). The 
reason might be the one week diet (including plant based food) designed for athletes, but not 
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for non-trained volunteers. Gut bacteria influenced by diet (Vendrame et al., 2011, 
Roberfroid et al., 1995), might change bioavailability and metabolism of flavanone. In 
addition, exercising modifies physiological function, such as gastrointestinal hormones 
(O'connor et al., 1995), blood flow (Duncker and Bache, 2008, Flamm et al., 1990, 
Khazaeinia et al., 2000), in turn probably affected urinary excretion of flavanone metabolites.  
In addition, food sources affected metabolism of flavanone in the GI tract (chapter 3). 
Bioavailability of flavanones could be different, even though both of groups daily consumed 
similar amounts of flavanone. 
What is more, flavanone sulfates are resistant to hydrolysis by glucuronidase. As a result, 
hydrolysis of urine might cause inaccurate evaluation of flavanone metabolites in Medina’s 
study. However, it provided an insight that physical exercise tended to affect bioavailability 
of flavanone, perhaps due to physiological changes of the intestine and gut function (Lippi et 
al., 2008, Medina et al., 2012). 
In our study, 4 weeks intensive exercise reduced 0-5 h urinary excretion of hesperetin 
metabolites (21.6 ± 2.8 µmol vs. 14.0 ± 2.0 µm, p < 0.05), and 24 h urinary excretion of 
hesperetin -O- glucuronide (10.4 ± 2.9 µmol vs. 6.2±1.7 µm, p < 0.02), and 3-
hydroxyphenylacetic acid (11.8 ± 3.4 µmol vs. 6.0 ± 2.3 µmol, p < 0.05) in previously 
sedentary females after orange juice intake. Physico-chemical characteristics of flavonoid and 
their metabolites, hydroxyl groups of the A and B ring, their methylation and unsaturated 
bond, affinity to human serum albumin, their distribution to target tissues, and remaining in 
faeces influence their bioavailability in the host (Xiao and Kai, 2012, Bolli et al., 2010, 
Czank et al., 2013, Faria et al., 2013, Wang et al., 2013, Challa et al., 2013, Perez-Vizcaino et 
al., 2012, Gonzales et al., 2015). Whole bowel transit time was shortened in humans by 
chronic exercise (Koffler et al., 1992, Oettle, 1991).Thus, it is supposed that physical activity 
might influence distribution and elimination of flavanone metabolites in subjects, or  decrease 
time of cleavage by gut bacteria in the colon. 
On the other hand, the degradation of flavanones depends on cleavage activity of gut bacteria. 
Some species are responsible for demethylation, dihydroxylation, decarboxylation, C-ring 
fission of flavonoids (Aura, 2008, Selma et al., 2009). Ruminococcus, Eggertheilla, 
Bifidobacterium, Clostridium, Bacterioides, Eubacterium, Streptococcus and Lactobacillus 
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bacteria have been evidenced their capacities to degrade flavonoids (Clavel et al., 2005, 
Keppler and Humpf, 2005, Schneider et al., 1999, Blaut and Clavel, 2007, Kim et al., 1998).  
The composition and amount of gut microbiota are individually variable due to diet, life-
style, disease, and antibiotic use (Nicholson et al., 2012). In an animal study, the number 
of Lactobacillus, Bifidobacterium and B. coccoides–E. rectale group increased in rats 
subjected to a fixed 6 days exercise, in comparison with rats restricted to exercise (Queipo-
Ortuño et al., 2013). In addition, 6 weeks of exercise increased Bifidobacterium spp. in 
normal mice, but not diabetic mice (Lambert et al., 2015). As mentioned before, higher 
diversity of gut microbiota has been observed in rugby players compared with sedentary 
subjects (Clarke et al., 2014). In this study, the 24 h urinary excretion of hesperetin-O- 
glucuronide and 3-hydroxyphenylacetic acid reduced in females after the 4 week exercise, 
which also indicated that gut bacteria was probably affected by the intensive exercise. In 
addition, Clark and colleagues revealed a higher diversity of gut bacteria in athletes than in 
sedentary controls when  their diet was considered, Lactobacillaceae, Bacteroides and 
lactobacillus were similar between athlete and control (BMI < 25) (Clarke et al., 2014), 
which were confirmed their ability to hydrolyse flavonoids (Hawksworth et al., 1971, Kim et 
al., 1998). Thus, the production of metabolites over 24 h might be attributed to gut bacteria 
related to metabolism of flavanone that should be investigated in future. 
In conclusion, 4 weeks physical exercise modified the dynamics of flavanone metabolism in 
the sedentary females to some extent but had no impact on the 24 h bioavailability of 
flavanone and phenolic metabolites. The 4 weeks moderate intensity physical exercise 
prolonged MCTT so that delay metabolism of flavanone by gut bacteria to reduce 0-5 h 
urinary excretion of hesperidin and 0-10 h urinary excretion of naringenin after the 
consumption of  orange juice with bits. In this study, ~ 67 % of flavanone intake was not 
recovered in urine 24 h after consumption of orange juice ‘with bits’. It is worth investigating 
their pharmacokinetics in plasma and faecal samples to further reveal the effects of physical 
exercise on metabolism of flavanones. The composition of the gut microbiota should be 
further investigated to assess effects of physical exercise relevant to metabolism of flavanone.  
In addition, animal studies would be a good way to explore effects of physical exercise on 
tissue distribution of metabolites. Considering the complex profile of phenolic metabolites, it 
would be interesting to explore if modification of metabolites can be the mechanism which 
associates physical activity with benefits against chronic diseases and cancers.   
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Flavonoid metabolites as markers in plasma and/or urine are used to investigate the 
bioavailability of flavonoids and relate their intake to human health (Serra et al., 2012, Roura 
et al., 2007a, Perez-Jimenez et al., 2010, Day et al., 2001, Gao et al., 2006a, Grün et al., 2008, 
Keppler and Humpf, 2005, Mullen et al., 2008a, Jaganath et al., 2009). Flavonoids can be 
absorbed as the parent compound, conjugated metabolites or phenolic acids, which are 
produced in the large intestine. After consideration of the relevant literature, it was clear that 
food sources, food matrix, age, ethnicity and lifestyle (alcohol consumption, smoking, 
physical activity) (Figure 7-1) may have positive or negative effects on metabolism of dietary 
polyphenols and phenolic acids in the host. 
 
Figure 7-1 Factors affect metabolism of flavonoids in the host 
 
7.1 Research questions  
The research questions addressed in this thesis build on previously established evidence that 
bioavailability of dietary flavanones varied substantially ranging from 0.8 ~ 16 % in humans 
after consumption of orange juice (Pereira-Caro et al., 2014b, Brett et al., 2009, Bredsdorff et 
al., 2010, Erlund et al., 2001c, Silveira et al., 2014, Vallejo et al., 2010c, Tomas-Navarro et 
al., 2014, Manach et al., 2003), and how to enhance bioavailability of flavanone to enhance 
health in humans. On the other hand, inclusion of phenolic acids (ring fission products of 
flavanone) in the calculation to estimate bioavailability resulted in urinary excretion values 
ranging from 37 to 88 % after orange juice intake (Pereira-Caro et al., 2014a, Roowi et al., 
2009a). In the past, studies reported individually different bioavailability of flavonoids in 
humans (Alkhaldy et al., 2012b, Halm et al., 2007, Alkhaldy et al., 2012a). Thus, in this 
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thesis, we focused on other factors. One factor highly likely to affect the colonic bacterial 
metabolism of flavanones and production of phenolic acids is the presence of dietary fibre.  
Very little has been published on the impact of dietary fibre in this context although there is 
evidence that inclusion of fermentable carbohydrate in in vitro fermentations can alter the 
phenolic acids produced but the exact effect depended on the type of carbohydrate included. 
In previous studies, glucose enhanced rate of rutin disappearance in in vitro fermentation 
(Jaganath et al., 2009), but it did not affect metabolism of hesperidin (Hou et al., 2015). 
However, dietary fibre (pectin, raftiline and ispaghula) reduced phenolic acid production 
from rutin (Mansoorian et al., 2015). 
In addition, Mullen et al reported reduced urinary excretion of flavanone metabolites 0-5 h 
after orange juice consumption combined with intake full fat natural yoghurt (Mullen et al., 
2008a). The yoghurt also reduced urinary excretion of five phenolic acids including 3-
hydroxyphenylacetic acid, 3-hydroxyphenylhydracrylic acid, dihydroferulic acid, 3-methoxy-
4-hydroxyphenylhydracrylic acid and 3-hydroxyhippuric acid from 62 ± 18 μmol to 6.7 ± 1.8 
μmol (Roowi et al., 2009a).  However, mechanisms responsible for yoghurt affects 
bioavailability of flavanone in humans remain unclear.  
There is some evidence to suggest that the level of physical activity is also among host 
factors influencing bioavailability of flavanone metabolites. The study of Medina et al 
reported that urinary excretion of flavanone metabolites after consumption aronia juice intake 
was five times greater in triathletes than sedentary individuals (Medina et al. 2012). Indirect 
evidence suggests that increased bioavailability of polyphenols reported in trained athletes 
might be related to greater diversity in the gut bacteria of athletic individuals (Clark et al, 
2014). However, it should be noted that the cross sectional design of the Medina’s study did 
not allow control for rather large inter-individual variation in urinary excretion of flavanone 
metabolites and may provide misleading information. Thus, more and better designed studies 
are needed. Indeed, the expectation that enhanced participation in exercise should increase 
bioavailability might be misleading since several mechanisms operate and might interact with 
each other to influence of bioavailability under trained and sedentary conditions. For 
example, a study  using radio-opaque markers to measure  whole gut transit time reported that 
both cycling and running for one week significantly reduces total gut transit time  (how long 
it takes for the food to move from mouth to the end of intestine) (Oettle, 1991) and thus 
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indirectly suggests that exercise training can be expected to reduce rather than increase 
flavanone metabolite bioavailability.   
The aim of the research in this thesis therefore was to understand how bioavailability of 
flavanones is low and variable in humans, and increase awareness of these issues for 
designing future studies. This led to the following questions: 
 Does the food matrix (in this case fermentable fibre and yoghurt) affect the digestion 
and degradation of flavanones in the gastrointestinal tract? 
 How variable is the content of flavanones in different brands of orange juice and how 
is affected by the pulp content or fermentable carbohydrate? 
 Does yoghurt affect bioavailability of flavanones and if so what is the mechanism-, eg 
probiotic bacteria, and are the effects in the small intestine or in the colon by 
changing bacterial degradation? 
 Does participation in physical exercise affect the bioavailability and metabolism of 
orange juice flavanone in healthy sedentary humans? 
 
7.1.1 Does the food matrix affect digestion and degradation of 
flavanones in the gastrointestinal tract? 
The digestion and degradation of flavanone was investigated by using in vitro and in vivo 
models. The metabolites detected in urine in humans after ingesting orange juice enriched 
with pulp were, hesperetin-O-glucuronide (3 isomers), naringenin-O-glucuronide (2 isomers), 
naringenin-O-sulfate (2 isomers), hesperetin-O-diglucuronide, hesperetin-O-sulfate-O-
glucuronide, hesperetin-O-sulfate-O-glucoside, hesperetin-O-sulfate and naringenin-O-
diglucuronide. Urinary excretion of flavanones metabolites in this study was 9.4 % of 
flavanone intake. When this was compared with other published studies it was clear that there 
was a large variability in reported bioavailability ranging from 0.8 % to 16 % from different 
sources (Vallejo et al., 2010c, Mullen et al., 2008a, Manach et al., 2003, Bredsdorff et al., 
2010, Perez-Jimenez et al., 2010, Ameer et al., 1996). In these studies there was very little 
detail of the source or composition of the orange juice used. Silveira et al compared freshly-
squeezed and commercially processed orange juices and showed processed orange juice had 
lower bioavailability (4.1 % and 3.8 % of hesperidin intake, 3.8 % and 8.7 % of naringenin 
intake) (Silveira et al., 2014). However, the reasons for the large variability in bioavailability 
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in published studies have not been investigated. This was why in this thesis. I chose to study 
different factors that may affect the variability in gut metabolism of flavanones and phenolic 
acid production. 
I used a simulated GI tract model which mimicked the stomach, small intestine and large 
intestine of humans. This model is often used in studies of digestion (Pérez-Vicente et al., 
2002, McDougall et al., 2005, Sengul et al., 2014, Gil-Izquierdo et al., 2003, Gil-Izquierdo et 
al., 2001) and fermentation (Saura-Calixto et al., 2010, Serra et al., 2012) and was a good 
way to consider any factors which influenced the release of metabolites from foods and the 
colonic bacterial degradation of flavanones. In this thesis, in vitro model used gastrointestinal 
digestion and colonic fermentation with gut bacteria to reveal stability / release of flavanone 
in orange juice, degradation of flavanone and production of phenolic acids by gut bacteria, 
and effects of food matrix on these indexes.   
In our study of the metabolism and degradation by gut bacteria of orange juice flavanones 
from different sources (Chapter 3), we had thought that orange juice with bits may be 
affected by the presence of dietary fibre in the bits. However, the juices with and without bits 
had no difference in their fibre content and indeed not much difference in the flavanone 
content. In addition we thought that there might be non-extractable polyphenols that are 
linked to cell wall constituents (polysaccharides and protein) or can bind with food matrix by 
hydrophobic characteristics (Arranz et al., 2010, Hasni et al., 2011, Yuksel et al., 2010) in the 
‘ bits’ that were not detected by the usual analytical procedures (Perez-Jimenez et al., 2013). 
However, there were similar amounts of polyphenols in orange juice with bits after enzymatic 
hydrolysis with pectinase / cellulose or driselase compared with the extraction process by 
measuring total phenols. Hesperidin can be transformed to chalcones under GI physiological 
conditions and precipitated to interact with proteins, pectins, or other carbohydrates in orange 
juice (Gil-Izquierdo et al., 2001). In chapter 3, hesperidin was found to be more stable in 
smooth orange juice than orange juice ‘with bits’ in the upper GI tract, especially the gastric 
phase, while narirutin was similar in both juices. Thus, these ‘bits’ indeed affected passage of 
hesperidin to the colon for fermentation, but it was not due to dietary fibre which was not 
found in significant amounts in the juice. Higher concentrations of hesperidin and total 
flavanones (hesperidin, hesperetin, narirutin and naringenin) were found from orange juice 
with ‘bits’ after 2 h fermentation with gut bacteria than orange juice without bits. Significant 
higher phenolic acids were observed at 6 h of fermentation by gut bacteria from orange juice 
176 
 
 
 
with bits. In this study, the metabolism of flavanone was therefore increased, but not due to 
the fibre content in orange juice. This may be related to transformed chalcones degraded by 
gut bacteria in the models. 
Fermentable carbohydrates (dietary fibre) however in the food matrix may affect the bacterial 
metabolism of flavanones, such as hesperidin that is insoluble and abundant in orange juice, 
as they provide an energy source for the gut bacteria and may change the physico chemical 
properties of the colonic contents, eg by reducing pH. For instance, raftiline reduced phenolic 
acid production from rutin (Mansoorian et al., 2015).Thus, we studied the impact of raftiline 
as a soluble fibre which selectively stimulates the growth of lactic acid bacteria and is not 
viscous, on colonic bacterial metabolism of hesperidin and compared its effects to glucose 
which is fermented by most bacteria. In this study, raftiline also reduced production of 
phenolic acids by gut bacteria. In addition, the levels of aglycone remained higher during the 
fermentation. The gut microflora plays an essential role in the metabolism and bioavailability 
of flavonoids. They were deconjugated to release the aglycone and then produce metabolites 
such as phenolic acids (Selma et al., 2009). In several studies, dietary fibre has been shown to 
impact on intestinal microbiota composition, such as stimulated growth of Bifidobacterium 
and Lactobacillus, E. rectale, Roseburia intestinalis, and Anaerostipes caccae (Bouhnik et 
al., 1997, Holscher et al., 2015, Steer et al., 2003, Turner, 2008, Yang et al., 2013, Duncan et 
al., 2002, Hamaker and Tuncil, 2014). Bacteroides, Bifidobacteria, and Lactobacilli have the 
highest activity of the β-glucosidases and sulfatases responsible for glycoside hydrolysis and 
subsequent aglycone cleavage (Steer et al., 2003, Turner, 2008). In this study, raftiline 
significantly decreased production of phenolic acids from 220.3 ± 46.8 µM to 126.6 ± 44.1 
µM by the 24 h fermentation of hesperidin by gut bacteria (p < 0.05). However, glucose as 
energy source for most of bacteria fastedcleavage of hesperidin during fermentation, but did 
not affect the production of phenolic acids after 24 h of fermentation. Thus, dietary fibre 
should be considered as a factor to influence metabolism of flavanone in the colon. 
7.1.2 Does yoghurt affect flavanone release from orange juices in 
the gastrointestinal tract? 
Full fat natural yoghurt reduced urinary excretion of flavanone metabolites 0-5 hours after 
orange juice ingestion and 24 h urinary excretion of five phenolic acids in previous studies 
(Mullen et al., 2008a, Roowi et al., 2009b). In this thesis, the mechanism of yoghurt affecting 
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metabolism of flavanone in the GI tract was investigated by using GI digestion and 
fermentation models (Chapter 4). Our study was inconsistent with Roowi study that full fat 
natural yoghurt reduced urinary excretion of phenolic acids six fold in healthy subjects after 
consumption of orange juice. In our study, full fat natural yoghurt enhanced the recovery of 
hesperidin content in smooth orange juice and orange juice with bits during the upper GI 
digestion, but did not affect the concentration of hesperetin and naringenin derived from 
hesperidin and naringenin in orange juice with bits by gut bacteria, and phenolic acids 
production during the colonic fermentation. 
Yoghurt also contains lactic acid bacteria, Streptococcus thermophilus and Lactobacillus 
delbrueckii spp. Bulgaricus (Ng et al., 2011), as probiotic yoghurt for health properties. 
These bacteria might also impact metabolism of flavanone in orange juice when consumed 
with this type of yoghurt. At the same time, In a previous study, passion fruit or mixed berry 
improved survival of L. acidophilus LAFTI L10 during storage (Kailasapathy et al., 2008). In 
addition, fruits in yoghurt provide extra polyphenols to orange juice. Thus, fruit yoghurt 
might have different effects on release / stability of flavanone and production of phenolic 
acids during the upper GI digestion. In our study, the yoghurt significantly increased four 
phenolic acids in OJ during the upper GI digestion, but not in OJ bits. It indicated that types 
of yoghurt has different effects of phenolic acids, even  yoghurt provided Bifidobacterium 
spp and Lactobacillus acidophilus that might enhance production of phenolic acids derived 
from flavanones during the upper GI digestion. Moreover, full fat natural yoghurt increased 
phenolic acids in OJ bits. Variable yoghurt had different effects on phenolic acids during the 
digestion in vitro. Even though yoghurt starter culture bacteria could not survive in the acidic 
stomach condition, as shown by lack of growth on selective plates after the gastric phase in 
vitro model, but survival of probiotics and probiotics in the presence of polyphenols under 
the upper GI conditions has not been verified. Thus, survival of probiotics should be assessed 
so that potential effects of probiotics on metabolism of flavanone could be uncovered and 
reveal if these bacteria can play their role in the human colon and potential interaction 
between polyphenols and probiotics in the GI tract. Furthermore, the effect of yoghurt on 
absorption should be considered due to production of phenolic acids between in vivo and in 
vitro study. 
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7.1.3 Does physical exercise affect bioavailability and metabolism 
of orange juice flavanone in healthy sedentary humans? 
In a cross sectional study, it was found that 24 h urinary excretion of naringenin, eriodictyol, 
and hesperetin metabolites were 92 %, 88 %, and 53 % higher  in very well trained athletes 
than in sedentary individuals after ingestion of aronia-citrus juice (a mixture of citrus juice 
(95%) with 5% of A. melanocarpa juice containing 86.1 mg of flavanone per 400 ml)  
(Medina et al., 2012). Clark et al reported that there were 48 taxa significantly greater 
abundant in athletes than in high BMI (> 28) controls excluding Bacteroidetes, and 40 taxa 
excluding Lactobacillaceae, Bacteroides and Lactobacillus than low BMI (< 25) controls by 
measuring 16S rRNA of fresh stool samples (Clarke et al., 2014). Thus, the hypothesis in this 
thesis was that intensive physical activity affects flavanone bioavailability in sedentary 
humans. However, several previous studies focused on cross sectional populations with 
different lifestyles (active and sedentary), or animal models. Up to now, no study investigated 
effects of increased physical activity on bioavailability of flavanones, and phenolic 
metabolites in sedentary people. In our study, physical exercise involved a 4 week 
intervention in sedentary females, which would be better to provide information for general 
population and discover mechanism how physical activity affects bioavailability.  
It was found that participation in 4 week moderate intensity exercise programme reduced 
urinary excretion of one isomer of hesperetin-O-glucuronide and 3-hydroxyphenylacetic 
acids, even though there was no effects on total flavanone metabolites and phenolic acids 
over 24 h after orange juice intake in females. Even though the results were contrary with 
Medina’s study it should be noted that the current study allowed to control for large inter-
individual variation in urinary excretion of flavanone metabolites and had longitudinal design 
allowing to compare bioavailability before and after exercise training. Even though higher 
diversity of gut bacteria was found in athletes, Lactobacillaceae, Bacteroides and 
Lactobacillus were similar with low BMI (< 25) sedentary controls (Clarke et al., 2014). In 
our study, finding of negative effect of 4 weeks of exercise programme on 24 h urinary 
excretions after orange juice intake in previously sedentary females may indicated that gut 
bacteria responsible for metabolism of flavanone was affected by 4 weeks moderate intensity 
physical exercise.   
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The 4 week exercise programme significantly reduced 0-5 urinary excretion of hesperetin 
metabolites after consumption of orange juice, and prolonged the mouth to caecum transit 
time, In addition to studies that the shortened whole bowel transit time (time from mouth to 
the end of intestine) by chronic exercise (Koffler et al., 1992, Oettle, 1991), which implies 
that gut physiological function potentially affect metabolism and absorption of flavanone. 
In general, this study provides an insight that rate of flavanone metabolism tends to change 
directly by physical activity via intestinal physiological function. In relation to gut bacteria, 
extent of flavanone degradation was not observed. However, the pharmacokinetics of 
flavanone metabolites and phenolic metabolites and composition of gut bacteria have not 
been investigated in this thesis due to time constraints. Thus, we should be very cautious to 
conclude a limited effect of physical activity on the bioavailability of orange juice flavanone 
against Medina’s and Clark’s studies between well trained and sedentary populations.   
7.2 Relevance and applications of findings: 
This thesis provides information about some of the factors affecting metabolism and 
bioavailability of orange juice flavanone which may be linked to benefits of flavonoids and 
flavonoids enrich food in humans. These data may inform future research in epidemiological 
studies, experimental studies, and nutritional industries. 
7.2.1 Implication for epidemiological and clinical researches 
Many studies have demonstrated an association of polyphenols consumption with reduced 
risk of several chronic diseases and cancers. Diet, nutritional status, and lifestyle constitute 
comprehensive factors to act incidence of cancer and other chronic diseases (Edmands et al., 
2015). In this thesis, food sources, food matrix (yoghurts and dietary fibre), and physical 
activities affected metabolism of flavanones, which might influence protective property of 
dietary flavonoids. Health properties of dietary polyphenols in studies might be 
misunderstood without considering food source, interaction with food matrix, and physical 
exercise. In addition, the details of sources of orange juice, or other polyphenol enrich food 
and food matrix should be carefully considered. Thus, these factors might enhance accuracy 
of future studies. 
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On the other hand, some clinical studies used pure polyphenol and randomly chosen 
polyphenol enriched diets without consideration of the food sources and aspects of the food 
matrix which may affect the final amounts of bioactive metabolites that will reach the tissues. 
This may impact on the possibility for correctly assessing the role of flavanones in reducing 
disease risk and cause error. Based on this thesis, these factors should be noted in future 
studies. In addition, metabolites are more abundant than their mother compounds. The 
amounts and types of metabolites released in the gut and reaching the tissues should also be 
considered for their bioactivity and such consideration may strengthen the association 
between flavanone intake and reduced incidence of diseases and cancers. 
7.2.2 Implication for experimental and animal studies 
Epidemiological and human clinical studies are important to understand the benefits of both 
polyphenol and polyphenol-rich foods. However, due to their expensive cost and time 
consuming nature, cell-culture techniques and animal models have been widely conducted to 
investigate mechanisms of polyphenols lowering risk of chronic disease. However, these 
studies usually use pure polyphenols rather than their metabolites to evaluate biological 
properties. These pure compounds or mixtures will not reflect real physiological bioactivities 
through consumption of flavonoids or flavonoids contained diet. Metabolites more complex 
than single or few metabolites used in those in vitro studies, which might display synergistic 
and / or antagonistic effects of metabolites in the host.  
On the other hand, in animal studies, high doses of polyphenols are often fed with other 
foods, such as dietary fibre, to observe biological effects. Their interaction in metabolism 
might cause error in bioactivity of flavonoids in humans. In addition, both of humans and 
animals have some differences in metabolic processes, especially conjugation process 
(Manach et al., 2004). Composition of polyphenol intake regarding to metabolites level in 
blood and / or urine might be more useful and valuable to evaluate health effects by using 
animal models. Thus, this thesis might be able to provide some information for these studies 
to improve study design to obtain valuable achievements.  
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7.2.3 Implication for nutrition and food industry 
Polyphenols have been increasingly introduced in foods by the nutritional and food 
industries. In this thesis, it has been found that the bioavailability of polyphenols is 
influenced by food matrix, food matrix and lifestyles. In this thesis, the effects of food 
sources, food matrix and physical activities have been demonstrated in order to provide some 
information for nutrition and food industries to enhance polyphenols properties when they 
design new supplements or food products for consumers.     
In general, this thesis has important data to improve other relevant flavonoid research, and 
other bioactive food components. These efforts hopefully provide scientific foundation for 
researches on potential health effects of flavonoids, and put academia, industry and the public 
together to improve human health.  
7.3 Strengths and limitations  
Strengths of this thesis was that the in vitro GI metabolism model was conducted to 
investigate mechanisms of factors (food sources and food matrix) affecting bioavailability of 
orange juice flavanone, including various stability /release of flavanone from different orange 
juice sources during the upper GI digestion, effects of yoghurts and carbohydrates on colonic 
metabolism. The physical activity intervention study explored effects of physical activity on 
the bioavailability of flavanones in a sedentary population through modification of 
physiological functions and/or gut bacteria.  
Limitations and challenges in this PhD study included the stimulated GI models, recruitment 
of volunteers and other confounding factors, time limitations as followed. Firstly, it was very 
difficult to stimulate real physiological environment of GI tract by using in vitro model to 
reveal the bioavailability of flavanone in the gastrointestinal tract involving absorption. The 
limitation was that all types of yoghurt were not compared their effects on colonic 
metabolism by gut bacteria due to time limitation. In addition, intestinal absorption of 
flavanone in vitro was not involved by in vitro models in this thesis, which could reveal more 
information about effects of food sources and food matrix. Study recruitment took longer 
than expected as it was difficult to find females who were healthy Caucasian with sedentary 
lifestyle (less than 1h of physical activity), normotensive, non-smokers, and not taking any 
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medications, and were willing to change lifestyle for 4 weeks. In addition, many potential 
participants refused to participate in this study because of restricted intake of fruit, 
vegetables, dietary fibre, coffee, and tea for 3 days before and after the intervention. Some 
participants were not willing to change their lifestyle, because they did not want to spend 4 
weeks on moderate intensity exercise. In addition, it was difficult for participants to stay in 
the metabolic room for 8 h to wait for sample collection during trial days.  
Finally, survival of probiotics in probiotic yoghurt was not measured, even though it had a 
similar effect with full fat natural yoghurt on stability / release of flavanone during the upper 
GI digestion, where yoghurt starter culture bacteria could not be resistant to the gastric 
digestion. In addition, measurements of flavanone metabolites in control group and flavanone 
metabolites and phenolic metabolites in plasma and faeces were limited due to deadline of 
thesis submission, which potentially illustrate overall flavonoid metabolism in the host to 
reveal more details for academic, industrial and individual recommendation. In general, based 
on results in this thesis, the effects of food sources, food matrix and lifestyle should be 
considered as preliminary data to build up a bridge between polyphenols and their health 
effects in humans in future works.  
7.4 Future work 
Although this thesis investigated effects of food sources and food matrix on metabolism of 
orange juice flavanones, absorption was not assessed in this thesis. Absorption of flavonoids 
is linked to bioactivity of dietary flavonoids in the host (Gonzales et al., 2015). Thus, it is 
necessary to investigate if these factors influence absorption of flavonoids and phenolic acids. 
In this thesis, food sources, food matrix and physical activity affected metabolism of orange 
juice flavanone (flavanone and phenolic acids). In addition, bioactive concentration of 
metabolites in tissues should be established. If it can be built up, the effects of food sources, 
food matrix and physical activity on health will be confirmed so that these factors must be 
considered and provided in future epidemiological, experimental and clinical studies. 
Although physical exercise was shown to affect urinary excretion of flavanone metabolites 
and phenolic acids, pharmacokinetic and faecal data have not investigated yet. These results 
will provide more details about the effects of physical exercise related on dietary flavonoids. 
The composition of gut bacteria should be estimated in order to explore if physical exercise 
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can modify gut bacteria relevant to metabolism of dietary flavanones. Thus, the following 
further research might help to provide more information: 
 In vitro studies: 
1. To stimulate absorption of hesperetin, naringenin and phenolic acids through 
the intestinal  epithelium cells by using cell lines,  such as Caco 2,  to 
investigate  if absorption is synchronous with dynamic metabolism of orange 
juice flavanone so that influence concentration of metabolites in the host 
2. To investigate bioactivity of flavanone and phenolic acids in a range of 
physiological concentrations by using cellular techniques.  
3. To test survival of probiotics in probiotic yoghurt and polyphenol containing 
yogurt during the gastric digestion 
 Intervention studies: 
1. Metabolites in plasma and faeces could be measured  to investigate 
pharmacokinetics of metabolites and metabolite profiles, and distribution of 
metabolites in the host  
2. Biomarkers (oxidative stress, glucose, insulin, CRP) could be measured to 
investigate effects of orange juice flavanone in humans induced by physical 
exercise 
3. Gut bacteria could be  identified and quantified to reveal if physical exercise 
can link to metabolism and bioavailability of flavanone through gut bacteria 
7.5 Conclusion 
Food sources and food matrix (yoghurt and carbohydrates) affected stability / release of 
flavanone during the upper GI digestion, and cleavage of flavanone and production of 
phenolic acids in the colon.  Physical exercise affected MCTT so there was a shorter time 
period of flavanone metabolism after consumption of orange juice. Phenolic acids accounted 
for the majority of metabolites. Based on these results, metabolism of orange juice flavanone 
could be modified to some extent, so that more details about tested food (orange juice, other 
flavonoid-rich food), food matrix (yoghurts and fibre) and exercise levels of participants, as 
well as some unknown factors (diet habits, physical conditions) should be provided to 
enhance outcomes in current and future flavonoid relevant studies. On the other hand, in the 
past, there were a number of studies revealing bioactive properties of conjugated flavonoid 
aglycones (Trzeciakiewicz et al., 2009, Suri et al., 2010, Dueñas et al., 2011, Yamazaki et al., 
2014) , and phenolic acids (Kampa et al., 2004, Amin et al., 2015, Henning et al., 2013, Kim 
et al., 1998). However, these compounds are conjugated as sulphated, glucuronided and 
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methylated metabolites present in circulatory system (Pimpao et al., 2015, Heleno et al., 
2015), which have been very little studied (Gesso et al., 2015). Thus, there is a need to 
consider factors above to assess bioactivity and beneficial effects of dietary flavonoids in in 
vivo studies, and take attention to physiological concentrations induced by factors in in vitro 
studies.  
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Appendices 
Appendix-1 
Labelled ingredients of orange juice in bottles 
  
Energy 
(KJ/Kcal) 
Fat(g) saturates(g) Carbohydrates(g) sugars (g) 
Fibre 
(g) 
Protein(g) Salt(g) Vitamin C 
Tropicana 
OJ 201/48 0 0 10 10 0.8 0.8 0 33 
OJ bits 204/48 0 0 10 10 0.7 0.8 0 32 
Tesco 
OJ 186/44 <0.1 <0.1 10.1 7.8 <0.1 0.8 <0.01 30 
OJ bits 186 <0.1 <0.1 10.1 8.1 <0.1 0.8 <0.01 30 
Innocent 
OJ 180/42 0.1 0 9.4 8.1 0.6 0.7 0.01 21 
OJ bits 185/44 0.1 0 9.7 8.2 0.6 0.7 0.01 25 
Morrison’s 
OJ 163/38 0.1 0 8.7 8.1 0.2 0.6 0 24 
OJ bits 164/39 0.1 0 8.8 8.3 0.2 0.5 0 24 
Waitrose 
OJ 181/43 0.1 -- 9.5 9.3 0.5 0.7 0 46 
OJ bits 159/37 0.2 -- 8.4 6.7 0.3 0.5 0.04 46 
Sainsbury’s 
OJ 226/53 <0.5 <0.1 11.4 9.2 <0.5 0.7 0.03 40 
OJ bits 226/53 <0.5 <0.1 11.4 9.2 <0.5 0.7 0.03 40 
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Appendix-2 
 
 
Title of study  
 
In vitro catabolism of Orange juice, hesperidin and narirutin by human faecal bacteria 
 
Invitation to take part 
Thank you for reading this. 
You are being invited to take part in a research study.  Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you wish.  Please ask 
us if there is anything that is not clear or if you would like more information.  Take time to 
decide whether or not you wish to take part 
 
What is the purpose of the study? 
In previous study, the bioavailability of flavanones in orange juice, especially hesperidin and 
narirutin, was investigated in humans. Therefore this study will help to monitor the 
degradation products of dietary flavonoids and food matrix effects and to delineate the 
possible catabolic pathways involved in the degradation of flavonoids. 
 
Why have I been chosen? 
You are: 
i) a healthy individual, aged 18-60, not obese, non-smoker, in good general health, 
not taking any supplement or medication 
ii) you do not suffer from any allergy or condition affecting bowel health 
 
Do I have to take part? 
If you do decide to take part you will be given this information sheet to keep and will be 
asked to sign a consent form.  If you decide to take part you are still free to withdraw at any 
PARTICIPANT INFORMATION SHEET 
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time and without giving a reason.  A decision to withdraw at any time, or a decision not to 
take part, will not affect the standard of care you receive. 
 
What will happen to me if I take part? 
You will meet a member of the Research Team from the University of Glasgow who will 
explain the study at a convenient time.  All transport costs as well as costs associated to the 
study will be reimbursed, but we cannot offer any fees.  
 
What do I have to do? 
You will be invited to follow low polyphenol diet for two days (48 h).  Diet sheets will be 
provided, and you will also be given a telephone number, to be able to call a member of the 
Research Team with any queries.  You will be asked to tell us if you think you may have 
slipped up with any of the dietary advice.  
 
Example of a typical intervention 
Day 1    8 am    Start of the low phenolic diet (see examples) 
 
Day 2   8 am  (24 hr)      Low phenolic diet 
 
Day 3   8 am (48h)  Return in the morning with faeces sample 
 
 
The diet involves foods with low polyphenol content, such as meats, fish, pasta, bread (but 
avoiding tea, coffee, colourful fruits and vegetables). During this period, you will be asked to 
keep a dietary intake record. 
You will be asked to record any possible slip-ups (e.g. eating high polyphenol foods by 
mistake during the low-polyphenol diet).  It is very easy to make mistakes, but vital that we 
know in order to get reliable results.   
At the end of the diet (after 48 h of low polyphenol diet) a faecal sample will be collected. 
The faecal sample should be collected in a special pot provided together with anaerobic 
pouch to keep the sample in anaerobic condition and send on the morning of day 3. 
 
What are the possible disadvantages and risks of taking part? 
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There are no risks or disadvantages associated with this study other than time loss and 
inconvenience of following dietary restrictions. 
 
What are the possible benefits of taking part? 
There are no direct benefits to the volunteers associated with taking part. This study will 
provide us with a better understanding of the association between polyphenol-rich food 
consumption and colonic health. All participants who completed the study will be 
compensated. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential.  Any information about you which leaves the hospital/university will 
have your name and address removed so that you cannot be recognised from it. 
 
What will happen to the results of the research study? 
Results will be presented at meetings of learned societies and published in scientific journals. 
Results will also be included in student project reports, when applicable. We will arrange a 
meeting to discuss the results with participant volunteers if they would like that. 
 
Who is organising and funding the research? 
This project is being organised by the Plant Product and Human Nutrition Group, at the 
University of Glasgow.   
 
 
Who has reviewed the study? 
This project has been reviewed by the University of Glasgow, Faculty of Medicine, Ethics 
Committee. 
 
Contact for further information 
If you require further information please contact  
 
Thank you for reading this information sheet 
Study Number: 
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Appendix -3 
DIETARY GUIDELINES FOR LOW POLYPHENOL DIET 2014 
Baseline diet: 
Avoid all fruits, vegetables, onions, coffee, tea, chocolate, fruit juices, soft drink (i.e. irn 
bru, coca cola), alcohol, vanilla and similar flavourings, wholemeal products, spices (i.e. 
curry), tomato sauce, and beans (i.e. lentils, green beans, peas). Avoid all dietary 
supplements (vitamins, mineral, and herbal products) and fibre rich products (oats, wheat, 
bran, fibre cereal, wholemeal bread or biscuits). Vegetable oil avoids olive oil, Honey. 
Examples of suitable breakfast include: 
Eggs 
Cheeses  
Sausage  
Bacon 
Fish  
White Toast 
White Bread  
Croissant (NO chocolate, no almonds) 
Waffles, pancakes with butter and sugar (NO jam, no chocolate, no fruits) 
Butter 
Milk 
Rice based cereals (NOT Coco pops)  
Examples of suitable lunch & dinners include: 
Tuna, chicken and egg sandwiches (mayonnaise ok) 
Burger and chips (NO ketchup, relish, gherkins) 
Sausage rolls 
White pasta and cheese / cream  
Chicken / sausages and mashed potatoes (NO gravy) 
Omelette (with cheese, ham) 
Potatoes without skin 
Meats (NO ketchup, brown sauce) 
Cheese and cream cheese (NO garlic or onion-based cheeses) 
Fish and chips with salt (NO ketchup) 
Chicken fried rice with eggs (NO soya products or vegetables) 
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Roast Chicken/ prawns with white rice 
Chicken nuggets and chips 
Roast Beef Sandwich with crisps 
Salmon with white rice 
Steak and chips (No tomato sauce) 
Examples of suitable snacks include: 
Biscuits (NOT wholemeal, chocolate, or fruit containing) 
Shortbreads 
Custard rice puddings 
Crisps (ready salted) 
Cheese and crackers 
Plain donut without chocolate or fruit fillings 
Salted rice crackers 
Rice cakes  
Examples of suitable drinks include: Water and milk 
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Appendix -4 
 
DIETARY INTAKE RECORD 
During the day which you have to follow the diet described previously, we are going to ask 
you to record what you have been eaten at every meals. 
By asking you to record your daily diet (quantities do not have to be written down), this may 
be easier for you to choose and plan what you can eat, and this may also help you 
remembering that you are on a `special diet’. Please write down and food/drink consumed 
DAY -- Date:_____________ 
Breakfast: 
......................................................................................................................................................
......................................................................................................................................................
......................................................................................................................................................
......................................................................................................................................................
...................................................................................................................................................... 
 
Lunch: 
......................................................................................................................................................
......................................................................................................................................................
......................................................................................................................................................
...................................................................................................................................................... 
 
Dinner: 
......................................................................................................................................................
......................................................................................................................................................
......................................................................................................................................................
................. 
 
All-day snacks: 
......................................................................................................................................................
......................................................................................................................................................
...................................................................................................................................................... 
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Apendix-5 
 
PARTICIPANT INFORMATION SHEET 
Impact of Exercise Training on Bioavailability of Flavanones from Orange Juice 
You are being invited to take part in a research study. Before you decide whether or not to 
take part, it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully. If you feel that 
something is not entirely clear or if you would like more information, do not hesitate to 
contact us. Take time to decide whether or not you wish to take part. Thank you for reading 
this. 
What is the purpose of the study? 
Flavonoids are compounds that may have a beneficial effect on health, such as reducing the 
risk of developing cardiovascular disease and, in some cases, cancer. Orange juice has high 
flavonoid content. However, the absorption of flavanones into the body is limited. This study 
will investigate whether participation in physically active improves the absorption of 
flavanones into the body. 
Why have you been chosen? 
You have been chosen because you are 18-45 years old male or female and have been 
sedentary for at least 6 weeks. You also meet the following criteria: non-smoker, not taking 
any drug therapy, no gastrointestinal disease, non-vegetarian, non-pregnant.  
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part, you will be 
given this information sheet to keep and you will be asked to sign a consent form. If you 
decide to take part, you are still free to withdraw at any time and without giving a reason. A 
decision to withdraw at any time, or a decision not to take part, will not affect the standard of 
care you receive. 
What will happen once I decide to take part? 
Screening Procedures 
In order for us to determine whether you fall into the group of people we wish to study, you 
will be asked to attend a screening visit in which you will complete a Health Screening and 
Physical Readiness Questionnaires. We will also measure your height and weight and 
calculate body mass index. 
Experimental Tests 
You will be randomized to one of two groups. We will ask you to undertake 2 experimental 
tests: one before the intervention and the other after 4 weeks training intervention. On the day 
of each experimental test you will be asked to come to the metabolic investigation room 
between 8 and 9 am. We will place a tiny plastic tube called a ‘cannula’ into a vein in your 
forearm, from which we will take blood samples. This is no more painful than a simple blood 
test. Following this, you will be asked to consume 1000 mg of paracetamol (standard dose) with 100 
ml of water. Then you will be asked to consume 500 ml of freshly squeezed orange juice. 
Further blood samples will be obtained at 1, 2, 3, 4, 5, 6, 7, 8 hours after the juice intake. A 
total of 90 ml of blood will be taken over the course of the day. Expiratory breath hydrogen 
levels will be monitored every 30 minutes for 8 hours after the orange juice intake. At 4 hours after 
juice consumption you will be provided with a white roll with butter and some cheese and at 
the end of the experimental test with a polyphenol-free dinner. You will be allowed to leave 
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after dinner and instructed to avoid polyphenol containing foods during the rest of the day 
and record all food and drink consumed. We will ask you to come back to the metabolic 
investigation room in the fasted state next morning for the last blood sampling. Then you will 
be provided with breakfast. Prior to the experimental test you will be asked to collect 24 hour 
urine in two fractions (day fraction and overnight fraction). You will be also asked to collect 
urine for 24 h after the juice ingestion, in different fractions: 0–2, 2–5, 5-8, 8-10, 10–20, 20-
24 h.  
Interventions 
Exercise training will involve  endurance type exercise (cycling , running or combination of 
both) for 30 minutes in week 1,  40 minutes in week 2, 50 minutes in week 3 and 60 minutes 
in week 4.  The work load of cycling and running speed will correspond to the work load 
achieved at 70-80% of the predicted maximal heart rate. All training sessions will take place 
at Exercise and Energy Balance Laboratory (New Lister Building, the Royal Infirmary and be 
supervised by a researcher. The time and day of each training session will be agreed between 
the investigator and the participant and will be based around the participant’s availability. 
Participants of the Control group will be asked to carry on with their habitual life style for 4 
weeks. Following this they will be given access to exercise laboratory for physical training.   
Other than specific tasks described above, for 2 days prior each experimental test you will be 
asked to follow a polyphenol-free diet. A list with polyphenol-free food is provided bellow. 
We will ask you to record your food intake throughout these 2 days before the first 
experimental test and replicate this food intake prior the second one. List of the foods that 
should not be eaten and foods that you may eat during the polyphenol free diet will be 
provided. Prior to the experimental tests you will be asked to collect 24 hour urine. We will 
also ask you to collect a stool sample before and during one of the very last days of the 
intervention.  
Will I be rewarded for taking part in this study? 
After the completion of the study, the participants of the exercise group will be offered a 
financial remuneration of either £80 (participants of exercise group) or £40 (participants of 
the control group). 
What are possible disadvantages and risks of taking part?  
Blood sampling via cannula may cause minor bruising (a small accumulation of blood under 
the skin). Some people may feel faint when they give blood. Training intervention is not 
expected to cause any health related issues.  
What if something goes wrong? 
The chance of something going wrong is extremely small. In the unlikely event that you are 
harmed due to someone’s negligence, then you may have grounds for legal action. If you 
wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated during the course of the study, the University of Glasgow complaints 
mechanism may be available to you. 
Will my taking part in this study be kept confidential? 
Any information which is collected about you during the course of the research will be kept 
strictly confidential. You will be identified by an ID number. Furthermore, findings from the 
study that are published will contain only the results. We will not pass on confidential 
personal information to others. 
Who has reviewed the study? 
This study has been reviewed and approved by the College of Medical, Veterinary and Life 
Sciences Ethics Committee for Non Clinical Research Involving Human Subjects. 
Contact for Further Information 
Any questions about the procedures used in this study are encouraged. If you have any doubts 
or questions, please ask for further explanations by contacting 
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Min Hou: 
E-mail: min-hou710@hotamil.com; m.hou.1@research.gla.ac.uk; Contact phone number: 
07565398155 
Dr Dalia Malkova:  
E-mail: Dalia.Malkova@glasgow.ac.uk; Contact phone number: 0141 2010648 
You will be given a copy of this information sheet and a signed consent form to keep for 
your records. 
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Appendix-7 
FOOD INVENTORY INSTRUCTIONS 
It is important that you weigh and record everything that you eat and drink for the two days 
prior to each oral fat tolerance test (OFTT).  Please do not take any alcohol on these days.  
Your last food and drink should be taken 12 hours before your OFTT appointment.   
Please (i) start a separate page for each day. 
 (ii) start a separate line for each item. 
Column 1 
Record meal and time and place of eating. 
Column 2 
Describe each item as accurately as possible, stating where relevant: 
 (i) type and brand 
 (ii) whether food is fresh, dried, canned, frozen, salted, smoked, etc. 
 (iii) whether food is cooked, if so give method of cooking e.g. fried, baked, etc. 
Column 3 
Record the weight of each item after cooking: 
 (i) place scales on a level surface 
 (ii) place plate or container on top of scales 
 (iii) press ‘ON/Reset’ button to turn on scales 
 (iv) once zero appears, add first item of food 
 (v) record weight displayed 
 (vi) press reset button before weighing next item 
Wherever possible, record weights in grams.  If this is not possible, record weights in 
household measures (e.g. sugar or jam in teaspoons, stating whether level, rounded, or 
heaped). 
Column 4 
Record the weight of any leftovers, such as food remaining on plate, weight of container in 
which food has been weighed, apple cores, etc. 
Columns 5 and 6 
Please leave blank. 
If food consists of several items, please list each on a separate line i.e. instead of writing ‘one 
cheese sandwich’, record separately the weights of bread margarine, cheese, etc. 
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Please remember to record all drinks, as well as food, giving weights where possible, or 
volumes if these are known.  Record separately the weights of added milk and sugar. 
An example is shown overleaf. 
  
Food Inventory 
Name___________________________________           Date ____________________ 
1. 2. 3. Weight of 4. Weight 
of 
Leav
e 
Time/Place Description of 
food/drink 
food/drink container/ Blan
k   (g) leftovers 
(g) 
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Appendix-8 
DIETARY GUIDELINES FOR LOW POLYPHENOL DIET 2014 
Baseline diet: 
Avoid all fruits, vegetables, onions, coffee, tea, chocolate, fruit juices, soft drink (i.e. irn 
bru, coca cola), alcohol, vanilla and similar flavourings, wholemeal products, spices (i.e. 
curry), tomato sauce, and beans (i.e. lentils, green beans, peas). Avoid all dietary 
supplements (vitamins, mineral, and herbal products) and fibre rich products (oats, wheat, 
bran, fibre cereal, wholemeal bread or biscuits). Vegetable oil avoids olive oil. Honey. 
Examples of suitable breakfast include: 
Eggs 
Cheeses  
Sausage  
Bacon 
Fish  
White Toast 
White Bread  
Croissant (NO chocolate, no almonds) 
Waffles, pancakes with butter and sugar (NO jam, no chocolate, no fruits) 
Butter Milk 
Rice based cereals (NOT Coco pops)  
Examples of suitable lunch & dinners include: 
Tuna, chicken and egg sandwiches (mayonnaise ok) 
Burger and chips (NO ketchup, relish, gherkins) 
Sausage rolls 
White pasta and cheese / cream  
Chicken / sausages and mashed potatoes (NO gravy) 
Omelette (with cheese, ham) 
Potatoes without skin 
Meats (NO ketchup, brown sauce) 
Cheese and cream cheese (NO garlic or onion-based cheeses) 
Fish and chips with salt (NO ketchup) 
Chicken fried rice with eggs (NO soya products or vegetables) 
Roast Chicken/ prawns with white rice 
Chicken nuggets and chips 
Roast Beef Sandwich with crisps 
Salmon with white rice 
Steak and chips (No tomato sauce) 
Examples of suitable snacks include: 
Biscuits (NOT wholemeal, chocolate, or fruit containing) 
Shortbreads 
Custard rice puddings 
Crisps (ready salted) 
Cheese and crackers 
Plain donut without chocolate or fruit fillings 
Salted rice crackers 
Rice cakes  
Examples of suitable drinks include: Water and milk 
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Appendix- 9 
RATING OF PERCEIVED EXERTION-RPE 
6  
7 Very, very light 
8  
9 Very light 
10  
11 Fairly light 
12  
13 Somewhat hard 
14  
15 Hard 
16  
17 Very hard 
18  
19 Very, very  hard 
20  
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Appendix-10 
 
HEALTH SCREEN FOR STUDY VOLUNTEERS 
 
Name: ………………………………………………………. 
 
It is important that volunteers participating in research studies are currently in good health and have 
had no significant medical problems in the past.  This is to ensure (i) their own continuing well-being 
and (ii) to avoid the possibility of individual health issues confounding study outcomes. 
 
Please complete this brief questionnaire to confirm fitness to participate: 
 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise  yes [ ] no [ ] 
(b) attending your general practitioner    yes [ ] no [ ] 
(c) on a hospital waiting list    yes [ ] no [ ] 
2. In the past two years, have you had any illness which required you to: 
(a) consult your GP      yes [ ] no [ ] 
(b) attend a hospital outpatient department   yes [ ] no [ ] 
(c) be admitted to hospital      yes [ ] no [ ] 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy    yes [ ] no [ ] 
(b) Asthma      yes [ ] no [ ] 
(c)  Eczema      yes [ ] no [ ] 
(d)  Diabetes        yes [ ] no [ ] 
(e) A blood disorder     yes [ ] no [ ] 
(f) Head injury     yes [ ] no [ ] 
(g)  Digestive problems     yes [ ] no [ ] 
(h) Hearing problems     yes [ ] no [ ] 
(i) Problems with bones or joints   yes [ ] no [ ] 
(j) Disturbance of balance/co-ordination  yes [ ] no [ ] 
(k) Numbness in hands or feet    yes [ ] no [ ] 
(l) Disturbance of vision    yes [ ] no [ ] 
(m) Thyroid problems     yes [ ] no [ ] 
(n) Kidney or liver problems    yes [ ] no [ ] 
(o) Chest pain or heart problems   yes [ ] no [ ] 
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(p) Any other health problems    yes [ ] no [ ] 
 
4. For female volunteers only 
(a) Are you pregnant or think that you might be pregnant  yes [ ] no [ ] 
(b) Do you take the contraceptive pill or other hormone-based contraceptivesyes [ ] no [  
(c)  Are you postmenopausal      yes [ ] no [ ] 
(d)  Are you receiving Hormone Replacement Therapy (HRT)  yes [ ] no [ ] 
5.  Have any of your immediate family ever had any of the following: (if yes please give details 
including age of first diagnosis) 
(a) Any heart problems    yes [ ] no [ ] 
(b) Diabetes      yes [ ] no [ ] 
(c)  Stroke      yes [ ] no [ ] 
(d)  Any other family illnesses    yes [ ] no [ ] 
 
6. Do you currently smoke    yes [ ] no [ ] 
 Have you ever smoked    yes [ ] no [ ] 
  
 If so, for how long did you smoke and when did you stop? …………………… 
 
5. How many units of alcohol do you typically drink in a week? …………………. 
 
If YES to any question, please describe briefly if you wish (e.g. to confirm whether problem was 
short-lived, insignificant or well controlled.) (Use a separate sheet if necessary) 
……………………………………………………………………………………………………………
……… 
……………………………………………………………………………………………………………
……….….………………………………………………………………………………………………
……………………………………………………………………………………………………………
………………………..…………………………………………………………………………………
…………………………………….……………………………………………………………………
………………………………………………. 
 
Name and address of GP 
………………………………………………………………………………… 
…………………………………………………………………………………  
 
Blood pressure measured at screening…………………..mm Hg  
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Appendix-11 
 
Physical activity questionnaire 
 
